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ABSTRACT
The present studies describe, as a primary goal, our recent progess toward the
synthesis of morphine alkaloids from aromatic precursors. Model substrates were
synthesized which allowed investigation into Diels-Alder, radical cascade, and
palladium-catalyzed bond-forming reactions as possible routes to the morphine alkaloid
skeleton. As a secondary objective, three separate series of aromatic substrates were
subjected to whole-cell oxidation with Escherichia coli JM 109 (pDTG601), a
recombinant organism over-expressing the enzyme toluene dioxygenase. Included in
this study were bromothioanisoles, dibromobenzenes, and cyclopropylbenzene
derivatives. The products of oxidation were characterized by chemical conversion to
known intermediates. The synthetic utility of one of these bacterial metabolites, derived
from oxidation of o-dibromobenezene, was demonstrated by chemical conversion to (-)-
conduritol E.
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I. Introduction
The formation of chemical bonds with complete regio- and stereochemical control is
becoming a paradigm in organic synthesis. Enzymes, nature's chemical catalysts, are
recognized for their ability to perform chemical transformations with extraordinarily high
levels of stereo- and chemoselectivity. Several enzymatic reactions are amenable to
scalable synthetic applications, including Baeyer-Villiger Monooxygenases (used in the
synthesis of chiral lactones), fungal enzymes (known to hydroxylate a wide variety of
substrates), dioxygenase enzymes (which install two oxygen atoms into their substrate),
and lipases, which may be utilized either as a highly-selective acylation catalyst, or most
often, in resolution of alcohols by intermediacy of their ester precursors. With increased
restrictions on waste generation, industrial chemists continue to seek out more
environmentally benign methods of chemical transformation. As most enzymatic
reactions require aqueous conditions, the problem of organic waste disposal is reduced
for such reactions.
Oxidations of aromatic compounds by prokaryotic organisms represent an
important class of enzymatic reactions.The research in the Hudlicky group is directed at
the synthesis of natural products and their derivatives using starting materials which are
generated by enzymatic transformations. In 1968, Professor David Gibson (University of
Iowa) reported the isolation of Pseudomonas putida, a soil bacterium which utilized
ethylbenzene or toluene as its sole source of carbon and energy.1 Gibson's research into
the catabolic pathways of this organism led to his isolation of a mutant strain,
Pseudomonas putida F1, which converted arenes to their homochiral cyclohexadiene-cis-
1,2-diols. In 1989, Gibson reported ,the construction of a genetically engineered
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Escherichia coli organism which provided synthetically useful amounts of the
metabolites from fermentation.2 Since the time of Gibsons's 1968 publication, over 300
dienediol metabolites have been reported. The homochiral diol metabolites isolated
from whole-cell fermentation of halobenzenes with Escherichia coli JM 109 (pDTG601)
have been employed in a variety of enantioselective syntheses. We are engaged in a
program directed at the isolation of new metabolites with emphasis on their application in
the enantioselective synthesis of complex target molecules. New directions in this area
include studies on the oxidation of aromatic sulfur-containing compounds and aromatic
compounds bearing an asymmetric center proximal to the site of oxidation.
In addition to the provision of more elaborate compounds for synthetic utility, the
present study provides a more complete picture of the mechanism of oxidation, which has
yet to be elucidated. It has been known for some time that the enzyme toluene
dioxygenase is highly promiscuous, that is, it exhibits a 19W specificity for its natural
substrate, toluene. Promiscuous enzymes are of some import to the synthetic community
because such enzymes often have the ability to accept and transform hundreds of
different compounds with a variety of functional content and substitution.
A significant part of the present study is devoted to the isolation and
characterization of new enzymatic metabolites. In particular, we consider the oxidation
of a series of bromo-thioanisoles, Figure 1. It will be shown that (1) the enzyme toluene
dioxygenase is capable of carrying out selective oxidations of halo-thioanisoles at sulfur,
yielding in many cases (R)-sulfoxides, and (2) the outcome of oxidation is (sulfur
oxidation vs. ring oxidation) is highly influenced by the substitution patterns on the ring.
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Figure 1. Oxidation of thioanisoles to give dienediols or chiral sulfoxides.
Previously, the dienediol derived .from m-dibromobenzene had been employed in
the synthesis of narciclasine by Hudlicky and co-workers.3 Although very few m-
substituted aromatics are known to be good substrates for the enzyme toluene
dioxygenase, this particular metabolite is an exception because of its inherent plane of
symmetry. The results of whole-cell fermentations with the remaining members of this
series of dibromobenzenes, the meta- and ortho-isomers, will be presented and discussed
with regard to their symmetries. The potential for broad application of these metabolites
to the synthesis of cyclitols will be presented.
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Figure 2. Projected synthesis of cyclitols from o-dibromobenzene.
The metabolites from fermentation, such as ·5 may be converted to cyclitols or
aminocyclitols through epoxidation or aziridination reactions, respectively. The selective
opening of either epoxidesor aziridines allows for a programmed approach to the
synthesis of cyclitols, aminocyclitols, or their unnatural derivatives. A general study of
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the application of silica gel as a mild catalyst for the opening of vinyl aziridine and vinyl
epoxides is presented.
One question that has yet to be completely answered is whether the enzyme is
capable of resolving racemic centers proximal to the site of oxidation, and if so, what
structural requirements must these substrates exhibit in order to effect chiral resolution.
We will study the outcomes of such oxidation reactions by preparing several racemic
aromatic cyclopropanes, which will be subjected to enzymatic oxidation as shown in
Figure 3.
R2
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Figure 3.
The outcome of these substrate specificity studies will strengthen Boyd's4 hypothesis
that it is the larger substituent on the aromatic ring which influences the outcome of
oxidation on the ring.
Our interest in aromatic and sulfur oxidations combined with our long-standing
involvement in morphine synthesis allows the implementation of a thiophene-oxide/
Diels-Alder strategy toward thebaine. The key step in this new approach would rely on a
tandem thiophene oxidation followed by trapping of the thiophene oxide with an
intramolecular olefin tether. The approach is based on several reports of thiophene
derivatives undergoing enzymatic or chemical oxidations at sulfur. The oxidation, which
destroys aromaticity in the heteraromatic nucleus, unmasks a reactive latent diene in the
4
form of the heterocycle. The results of our efforts in this approach are presented in
Chapter 111-6.8.
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Figure 4. Retrosynthetic analysis of thebaine synthesis.
Finally, several chemoenzymatic approaches to the synthesis of morphine will be
presented. The Heck reaction, used in Overman's,5 Trost's,6 and Hudlicky's7 morphinan
synthesis to establish the C-13 quaternary center, was re-visited in a series of model
substrates-all of which were derived from fermentation. A second approach, which also
features palladium catalysis, would allow the introduction of the aromatic A-ring portion
to the C-ring by means of allylic acetate displacement chemistry developed in Trost's
laboratories. The results of a detailed study of these reactions in addition to future
directions for morphine synthesis are described.
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Figure 5.
Since its first reported total synthesis a little more than a half century ago,
morphine remains a considerable challenge to the synthetic chemist. There have been
just under thirty formal or total syntheses of the natural product; each of these strategies
is unique in addressing the issues of complexity. The introduction of asymmetry in the
starting material represents a key step in the synth,esis of Gates', Trost's, Overman's, and
Parker's non-racemic syntheses of morphine, or its derivatives. Hudlicky's approach is
unique in that chirality in the starting material is generated through enzymatic methods.
A brief account of the historical development of this chemistry is described in the
following section. The design elements and key steps of a selected number of total
syntheses featuring Diels-Alder, radical cyclizations, or Pd-catalyzed cyclizations will be
discussed in Chapter 3.
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II. Historical
11-1 Aromatic Dioxygenases
11-1.1 History of Microbial Oxidation of Aromatics
As early as 1908, Stormer isolated a bacterium, Bacillus hexcarbavorum, which
utilized toluene and xylene for growth.8 Several years later, in 1913, Sohngen described
microorganisms which grew in the presence of benzene.9 Subsequent studies by Haccius
and Helfrichlo with the organism Nocardia coralline determined that catechol was the
major product from the fermentation of benzene. These, and other, early reports
generated significant interest in both the specificity of microbes for various substrates,
and the mechanisms of such oxidations. At the time, there was some question of whether
or not the catechol was formed through the intermediacy of phenol, or rather through
oxidation of an aromatic diol. An elegant study by Marr and Stonell using P. aeruginosa
and Mycobacterium rhodochrous, which were isolated from soil samples, showed that
both strains oxidized benzene to catechol. The organisms were capable of growing solely
on catechol as well, but not in the prescence of phenol, which led them to discount phenol
as ail intermediate in the degradive pathway of benzene. Although they were unable to
isolate the trans-cyclohexa-3,5-diene-l,2-diol as an intermediate, Marr and Stone
nonetheless proposed its intermediate role in the formation of catechol from benzene
based on analogy to eukaryotic organisms which were reported to oxidize trans-
cyclohexa-3,5-diene-l,2-diol to catechol.
In 1968, Gibson, Kallio, and Koch reported a strain of Pseudomonas putida that
utilized ethylbenzene, toluene, or benzene as its source of carbon.1 They found that the
7
cell-extracts from the organism oxidized these aromatic hydrocarbons at equal rates.
They performed oxygen uptake experiments in which the. organism was incubated with
both cis- and trans-cyclohexa-3,5-diene-1,2-diols. These experiments revealed that the
cis-isomer was oxidized approximately 6 times faster than its trans-isomer. The result of
this experiment, combined with their inability to detect phenol as an intermediate in the
pathway led to the initial mechanistic proposal depicted in Scheme 1.
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Scheme 1. Gibson's original mechanistic proposal for dihydroxylation of benzene.
11-1.2 On the Mechanism and Stereochemistry of Aromatic Oxidation
In 1970, Gibson extended his work on aromatic oxidations by Pseudomonas
putida to include halogenated aromatic derivatives. He reasoned that, because of the
deactivating nature of the halogen substituent, metabolism may be retarded such that the
intermediate compounds in the degradive pathway may be isolated and characterized.
Indeed, Gibson found that oxidation of toluene, fluoro-, chloro-, bromo-, and
iodobenzene gave the corresponding m-substituted catechols. The oxidation of p-
chlorotoluene 22, however, gave a mixture of the 2,3-dihydroarene dial 23 and the
corresponding catechol 24, Figure 6. On the basis of Crigee's triacetylosmate test and
NMR spectroscopic evidence, Gibson was confident that he had originally been correct in
postulating the existence of a 1,2-cis-diol intermediate.
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Figure 6. Gibson's isolation of intermediates in aromatic degradation.
The proof of stereochemistry for the dienediol derived from oxidation of toluene
was reported in 1973. 12 The proof involved hydrogenation of (+)-cis-l,2-dihydroxy-3-
methylcyclohexa-3,5-diene, and further oxidation under Jones conditions to the
corresponding di-acid. Upon· comparison of this material to the known (-)-2-(R)-
methyladipic acid, they reported an unambiguous stereochemical assignment of the cis-
diol. This particular experiment, however, only permits an absolute stereochemical
assignment of the methyl group. The authors assume that hydrogenation occurs from the
a-face of the molecule, which was later shown to be the predominant, but not exclusive,
pathway.13 The absolute proof of the absolute configuration had to await the synthesis of
PGE2a in 1988.13
Mechanistic studies aimed at elucidation of the pathways for the formation of
diols and catechols from aromatic precursors had constituted an active area of research
since the early 1950's. A study by Booth, et ale in 1960 involved the incubation of either
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benzene or naphthalene with NADPH, 1802, and rat liver microsomes.14 Under these
conditions, aromatic substrates showed incorporation of only one labeled atom of
oxygen, implying the intermediacy of an epoxide, which is opened in a trans-diaxial
fashion to give trans-l,2-diols. In a seminal 1970 paper,15 Gibson proved unambiguously
through isotopic labeling studies that both oxygen atoms present in the cis-diol
functionality are derived from molecular oxygen. At this point, it became clear that the
mechanisms for oxidation of aromatics compounds in microbes differed from those in
mammalian systems.
Cytochrome P-450's, the broad class of hydroxylating enzymes common to
mammalial organisms, are known to oxidize aromatics to catechols via their epoxide
intermediates, Scheme 2.16 The intermediate epoxide may be hydrolyzed to its trans-l,2-
diol, an unstable intermediate which undergoes dehydration to give phenol. Dioxygenase
enzymes1? characteristically incorporate two oxygen atoms into their substrate, in the
case of toluene dioxygenase, molecular oxygen serves this function. Re-aromatization
occurs not as a result of dehydration, but rather by further oxidation mediated by a second
enzyme, catechol dehydrogenase.
o c~ochrome P-4~O [018]
27 28
Q1sH oH OHepoxide : OH 6hydrolase cr and• .,
-H2O
29 30 31
toluene dioxygenase
catechol(X018H dehYdrogenase.
°1SH
32
Scheme 2. Divergent modes of oxidation for cytochrome P450 and dioxygenases.
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Independent of Gibson, Ribbons and co-workers were investigating the pathway
by which p-cumene 37 (4-isopropyltoluene) was degraded by Pseudomonas strains.18
They found that co-incubation of wild-type Pseudomonas putida PL, known to oxidize p-
cumene to its catechol, with cumene in the presence of 4-halotoluenes resulted in the
accumulation of appreciable amounts of the intermediate 2,3-dihydroarenediol
intermediate derived from the halotoluene additive. Furthermore, they were unable to
detect the products arising from oxidation of cumene. They concluded that the production
of the intermediate halo-aromatic diolwas the result of the prescence of mutant strains of
Pseudomonas that were unable to grow in the prescence of p-cumene, Scheme 3. Such
additives which are enzymatically processed to compounds which interfere with
metabolic pathways have been termed "suicide compounds".19
Q2H Pseudomonas C02H Y$Hputida PL HO""¢ H+.. ..
HO"" 0 HO .0
CF3 CF3 CF3
34 35 36
Pseudomonas
putida PL
)( ..
HO
37 38
Scheme 3. Co-incubation of Pseudomonas putida PI with halo-toluenes results in
formation. of mutants strains.
Gibson was also interested in generation of mutant strains of bacteria responsible
for the catabolism of aromatics. By incubation of the wild strain of Pseudomonas putida
with N-methyl-N-nitrosoguanidine, he was able to generate mutant strains of the parent
organism. His work led to the isolation and characterization of a mutant strain, which he
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named Pseudo'monas putida F39D, devoid of the ability to carry out oxidation of the
intermediate dihydroarene diol. Incubation of this mutant organism with ethylbenzene or
toluene resulted in the accumulation of the cis-dihydroaromatic diol. Following
characterization of the mutants, the genes responsible for the production of toluene
dioxygenase were eventually expressed in Escherichia coli.2o Dioxygenase enzymes
produced by Pseudomonas putida, the soil bacteria which carry out these
transformations, are part of a catabolic pathway by which aromatics are degraded to
acetate- a source of carbon and energy for the organism. The transformations which
define this catabolic pathway are detailed in Figure 7.
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Figure 7. Catabolism of toluene in soil bacteria. Gene designations are shown in
parentheses.
Electron transport from NADH is facilitated by a reductase protein, which shuttles
electrons to a ferrodoxin protein, which in tum reduces an iron-sulfur protein. The iron
sulfur protein (ISPToL) reduces molecular oxygen, which is incorporated with cis-
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stereochemistry into the aromatic substrate with concomitant loss of aromaticity. In the
wild-type organism, cis-dihydrodienediol 40 undergoes an NADH-mediated oxidation to
its corresponding catechol 41 by the enzyme cis-toluene dihydrodiol dehydrogenase.
The action of a second dioxygenase enzyme, 3-methylcatechol 2,3-dioxygenase, is
responsible for the conversion of the catechol to 6-oxo-2,4-heptadienoate 42.
The nucleotide sequence of the toluene dioxygenase genes, elucidated through
isolation and characterization of the mutant strains, was reported in ·1989 by Gibson and
Zylstra.2 These genes were actively expressed in an Escherichia coli host. Even after the
genes had been cloned into E. coli (a significant feat given the length of the nucleotide
sequence and complexity of the enzyme system) there is continued interest in the study of
toluene dioxygenase and its related dioxygenases. The exact mechanism of the oxidation
of aromatic substrates by toluene dioxygenase remains unknown, although X-ray crystal
data of a related dioxygenase enzyme, that of naphthalene dioxygenase, is available.21
There are several advantages associated with the use of recombinant strains of E.
coli over the mutant strains. Mutant strains require an aromatic inducer of protein
production, normally chlorobenzene or toluene. As the inducer is itself a substrate,
difficulties are encountered in the purification of novel substrates. Enzyme production in
the recombinant organism, however, is initiated by a sugar analogue, fi-
isopropylthiogalactopyranoside, obviating the need for addition of an aromatic inducer.
Second, recombinant cells contain multiple copies of the plasmid, resulting in increased
production of the protein and hence increased yields of diols.
Nearly forty years after Gibson's isolation of the first stable cis-
cyclohexadienediol, there is continued interest in the application of these unique synthons
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in both natural products and materials chemistry. The dihydroxylating enzymes
responsible for the stereospecific installation of the cis-diol functionality to aromatic
nuclei with concomitant loss of aromaticity are unique to the world of enzymatic
transformations- there is as yet no equivalent reaction in standard reagent chemistry. One
exception is an attempt from Motherwell,22 who described a photochemically-mediated
oxidation of benzene, however, this oxidation is non-selective and is limited to benzene.
11-1.3 Utility of Dioxygenase Enzymes in Synthesis
It is remarkable that the evolution of the process from Gibson's discovery of the
first stable cis-dihydrodiol to industrial scale (>1000 L) production of cis-dihydrodiol has
taken less than forty years. The products derived from microbial dearomatization of
aromatics are ideal substrates for the synthesis of a variety of complex natural products
and analogues. Not only are the products formed in homochiral fashion, but also, all six
carbon atoms in the molecule all susceptible to selective functionalization. The olefins
are sterically and electronically differentiated and the diene functionality can be utilized
in intra- or intermolecular Diels-Alder reactions. The cis-diol functionality provides an
anchoring point for a variety of functional tethers, or may be exploited as a directing
element in enantioselective chemical reactions, as indicated in Figure 8. Indeed, there is
enormous potential for application of these diverse dihydroarenediols in synthesis. Since
Gibson's original paper describing the oxidation of arenes by Pseudomonas putida,l over
300 metabolites have since been reported. It is remarkable that twenty years had passed
from the isolation of the fITst arene diol before the synthetic potential of these metabolites
had materialized.
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Figure 8. Reactive options in diene diols.
The first application of cis-dihydrodiols in a synthetic endeavor is credited to Ley,
whose synthesis of racemic pinitol was reported in 1987.23 Ley's synthesis begins with
benzene, which was converted enzymatically to its meso-diol using the mutant strain of
Pseudomonas putida Fl, a bacterial strain expressing the enzyme toluene dioxygenase
and is devoid of the enzyme catechol dehydrogenase. The meso-diol was protected as its
bis-benzoate derivative 44 and the benzoates subjected to epoxidation with mCPBA. At
this stage of the synthesis, the mixture of epoxides 4S and 46 were easily separated by
column chromatography and the desired a-epoxide 46 opened with methanol in the
presence of camphor sulfonic acid. Osmium-mediated dihydroxylation gave the fully-
oxygenated derivative 48, which was deprotected by treatment with aqueous methanol in
the presence of triethylamine to afford racemic pinitol49.
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Reagents and Conditions: (a) Pseudomonas putita PI; (b) PhCOCI, DMAP, py; (c)
mCPBA, DCE, pH 8 phosphate buffer; (d) MeOH, CSA; (e) 0.1 % OS04, NMO,
tBuOHJTHPIH20; (t) Et3N, MeOH, H20.
Scheme 4. Ley's synthesis of racemic pinitol.
Just one year later, the chirality in the enzymatically-generated dienediol was
exploited in the synthesis of prostaglandin intermediates and perhydroazulene terpenes by
Hudlicky and co-workers. 13 The synthesis is noteworthy as it marked the first
enantioselective synthesis using dihydroarene diols.
0 a,b te°)( c ~>(.. ..~ 0
HO
39 50 51
0 0 Id
"\~ 0-0 d.,\ - COH 4 4 te°>(2 4~ ---fo O~c °OH
54 53 52
Reagents and Conditions: (a) Pseudomonas putita 39D (3 gIL); (b) 2,2-
dimethoxypropane, pTsOH, rt (85%); (c) 0 2/03, then dimethyl sulfide (56%);
(d) neutral alumina, DME, reflux, 15 min (95%).
Scheme 5. Hudlicky's chemoenzymatic preparation ofprostanoid synthon 53.
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As depicted in Scheme 5, Pseudomonas putida 39D, a mutant strain which
expresses the enzyme toluene dioxygenase, was used to oxidize toluene to its aromatic
diol, which was immediately protected as an acetonide 50. Treatment of this material
with ozone provided the isomeric mixture of hemiaminal 51. Heating the mixture in
DME in the presence of neutral alumina gave directly the a,~-unsaturated ketone 52,
which had previously been converted to prostagladins,24 thus completing a formal
synthesis of PGE2a from toluene in four operations.
Nearly 20 years have passed since Ley's first report of the application of
dienediols in synthesis. Since 1987, over 50 natural products and derivatives have been
synthesized from diene diols obtained by fermentation of aromatics.25 Although over
300 metabolites are known, nearly 70% of all the natural products originating from
aromatic nuclei were synthesized from either benzene, chlorobenzene, toluene, or
bromobenzene. The synthetic utility of the remaining 300 metabolites is yet a largely
unexplored area of research. A summary of some of the synthetic targets derived from
aromatic diols is given in Table 1 below. Several excellent reviews are devoted to the
application of diene diols in synthesis.26 Chlorobenzene served as starting material in the
synthesis of conduritol C,27 D-chiro-inositol,28 conduramine A_l,29 (-)-pinitol,27
hexoses,30 aminohexoses,31 and· carbasugars,31 L-ascorbic acid,32 kifunensine,33 both D-
and L-erythrose,34 both enantiomers of trihydroxyheliotridanes,35 natural and unnatural
sphingosines,36 specionin acetate,37 (+)-aspicillin,38 (-)-cladospolide A,39cladospolide B,40
and the isomeric D-chiro, L-chiro, muco-, neo-, and allo-inositols,41 and 3-deoxy-D-
glycero-D-galacto-2-nonulosonic acid.42 Bromodienediol has witnessed application in
the synthesis of pancratistatin,43 7-deoxypancratistatin,44 and truncated45 and modified
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aromatic46,47,48 derivatives of the pancratistatin core. It has been used in the synthesis of
lycoricidine49, amino-inositols,50 ent-bengamide E,51 morphinans,52 the core of CP-
225,917,53 steroidal nuclei,54 and aza-disaccharides,55 chiral polymers,56 and a host of
conduritols and conduramines.57 (-)-Gabosine remains the only target which has been
made through the intermediacy of iodobenzene dihydrodiol.58 The diol derived from
toluene was one of the first to find application in total synthesis. It has been used to
make (-)-patchoulenone,59 the ent-taxane A,B ring system,60 mannose derivatives,61
PGE2(l,13 morphinan ring systems,62 and hirsutene.63 Styrenedienediol has provided
access to zeylena64 and structurally complex Diels-Alder adducts.65 Bromoethylbenzene
diol has been used in approaches to natural morphinans,66 while its corresponding 0-
bromo isomer was used as an intermediate in the synthesis of isoquinoline derivatives
which were ultimately converted to ent-morphinans.67 Shkimic acid was synthesized
from benzenenitrile.68 m-Dibromobenzene served as starting material for the synthesis of
narciclasine,3 and its corresponding o-isomer was recently converted to (-)-conduritol E.69
The protesase inhibitor indinivir (Crixivan) was synthesized from the diol biocatalytically
derived from indane.7o (+)-Goniodiol was recently prepared from naphthalene diendiol by
Banwell and co-workers.71 p-Bromoiodo dienediol was used to make ent-7-
deoxypancratistatin.44 The diene derived from oxidation of azidoethylbenzene was used
in the synthesis of truncated morphinans.62 The diol derived from benzene has been
converted to either enantiomer of conduritol C,72 both enantiomers of methyl shkimate,73
and polyphenylene.74 Indole was biocatalytically converted to indigo.75
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Table 1. Examples of Natural Products and Materials Derived from Aromatic Diols.
A. Asymmetric Syntheses
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B. Non-asymmetric synthesesa
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aSyntheses in which either the product is devoid of chirality, or if the product is chiral, asymmetry was introduced by
some means to the meso-diol.
Recent advances in biotechnology have allowed access to synthetically useful
amounts of a variety of diols derived from aromatic nuclei. The the utility of dienediols
in asymmetric synthesis is clearly demonstrated by entries in Table 1. The diversity of
the metabolites shown in Table 1 is a testament to the high degree of tolerance of the
enzyme for both molecular shape and functional content in the aromatic substrate. There
are, no doubt, hundreds of metabolites that have yet to be isolated.
The metabolites derived from halobenzenes are especially amenable to further
functionalization and they have seen broad application in Diels-Alder chemistry,37,38 Pd-
catalyzed coupling reactions,49,66a ozonolysis,13 hydroxylation,41 and or, epoxidation41
reactions. While these substrates traditionally find application in the synthesis of natural
products, recently there have been a growing number of reports describing their usage in
the synthesis of non-natural medicinal agents, i.e. indinivir, chiral polymers, and
colorants (indigo). The growing number of substrates isolated from whole-cell
fermentation of aromatics bodes well for the field of chemo-enzymatic synthesis.
As demonstrated in Ley's synthesis of pinitol, dienediols are excellent substrates
for further selective oxidation reactions. On closer inspection, many of the targets
illustrated in Table 1 which retain an oxygenated core can be dissected into amino-
cyclitol or cyclitol fragments. A significant number of these natural products and
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materials result from an initial coupling of either epoxide or aziridine scaffolds with
various nucleophiles. To this end, there is significant research devoted to the
development of operationally simple, selective, and mild, catalytic systems to facilitate
opening of these functional synthetic intermediates. The following section presents the
use of silica gel as a mild alternative to acid or metal catalytic systems.
11-2 Reactions on Silica Surface
The rate enhancement and increased reactivity of many reactions on solid surfaces
is well-established. 13,47,76,77 Because of their extremely large surface area, solid phase
catalysts such as alumina, zeolites, and silica provide an enormous contact surface which
necessarily distributes reactants in a proximal arrangement, thereby lowering the reaction
activation energy. This phenomenon has been exploited in a number of diverse
applications from polyolefin polymerization78 to Diels-Alder and ene-reactions.79
Additionally, increasing demands for catalysts which are recyclable, non-toxic, and of
low cost have prompted many researchers to investigate the use of solid surface catalysts
as an environmentally-friendly alternative fo toxic, costly, and non-reusable transition
metal catalysts.80 Alumina, silica, and zeolite catalysts are among the most popular
oxide catalysts which are increasingly used as replacement technologies for metal
catalysts.81 Although many solid-phase catalysts share some general characteristics, i.e.,
high surface to volume ratio, only those reactions mediated by alumina or silica will be
discussed here, with special emphasis on silica gel-mediated reactions.
Silica gel is manufactured by treatment of sodium metasilicate (Na3Si03) with
acid.82 Typically, this involves sparging gaseous carbon dioxide (a weak acid) through a
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dilute aqueous solution of sodium metasilicate until neutral pH is attained. At pH of 7,
the mixture becomes gelatinous, and the- sodium ions are washed away. High
temperature baking (-200 °C) removes most of the excess water and leaves behind the
amorphous silica gel. At higher temperatures, (> 500 °C ) adjacent terminal siloxy
groups condense, resulting in further dehydration and reduced acidity through loss of
chemisorbed water molecules.
The catalytic cycle for heterogeneous reactions is somewhat more complex than
its homogenous counterpart. Part of the complexity resides in the fact that the exact
distribution of the catalyst in unknown. Additionally, the steps involved in mass
transport of the reagents and products to and from the active site of the catalyst obscure
the complete reaction picture. Augustine82 has delineated some factors necessary for
successful surface-catalyzed transformations: (1) the reagents must reach the active site;
(2) they must interact with the catalyst; (3) the reaction proceeds to give products; (4) the
products are desorbed from the catalyst; (5) the products (and unreacted starting
materials) are transported away from the catalyst. Step five is an extremely important
consideration. An aqueous work-up and final purification by silica gel chromatography
are often necessary steps following homogeneous reactions. If one can carry out the
same reactions on silica surface and simply desorb the reaction products by
chromatographic elution following the reaction, several unnecessary operations are
avoided and thus, time, materials, and mechanical losses are minimized in the process.
Several factors contribute to the enhanced reactivity of surface-mediated
reactions. In contrast to homogenous reactions, in which all reactants are uniformly
distributed throughout the reaction media, heterogeneous reactions depend on reactants
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coming in contact at the surface of the active site. Silica gel has an extremely high
surface to volume ratio; commercially available grade silica typically has a surface area
of approximately 500 m2/g. An important consideration for many processes is good
thermal and mechanical stability over a wide temperature range; silica gel also displays
these properties. Its compatibility with a broad range of solvents is attributed to the fact
that silica gel does not swell in organic solvents. Aside from the rate enhancement due
to its high surface area, silica gel possesses the unique property of having high silanol
density. As depicted in Figure 8, the terminal silanol groups on the silica surface form a
H-bond network, which dramatically enhances the rate of reactions requiring mild acid
catalysis. This "network" of H-bonds postions the active catalytic residues in close
proximity to the substrate, thereby lowering the transition state activation energy. The
carbonyl group in Figure 9 is activated by H-bonding to a hydrogen atom on the terminal
silanol functionality. This effect is magnified in silica gel which has been "activated" by
dehydration. Silica gel can be readily activated by washing with polar solvents to remove
residual water, followed. by high temperature baking under reduced pressure, to remove
excess solvent. Alternatively, commercially available silica gel may be "deactivated" by
thorough mixing with 10% (w/w) water. Chromatographic separation of acid-sensitive
compounds (epoxides, aldehydes, aziridines, etc.) often requires prior deactivation of
silica gel.
Figure 9. Activation of a carbonyl by H-bonding on the surface of silica gel.
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11-2.1 Applications of Surface-mediated Catalysts
The first applications of surface-mediated reactions probably date back to the use
of thoria (Th02) as a·surface catalyst in the alkylations of aniline.83 As an extention to
that work, Brown and Reid employed silica gel as a Lewis acid catalyst in the alkylation
of various amines with alcohol at high temperatures in 1924.84 Silica gel also found early
application in the production of formaldehyde. 85 Since these early reports, the solid state
chemistry of alumina76 and silica gel has been exploited in hydrolysis and deprotection
reactions,47 SN2 reactions,86 oxidations,87 Diels-Alder cyclizations,88 deoxygenation,89
nucleophilic addition reactions,9o and as a support for phase-transfer catalysts.91 The
reason for its broad application is primarily due to the combination of high surface area
and the mildly acidic nature of alumina and silica. Silica gel, in particular, is a versatile
catalyst, because of its ability to interact through both covalent and non-covalent
interactions. The nature of the interaction of silica with certain co-ordinatively
unsaturated metals is assumed to be a covalent association through its terminal siloxy
groups.92
~OH
~OH
+L-
Figure 9. Convalent association of a metal to silica surface.
The utility of heterogeneous catalysis in liquid phase has been amply demonstrated by
Hudlicky, who desribed the displacement reaction of alkylhalides with hydrozoic acid on
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an alumina surface.93 In this experiment, the reactants are simply applied to the top of an
alumina column, and after 16 h reaction time, the desired azides were eluted with hexane
and ether. In similar fashion, Marshal194 synthesized hydroazulenes by chromatographic
elution of aldehydes on silica gel, Scheme 6.
OY~CHO
133
silica gel, rt
..
134
Scheme 6. Silica gel-mediated Prins-reaction.
The synthesis of acylated cycloalkenes catalyzed by alumina was reported in1981 by
Hudlicky.77a The equilibrium mixture of acylated products was channeled to the desired
a,~-unsaturated ketone 139 by adsorption of the crude mixture on alumina followed by
elution with dichloromethane.
b
/ ? \
Q~ [fi0 -A~O + 'NO + QiO
R R R R
135 136 137 138 139
Reagents and Conditions: (a) AC20, ZnI2, ZnCI2, 0 °C; (b) neutral alumina, rt (74%).
Scheme 7. Synthesis of a,~-unsaturatedcyclic ketones.
As briefly mentioned in Section 11-1.4, Hudlicky achieved a facile intramolecular
cyclization of a keto-aldehyde in the formal synthesis of PGE2a on the surface of
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alumina.13 The fact that other "standard" methods to effect this intramolecular
condensation failed was noted by the authors.
0 ~>< 07:>< a &0JI: JI:-H2O oX:0 HO
52 140 53
Reagents and conditions: (a) Alumina, DME, relflux (65%); (b) Alumina,
benzene, reflux (65%)
Scheme 8. Synthesis of key intermediate in PGE2a on alumina surface.
The opening of epoxides with amine nucleophiles represents a general entry into
1,2-trans-disposed amino alcohols, important intermediates in .natural products95 and
asymmetric catalysis.96 In an effort to access these materials in the abscense of protic or
metal catalysts, Chakroborti97 has recently reported a simple and mild catalytic system
using silica at rt. The procedure simply calls for an addition of 1.0 equiv of the amine to
a stirred suspension of 2.5 equiv of epoxide and silica gel (10% (w/w)) at rt~ It is
noteworthy that the authors report no reaction takes place in the abscence of silica gel.
0 0 0 silica gel, rt CXOH+ • (exclusive)90% "'NHPh
141 142 143
0 0 OH NHPhif + silica gel, rt ~HPh mHJI: +(quant)
144 142 145 146
95 5
Scheme 9. Silica gel mediated opening of epoxides.
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As shown in Scheme 9, high selectivites for trans-disposed amino alcohols were
obtained. Additionally, the catalyst could be re-used a number of cycles without loss in
activity.
In 1996, Kotsuki and co-workers reports their results of a study directed at the
opening of various benzylic epoxides with indole and pyrrole nucleophiles.98 A
comparison was made between nucleophilic openings facilitated by high pressure (10
kbar) and those reactions at rt under the influence of silica gel catalysis. Although the
epoxide opening was significantly slower to react on silica, yields of the opened product
were consistently higher. A plausible mechanism for the influence of silica gel was
presented, see Figure 12.
Co~ Io N
H
147
+ d
Ph
o
144
silica gel, rt
..
7 days
1.0,1.0. I
-Si Si Si-
I I I
000
\l\{~
~CM f!{PhGL-llJ
..
PhccnHN
H
148
66°!c>
Figure 12. Mechanistic proposal for activation of epoxides by silica gel.
While aziridines are known to be more resistant to nucleophilic attack than their epoxide
counterparts, they are readily opened by nucleophiles in high yield with
phosphomolybdic acid supported on silica gel.99 The use of activated surface catalysts in
conjunction with PMA is a widely-used catalyst for vapor phase reactions; many of these
systems have become commercially available. loo Baskaran describes the opening of
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various aziridines on silica surface treated with 1 mol% phosphomolybdic acid. The
products shown below form exclusively under the conditions presented.
Table 2. Opening of Strained Heterocylcles on activated surfacea
Substrate Nucleophile Product Time (h) Yield (%)b
ONTS MeOH crOMe 0.5 91
"NHTs
C£NTS MeOH dOMe 0.25 95
"'NHTs
ONTS NaN3 crN3 2.5 91
"NHTs
ONTS NaCN creN 8 95
"NHTs
ONTS KBr crsr 10 95
"NHTs
C£NTS NaN3 d
NHTS 4 93
N3
a 1 mol% PMAlSi02 in MeCN at rt
bYields are isolated
There are several advantages associated with the use of silica gel as a mildly
acidic catalyst. Aside from its low cost, silica gel is recyclable, readily available, and
maintains its physical characteristics in a variety of solvents through a broad temperature
range. Additionally, silica gel reactions often require no solvent, thereby reducing costly
waste disposal. A last important consideration is that silica-gel mediated reactions are
31
generally operationally simple. With the growing number of expensive and specialty
catalysts decribed in the recent literature, general protocols for facilitation of simple
nucleophilic reactions are increasingly difficult to obtain. Chapter Three describes our
development of such a general procedure using indole nucleophiles to open strained
heterocycles and its eventual application in synthesis.
11-3 History of Morphine Synthesis
Morphine 149, and its congeners codeine 17, and thebaine 9, have attracted the
attention of chemists for nearly 200 years. The·combination of their powerful biological
activity and unique molecular architecture make the morphinan alkaloids both
challenging synthetic targets and indispensable narcotics. Morphinan alkaloids isolated
from the opium poppy, Papaver somniferum, have been used for thousands of years,
although morphine was not isolated in its pure form until 1806 by Serttirner. 101 Several
medi9inally useful derivatives of this class of alkaloids, namely naltrexone 150 and
naloxone 151, are produced commercially and are frequently used to treat opiate
overdoses and addictions. These derivatives, however, originate in synthetic
manipulations of the parent alkaloids isolated from the opium poppy; to date no fully
synthetic commercial route to morphine or its analogues exists.
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Ho"a
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149 morphine, R =H
17 codeine, R =Me
9
thebaine
150
naltrexone
151
naloxone
Figure 13. Morphine and its related derivatives.
Extraction of morphinan alkaloids from the opium· poppy is a relatively simple
process. The opium poppy seed pod is slit to allow excretion of the pinkish opium
latex,102 which is scraped from the surface and collected. The latex, which rapidly turns
black on exposure to air, is allowed to bake in the sun to remove excess water. This
crude product is termed Indian opium, and is comprised of more than 40 alkaloids, of
which morphine is the chief constituent, representing approximately 10-15% of the mass.
Morphine can be isolated in pure form according to the procedure reported by
Serttirner.103 The protocol involves trituration of Indian opium with hot water until the
filtrates become colorless. The filtrates are then concentrated, diluted with water while
still warm, and saturated with ammonia. The semi-crystalline material which precipitates
is then diluted with water and triturated with ethanol.
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Following Setiirner's initial isolation of morphine, over 100 years of effort was
devoted to its structural elucidation. Forty two years after the initial isolation of
morphine, Laurent104 disclosed its correct empirical formula-C17H19N03. The nature of
the oxygenation was ascertained largely throught the work of Wright,105 who is credited
with the first synthesis of heroin, or, diacetylmorphine as a result of that work. Shortly
after, in 1881, von Gerichten noted that distillation of morphine with Zn dust at 300 °C
yielded phenanthrene.106 Further degradive experiments of morphine and codeine by
Hofman and Pshorr confirmed the prescence of an oxygenated phenanthrene skeleton.107
Indeed, the work of Setiirner, Pshorr, Knorr, Liebig, Laurent, and other pioneers of that
time greatly accelerated development of the .disipline of organic chemistry as a result of
their pursuit of morphine structure elucidation .108 It was not until 1926 that the correct
connectivity of the pentacyclewas proposed by Robinson,109 and this proposal was
ultimately proved correct by Gates in 1952,111b when the first synthesis of morphine was
disclosed. Gates' completion of morphine is recognized asa landmark synthesis, not
only for its confirmation of Robinson's proposed structure, but because it stands as an
important illustration of·the power of total synthesis as a tool in structure determination
which stands to this day as the ultimate proof of structure.
Long after Gates' initial synthesis of morphine, it enjoys continued attention from
the synthetic community. Despite the relatively small size of morphine (bearing only 17
carbons) it remains an extremely complex and dissonantly assembled110 molecule. There
are a number of unique structural features which contribute to its complexity as a
synthetic target: the C-13 quaternary center, the C-4,C-5 ether linkage, five vicinal
stereocenters, and the pentacyclic framework. Though not comprehensive, the
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following section briefly describes a selection of synthetic efforts toward total synthesis
of morphine alkaloids which employ Diels-Alder, radical cyclizations, or palladium
cyclizations as key strategies.
Though initially reported in 1928, the Diels-Alder reaction continues to find wide
application in the synthesis of natural products. The broad applicability may be attributed
to the stereospecific nature of the reaction and its ability to generate multiple ring systems
(and therefore multiple stereocenters) in a single step. Several morphine approaches
discussed in the following section have relied on the Diels-Alder reaction to forge the
problematic C-13 quaternary center. Parker and Hudlicky have both considered radical-
based approaches to the morphinan skeleton. Radical-initiated reactions are particularly
attractive in that they are known to "zip up" the morphinan skeleton in single-operation
cascade reactions, greatly shortening the length of the synthetic sequence. Finally, the
utility of palladium catalysis will. be highlighted as both a means to access to chiral
synthons and as a powerful tool in the chemoselective generation of carbon-carbon
bonds, the cornerstone of organic synthesis.
11-3.1 Approaches Toward the Synthesis of the Morphine Skeleton using
Diels-Alder Cyclizations
Gates (1952, full disclosure in 1956)111
The first synthesis of morphine was completed in 1952 and spanned 24 steps in an
overall yield of 0.02%. The synthesis began from 2,6-dihydronaphthalene 152, a
common material used in the synthesis of dyes. The symmetry in the starting material
allowed Gates to carry out, in interative fashion, a nitrosationl reduction! oxidation
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sequence on what was to become both the A- and B-rings to provide 154. As was shown
in earlier model studies,112 the C-13 center could be forged using a Diels-Alder reaction
of 155 with butadiene to give 156.
HO 0 MeO
a,b,c 0 d,e,f,g MeO h,i
.. .. ..
0
OH OBz 0
152 153 154
MeO MeO
o ---:....
o
o
eN
155 156
Reagents and Conditions: a) BzCI, py, dioxane (72%); b) NaN02, AcOH (88%); c)
AcOH, Pd(C), H2, then FeCl3 (85%); d) S02, MeOH, (91 %); (e) K2C03, dimethyl sulfite,
t) KOH, MeOH, (87%); g) NaN02' AcOH, Pd(C), H2, then FeCI3, (82%), h) ethyl
cyanoacetate NEt3, then K3Fe(CN)6 (84%); i) Claisen's alkali, (97%); j) butadiene,
(66%).
Scheme 9. Gates synthesis of morphine intermediate 156.
The D-ring of morphine was installed in a rare reductive cyclization reaction mediated by
copper chromite catalyst under a medium-pressure of hydrogen gas at 130 °C. The
cyclization, discovered quite by accident in an earlier series of model studies, was
published in 1950.113 Gates, in his full disclosure of the synthesis of morphine,111 stated
that the course of this particular reaction "was far from clear". A mechanism for this
fortuitous cyclization has been proposed and is shown in Scheme 10.111
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MeO MeO MeO
0
H2
., 0 .. .,
copper chromite 0
CN CN HN156 157
MeO MeO MeO
159 160 161
Scheme 10. Proposed mechanism for the reductive cyclization.
The product of reductive cyclization 161 was transformed to morphinan 162, which
represents the entire carbon skeleton of morphine, Scheme 11. Resolution of racemic
162 was accomplished by crystallization with the enantiomorphic dibenzoyltartrate salts.
On a more practical note, having matched his synthetic d-P-~6-dihydrodesoxycodeine
methyl ethers with the natural material, Gates was now able to carryon the synthesis
from natural derivatives. Oxidation at C-6 and selective demethylation gave the ketone
164.
MeO MeO MeO MeO
MeO a,b,c MeO MeO e,f HOd
.,
..
..
HO
0
161 162 163 164
Reagents and Conditions: a) KOH, N2H2; b) NaH, Mel; c) LAH (54%); then dibenzoyl
tartrate resolution; d) dilute H2S04 (28%); e)KOH, ethylene glycol; f) tBuOK, Ph2CO
(89%);
Scheme 11.
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At this point, Gates faced the daunting task of establishing a cis-fused Band C ring
system through inversion of the C-14 center. This problem was ultimately solved by
treating the ketone 164 with 2 equivalents of bromine followed by hydrazone formation.
Indeed, introduction of the a,~-unsaturation unit in compound 166 allowed the
equilibration of the C-14 (morphine numbering) center, Scheme 12. Though an obvious
equilibrium exists, the ~-configuration of the C-14 hydrogen is energetically preferred. It
is noteworthy that Gates' sequence .remains, to this day, the method of choice for
equilibration of the C-14 center in morphine alkaloids. A plausible mechanism for this
valuable transformation is advanced in Scheme 12.
MeO Br MeO Br
Br2
HO HO
• .. ..
AcOH, 2,4-DNP
0 ArNHN
Br
165 166
MeO Br MeO Br MeO Br
HO HO Hel HO
,., .. •
ArNH¥ ArNHN 0
H H+BU 168 169 170
MeO Br
MeO
HO
o
167
164
Scheme 12. Proposed sequence for C-14 epimerization via hydrazone formation.
The last significant challenge presented itself in the form of the C-4,C-5
dihydrobenzofuran closure. Once again, Gates turned to the very same set of conditions
that so elegantly addressed the problem of C-14 epimerization.114 To this end, ketone 95
was treated with bromine followed by 2,4-DNP, which-i~ a single reaction vessel-
effected closure of the C-5 ether bond and introduced the 1l7-8 unsaturation unit.
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Liberation of the ketone from its hydrazone precursor gave morphinan 173, which was
converted to morphine in two further steps.
MeO
HO
o
171
a
172
b
173
c,d
..
(-) Morphine
149
Reagents and Conditions: a) Br2, AcOH, 2,4-dinitrophenylhydrazine (26%);
b) 12N HCl in acetone (27%); c) LAH (quant); d) Py·HCl (34%).
Scheme 13. Gates final transformations to (-)-morphine.
Ciganek (1981)115
Partial syntheses of the morphinan skeleton continue to an important tool in the
investigation of the structure activity relationship of morphine and its related compounds.
In 1981, Ciganek disclosed one of the few approaches to a truncated morphinan skeleton
which relies on a Diels-Alder reaction as the key transformation. The synthesis is unique
in that it was the first reported application of a benzofuran unit as a Diels-Alder ene
component and the approach utilized both tethered dienes and tethered pyrones as latent
diene equivalents. The key step was the Diels-Alder cyclization of pyrone 174, carried
out in 1,2,4-trichlorobenzene at 215°C to provide tetracycle 175 in 53% yield. The diene
was then subjected to hydrogenation to yield the truncated morphinan 176, bearing trans-
stereochemistry at C-13 and C-9 (morphine numbering). Borane reduction of the amide
and demethylation of the aryl ether provided compound 177, whose structure was
confirmed by X-ray crystallographic analysis of its methylcyclopropyl amine.
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Meo~I~ Mea MeoD HOD
a b I~ c,d I~
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.. .. o~ .. °tP~NMe ,I NMe ,I NMeIf ~
a a a
a
174 175 176 177
Reagents and Conditions: a) 215°C; b) H2, PdlC; c) BH3·DMS; d) nPrS-K+,
DMF.
Scheme 14. Ciganek's synthesis of truncated morphinan derivatives.
Similar fused ring systems were obtained in the diastereomeric series from the tethered
diene, albeit in significantly lower yields (10%). Diene tethered amide 178 was heated
at 240°C in toluene, affording the cis-fused morphinan 179 in 10% yield. Repetition of
the hydrogenation and amide reduction gave 181, which proved to.be the diastereoisomer
of derivative 177 previously synthesized from the pyrone cycloaddition. The relative
configuration of this morphinan was assigned by analysis of a single-crystal X-ray
structure. An alternative benzofuran Diels-Alder approach to morphine has been pursued
by Stork and was recently completed. 116
Meo~.I~
a
--
NR
uro
178
R=CH2-<]
a
179
b
180
c,d
181
NR
Reagents and Conditions: a) 240°C; b) H2, PdlC; c) BH3·DMS; d) nPrS-K+,
DMF.
Scheme 15. Ciganek's synthesis of morphinans from diene-tethered benzofurans.
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Tins (1992)117
Tius reported an interesting approach which involved a Diels-Alder reaction of a
suitably functionalized quinone with a styrene equivalent. Remarkably, the approach
constitutes the only route originating in a non-aromatic A-ring. Their strategy is unique
in that it offers, in a single operation, construction of the A, B, and C-fused ring systems
common to the morphine alkaloid family. The difficult issue of C-13 center formation is
thus addressed early in the synthesis through a quinone Diels-Alder reaction. The
substituted quinone 182, prepared in 7 steps from commercially available o-vanillin, was
reacted with masked styrene 183 to provide the endo-Diels-Alder adduct 184 as a single
isomer. The stereochemistry of 184 was rigorously established by single crystal X-ray
diffraction. While attempting to install a functional handle for oxidation of the A-ring
through chloroselenation, an unusual tandem selenocyclization was uncovered which led
to oxo-bridged adduct 185. The ketone was liberated and subjected to Davis oxidation,
followed by hydrogenation of the 10-11 bond over Pd/C. A Swem oxidation of this
material led to a re-aromatized derivative, which was converted directly to its methyl
ether 188 upon re-aromatization.
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Reagents and Conditions: a) toluene, 100°C (86%); b) PhSeCI, MeOH; c)
H20 2, THF (80%); d) aq HCI, THF; e) KHMDS, THF; f) 3-phenyloxaziradine,
THF (82%); g) H2, PdlC, THF (75%); h) TFAA, DMSO, NEt3; i) BF3-Et20; j)
CH3I, K2C03 (56% over three steps).
Scheme 16.
Several unsuccessful attempts were made to reductively cleave the N-C bond with
retention of the dihydrofuran ring. The problem was ultimately solved by cleavage of
both the C-N and dihydrofuran rings, and adjusting the oxidation state of the C-ring to
allow re-attachment of the aminoethyl bridge, Scheme 17. To this end, 188 was treated
with PhSeCI followed by oxidative work-up to give 189. The N-methyl functionality was
installed in three steps affording 190. The allylic alcohol was then re-oxidized with the
Dess-Martin reagent. Reduction of the dihydrofuran and pyrrolidine ring promoted a
conjugate addition of the amine onto the a,~-unsaturated ketone to give the morphinan
193. The final transformations to thebainone-A involved a [1,3]- transposition of the
ketone and acid-catalyzed epimerization of the C-14 hydrogen. Gates had previously
converted thebainone-A and ~- thebainone-A to morphine,111 and thus, Tius and Kerr
achieved a formal synthesis of morphine in 24 steps.
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Reagents and Conditions: k) PhSeCl, EtOAc, then H20 2, THF (70%); 1)
NaBH4, MeOH; m) MeLi, THF; n) HCOH, NaCNBH3, H20, CH3CN (54% over
three steps); 0) Dess-Martin periodinane, CH2C12 (75%); p) Zn, NH4Cl, EtOH,
H20 (73%, 60% conversion); q) DIBAL-H, THF; r) H30+ (quant); s) HOAc,
100°C (87%).
Scheme 17. Tius's final transformations to thebainone-A.
Hudlicky (1995)118
The Diels-Alder reaction has been exploited in the synthesis of a great number of
natural products and derivatives. Here, Hudlicky has applied the Intramolecular Diels-
Alder reaction of Furan (IMDAF) reaction toward the synthesis of the isoquinoline
derivatives, a structural motif common to all morphine alkaloids.
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R =H, OMe, alkyl R1 =H, OMe
R' =H, Me, alkyl R2 =H, aryl
Figure 14. Retrosynthetic analysis of Hudlicky's approach to isoquinoline morphine
synthons.
Model tricyclic systems were synthesized from olefin-tethered oxazolidinone 198, which
underwent thermal Diels-Alder cyclizations either by simple heating in toluene at 200 °C
(56%), or facilitated at much lower temperature (65-90 °C) by the addition of ~-
cyclodextrin (84%). The stereochemistry of the model tricycle was rigorously proven by
single-crystal X-ray analysis of thecis-diol 201. Based on this evidence, Hudlicky
postulated that the transition state favors a chair-like conformation in which the furan
adopts an exo-position as shown in Scheme 18.
198
a
proposed transition state
201
200
b
Reagents and Conditions: a) 90°C, cyclodextrin (84%); b) OS04, tBuOH-H20
(95%).
Scheme 18. Proposed transition state postulated for model isoquinoline cyclizations.
44
While the somewhat more sensitive 2-methoxyfuran fuctionality proved unstable toward
~-cyclodextrin catalysis, 2-methoxy-furanyl systems were found to readily undergo
thermal cyclizations at 165 °C to give the anisole 206 (40%) and the enone 208 (55%) on
simple, mono-substituted olefins. It is noteworthy that the oxo-bridged adduct was
neither isolated nor detected in crude reaction mixtures. The most advanced model
addressed the problem of installing the quaternary center via a Diels-Alder reaction.
According to this strategy, 2-methoxyfuran oxazolidinone 202 was alkylated with
mesylate 204 and the resulting compound heated in toluene in a sealed tube to provide
13% of advanced isoquinoline derivative 207..The stereochemistry of this compound
was established by correlation with analogous Diels-Alder adducts.
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Scheme 19.
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Hudlicky (1992, 1998)62
The aromatic dioxygenases discovered by Gibson are unique in that both the
chiral cyclohexadiene-cis-diol and its corresponding catechol are available from
enzymatic transformation of parent aromatic compounds. A close inspection of the
morphinan skeleton reveals that the A and C rings may be dissected into elements of both
the cyclohexadiene-cis-diol and the catechol functionality. Hudlicky envisaged a pseudo-
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symmetric approach to morphine in which both "halves" of the molecule may be
accessed through bio-transformation of aromatic compounds. Tethering the two pieces
at C-5 (morphine numbering) would set the stage for a Diels-Alder reaction to form the
dihydrobenzofuran core of the natural product.
NHMe
x
HO'"
HO
NHMe __;;::""",> CHO
HO",
HO
149 209 210
Figure 15. Hudlicky's retrosynthetic analysis of morphine through a Diels-Alder
reaction.
A preliminary model study, published in 1992, disclosed the synthesis of
truncated morphine derivatives 215 and 216. Dienediol 40, available from whole-cell
fermentation of toluene with E. coli JM109 (pDTG601), served as starting material for
the model study. The tetraene 212, rapidly assembled from toluene dienediol, was
heated to give the Diels-Alder adduct 213 as shown in Scheme 20. The expected Cope
rearrangement to tricycle 213 could only be effected after deprotection and oxidation of
the alcohol to its ketone. Luche reduction of the a,~-unsaturated ketone gave allylic
alcohol 216 possessing four stereocenters of the morphine skeleton in the correct
configuration.
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HO'" ~ THSO'" ~ THSO'" ~
40 211 212
d
216
e £9~""'. ~ ..'. III, ......:--_o ..&
215
~o
OTHS
213
j
~o
o
214
Reagents and Conditions: a) THS-CI, imid; b) NaH, sorbyl bromide; c) CCI4,
reflux; d) TBAF, then PCC, rt; e) xylenes, 250°C; CeCI3, NaBH4 0
Scheme 20. Hudlicky's synthesis of truncated morphine derivatives.
A similar model study was carried out using triene 218, which provided adduct
220, Scheme 20. Intramolecular Diels-Alder cyclization of 218 proceeded to give a
single diastereomer, whose structure was originally mis-assigned as 219 based on nOe
correlations in the NMR spectrum.
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Synthesis 1992
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220 R=THS I e
221 R=OH~
~eagents and Conditions: a) PAD, AcOH, MeOH; b) THS-CI, imid; c) NaH,
sorbyl bromide; d) toluene, 210°C; e) TBAF, THF.
Scheme 21. Hudlicky's correction of structure for truncated derivatives.
The error was detected when a more sophisticated model system was later developed
bearing the requisite nitrogen functionality for closure of the D ring. A single crystal X-
ray structure analysis of the free alcohol 122 revealed that the [4+2] cyclization had
proceeded through an exo-transition state, not through the endo-transition state as
originally expected. At this point, the cyclization of 218 was repeated, and the silyl
group removed following cyclization. A single crystal X-ray analysis of the resulting
alcohol 221 established that, analogous to amide 225, the cyclization proceeded through
an unexpected exo-transition state. The synthesis of 122 is of some import, as it provides
a very direct route to truncated morphinans possessing all of the stereocenters of the
natural product in correct configuration.
48
Br Br N3 V
I~ a HO", ~ b,c,d HO", e 0"oN3II II
.. THSO":
~ HO'\\ ~ THSO'\\
222 104 223 224
I f,9
~HACRO~OCAC h... °"'0THSO'\\
225
226 R=THS::J i
122 R= OH
Reagents and Conditions: a) Escherichia coli JMI09 (pDTG601); (10 gIL); b)
NaN3,DMF; c) PAD, AcOH, MeOH(72%); d) THS-CI, imid, DMF (99%); e)
NaH, sorbyl bromide, THF (62%); t) Ph3P, H20 (66%); g) AC20, py (quant); h)
toluene, sealed tube, 230°C (62%); i) 45% aq HF, MeCN (65%).
Scheme 22. Hudlicky's approach to the B,C,D ring system of morphine.
Rodrigo (1998)119
A stragetically similar Diels-Alder approach to that of Hudlicky was described by
Rodrigo. The approach exploits the tendency of o-substituted phenolic ethers to undergo
oxidative coupling with alcohols to give mixed ketals. In this manner, ketal formation
effectively tethers the diene to the ene, facilitating an intramolecular Diels-Alder reaction
as depicted in Scheme 23. The elegance in Rodrigo's strategy is that regardless of which
of the two possible Diels-Alder reactions take place, the products are degenerate. That is,
the cycloaddition product arising from an "aromatic" diene gives a bridged bicycle 230,
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which rearranges to give the regio-isomeric Diels-Alder product 229.
~OMe HO, ¢Je 0
'
0 + "::
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~ ..
~ 16°,,'0Me
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228 229
J
M~O [3,3]e ';: OMe
b 380/0
0
230
720/0
Reagents and Conditions: a) BTIB, THF;b) [3,3]-sigmatropic rearrangement
Scheme 23.
Rodrigo then embarked on a more advanced model employing methyl vanillate
231 as the ortho-quinone ketal precursor and allyl-substituted allylic alcohol 232 as the
diene component. In this way, the reaction sequence can be extended to give the
phenanthrofuran skeleton, comprising the A,B, and C rings of the morphine skeleton.
Treatment of these precursors with BTffi resulted in the formation of three Diels-Alder
adducts. Diastereomers 233 (13%) and 234 (11%) result from Diels-Alder addition
across the diene, whereas the bridged bicycle 235 (17%) is derived from [4+2]
cyclization with the diene component derived from the quinone. Thermal Cope
rearrangement of this compound gives the tetracycle 236, which undergoes
rearomatization to 237 upon saponification of the ester. Finally, the phenol was alkylated
using potassium carbonate and dimethyl sulfate to give the phenanthrofuran skeleton 238.
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11-3.2 Approaches to Mophine Involving Radical Cyclizations
Parker (1992, 1994)120, 121
Radical-cascades are remarkable in their ability to assemble complex ring systems
in a single operation. Their application in the synthesis of morphine, therefore, promises
to greatly shorten the overall synthetic sequence and address difficult tactical issues, such
as C-13 bond formation. Parker's original approach is based on a tandem radical
cyclization of an ortho-allyloxyl radical. 122 As an extention to this original work, Parker
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reported the radical cascade of o-methyloxime 239 as a rapid entry to the morphine
skeleton, Scheme 25.
Meo~~
1 0
o Br ::--...b N-OH
239
a
240
9 +
NH
I
OMe
241
Reagents and Conditions: a) nBu3SnH, AIBN, toluene, 110°C.
Scheme 25. Parker's first generation cascade approach to morphine.
Thus, in a single operation, the radical cascade provided morphinan derivatives 240 and
241, in which the correct relative stereochemistry at C-5, C-13, and C-14 was established.
The approach, however, failed to impart high selectivity in the relative stereochemistry at
C-9, giving only 31 % of the "natural" isomer 240. An alternative approach in the
racemic series addressed this issue and substitution at C-13. These model studies
culminated in a total synthesis .of racemic dihydroisocodeine in 11 steps from
commercially available m-methoxyphenethylamine. The synthesis was later re-designed
in the chiral sense- a summary of this work appears in a later section of this chapter.
Hudlicky (1996, 1998)123
Hudlicky's radical cascade approach resembled Parker's in that the initial radical
would originate in the aromatic A-ring, which would be introduced through Mitsunobu
alkylation of an appropriately substituted C-ring. In this case, the C-ring was fashioned
from diol 104, obtained from whole-cell fermentation of bromoethylbenzene with E. coli
JM 109 (pDTG601). A key issue here was the inversion of C-5 through an initial
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Mitsunobu reaction, and introduction of the aromatic piece through a second Mitsunobu
operation. Initiation of the radical cascade gave a predominatly one diastereoisomer,
morphinan 106, albeit in a low yield. The presence of diastereomer 105 was also
detected, however, this isomer was not rigorously characterized.
Br Br Br 0~ox5~I~ a HO", ~ b,c,d BzO e Ja BzO ~Ja Jar
0 HO\\\ 0 THSO\\\ THSO\\\
222 104 242 243
If,9
MeO 0MeO q ~O
h MeO ::....25~
:IE
TBSO\\' TBSO\\' THSO\\\
243
105 106
Reagents and Conditions: a) Escherichia coli JM109 (pDTG601); b) Potassium
azodicarboxylate (PAD), AcOH, MeOH 80%); c) TBS-OTf, iPrNEt2' CH2Cl2 (47%); d) PhCOOH,
BU3P, DEAD (84%); e) NaH, 2-oxazolidinone, DMSO (71 %); f) NaOH; g) 2-bromoisovanillan,
BU3P, DEAD (28% over two steps); h) (TMS)3SiH, AIBN, PhH (15%).
Scheme 26. Hudlicky's first generation radical approach to morphine.
The lack of stereoselectivity in the first generation approach prompted the design of a
stepwise radical closure which would improve the yield of the isomer having the correct
stereochemistry at C-13, C-14, and C-9. The approach relied on an initial radical-based
closure of bromide 246 to give an advanced isoquinoline synthon 248, Scheme 16.
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Reagents and Conditions: a) Escherichia coli JMI09 (pDTG601); b PAD), AcOH,
MeOH (50%); c) 2,2-dimethoxypropane, pTsOH (90%); d) NaH, 2-oxazolidinone,
DMSO (38%); e) nBu3SnH, AIBN (87%).
Scheme 18. Hudlicky's second generation "stepwise" radical approach to morphine.
Exposure of bromide 246 to tributyltin hydride/AIBN gave a 2: 1 ratio of diastereomeric
isoquinolines in 87% yield. The predominant isomer, which displayed an a-hydrogen,
was to become ent-configuration C-9 (morphine numbering) center and the synthesis of
unnatural (+)-morphine was pursued with this in mind. Introduction of the aromatic A-
ring by Mitsunobu alkylation furnished the radical cyclization precursor 248. Indeed,
exposure of 248 to tributyltinhydride and AIBN gave a single diastereoisomer 249 in
47% yield. Unmaksing the oxazolidinone with DIBAL installed the N-methyl
functionality and primary alcohol at C-IO. The alcohol was initially oxidized to its
aldehyde and treated with trifluoromethane sulfonic acid to induce Friedel-Crafts closure
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of the C-I0-C-ll bond. Alternatively, the des-oxy C-I0-C-ll bond formation was
achieved by conversion of the alcohol to its chloride and treatment with aluminum
chloride.
HO"
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+q Me0:Q MeaO"'(Q a,b,c TBso ..~r d... ..
. H" 'Fa I N
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Mea Ie
f,Q,h Mea
a OH109
TBSO'"Mea i,j
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Reagents and Conditions: (a) Dowex 50X8-100, MeOH (94%); (b) TBS-OTf, iPrNEt2, CH2C12
(85%); (c) 2-bromoisovani11an, BU3P, DEAD (94%); (d) BU3SnH, AIBN (47%); (e) DIBAL,
CH2C12 (87%); (f) TBAF, THF (quant); (g) (COCl)2, DMSO (66%); (h) CF3S03H (58%); (i)
MsCl, Et3N, LiCl (87%); G) AIC13, benzene.
Scheme 28. Hudlicky's second generation radical approach toward ent-morphinans.
Parker (2006)124
Parker's original synthesis of racemic dihydroc0deine, in which the morphine
skeleton was rapidly constructed through a radical cascade, was revisited in the chiral
sense, leading to an asymmetric synthesis of (-)-dihydrocodeinone. The key features of
the synthesis include elaboration of the asymmetric C-ring through Birch reduction,
acidic hydrolysis, and chiral reduction of the corresponding enone, and a radical-based
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cascade which set the C-5, C-13, and C-14 centers of the natural product. The final step,
a reductive de-tosylation, fortuitously installed the ethylamine bridge with correct
stereochemistry at C-9.
It is noteworthy that the diol 258 is very nearly the enantiomer of the arenediol
derived from fennentation of azidoethylbenzene, a synthon which will find application in
the several morphine approaches decribed in Chapter 111-6.4.
NH2 NH2 NMeTs NMeTs
a b,c d Br)II II II
MeO MeO 0 0252 253 254 255
H Ph
ffiPh NMeTs NMeTs NMeTs
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Me e Br f,g h HO
II .. II
HO RO
256 257 R=H 258C R = TBS 259
Reagents and Conditions: a) Li, NH3, t-BuOH (97%); b) TsCI, NEt3' then HCI (81 %); c) Mel,
K2C03, acetone (96%); d) Br2' NEt3 (91%); e) CBS reagent, catechol borane (84%); t) Na, Hg
(90%); g) mCPBA (92%); h) Ti(OiPr)4 (85%); i) TBS-CI, imid., DMF.
Scheme 29. Parker's asymmetric synthesis of the C-ring of morphine.
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Scheme 30. Introduction of the A-ring by Mitsunobu alkylation.
The aromatic A-ring was introduced via a Mitsunobu reaction125 with aromatic
ether 260. With the C-6 hydroxyl in the natural configuration of (-)-dihydroisocodeine,
the crucial radical cascade/C-13 closure was effected by treatment with tin hydride at 130
°C, presumably through the intermediacy of 263. It is noteworthy that only the
vinylthiophenol functionality gave good stereoslectivity in the radical-mediated closures.
Similar closures employing other radical acceptors failed· to produce single
diastereomers. Finally, treatment of 264 with Lilt-BuGH produced the nitrogen-centered
anion, which closed the E-ring with correct stereochemistry at C-9. Thus, an asymmetric
formal synthesis of morphine from (-)-dihydroisocodeine was achieved in 13 steps from
m-methoxyphenethylamine.
Meo~
~SPh
0" DrIII", ~ NMeTs
HO
262
264
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MeO
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(-)-dihydroisocodeine
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..
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Reagents and Conditions: a) nBu3SnH, AIBN, toluene (30%); b) Li, tBuOH
(85%)
Scheme 31. Parker's radical cascade toward the synthesis of dihydrocodeine.
57
11-3.3 Approaches to Morphine Involving Heck-type Cyclizations
Overman (1993)5
Overman's Heck-based strategy was notable in that it was only the second to
provide access to either enantiomer in the series of morphine alkaloids- the first
enantiodivergent synthesis was reported by Rice in 1980.126 The convergent design is
based on a key intramolecular Heck cyclization of the aryl halide 268 onto its tethered
octahydro- isoquinoline, providing the dextromorphinan ring system in 267.
Condensation of allyl silane 269 with aromatic aldehyde 270 afforded the chiral
isoquinoline synthon 268, which was utilized in the strategic palladium-catalyzed
cyclization.
o
(-)-dihydrocodeinone
266 267
MeO
OR
268
H
SiMe2Ph
mHR
__;.",,> 269
+
~CHO~II h OR
OMe
270
Figure 16. Retrosynthetic analysis of Overman's morphine approach.
For simplicity, the route toward natural morphine is described in Scheme 32.. The
synthesis began with an enantioselective reduction of 2-allylcyclohex-2-en-1-one with
catechol borane in conjuction with the (R)-CBS oxazaborlidine reagent, providing the
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precursor to natural morphine. The resulting enantioenriched alcohol was converted to
its carbamate and the olefin transformed to its diol, which was then protected as its
acetonide. It is noteworthy that the reduction of 271 using the (S)-enantiomer of the CBS
oxazaborilidine gives the expected allylic alcohol in similar yield .and with comparable
enantioselectivity. This enantiodivergent route allows access to both enantiomers of
morphine.
a,b,c
..
9CONHPh
()({
272
d ~{
273
e,f
..
Reagents and Conditions: a) CBS, catechol borane, (93%, 96% ee); b) phenyl
isocyanate (93%); c) OS04' R3NO, acetone, H+ (78%); d) nBuLi, CuI(Ph3P)2,
PhMe2SiLi (81 %); e) pTsOH, MeOH, NaI04, DBS-NH2(82%)
Scheme 32. Synthesis of allyl silane 274.
A suprafacial SN2' displacement of the carbamate with PhMe2SiLi in the presence of
nBuLi and Cul(Ph3P)2 gave the allyl silane 273 in 81 % yield. The diol was liberated and
subsequently cleaved to its corresponding aldehyde, which underwent condensation with
DBS-NH2 (dibenzylsuberylamine). Following cyanoborohydride reduction, the amine
was condensed with aryl aldehyde 275 in the presence of Znl2 to give isoquinoline
derivative 276, Scheme 33.
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Reagents and Conditions: f) 5 mol% ZnI2, EtOH, 60°C (82%); g)
Pd(TFA)2(Ph3P)2, 1,2,2,6,6-pentamethylpiperidine, toluene (60%); h) BF3e OEt2,
EtSH (79%); i) CSA, 3,5-dinitroperoxybenzoic acid, CH2CI2, 0 °C (60%); j)
TPAP, NMO (86%); k) H2, Pd(OH)2; I) HCHO, (80% over two steps).
Scheme 33. Overman's Heck cyclization and final transformations to morphine.
The Heck cyclization, critical to the establishment of the C-13 quaternary center, was
accomplished by treatment of 276 with 10 mol% Pd(TFA)(Ph3P)2 in refluxing toluene
using 1,2,2,6,6-pentamethylpiperidine as base. The tetracycle 277 having been
established, the remaining challenge was the closure of the benzofuran ring. This was
carried out by debenzylation to give 278, and epoxidation of the camphorsulfonic salt of
278, which gave the dihydrobenzofuran 279 in 60% yield. Oxidation of the resulting
alcohol provided (-)-dihydrocodeinone 266, which was further converted to natural
morphine as described by Rice.126,127
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Cheng (1997)128
Cheng reported the synthesis of truncated morphinans through the application of
an intramolecular Heck reaction as an alternative to radical cyclizations. Though he
originally investigated C-12 -C-13 bond closures by a radical cascade,129 Cheng
maintains that there are several advantages to the use of the Heck reaction over radical
reactions, such as the ability to carry out enantioselective closures mediated by chiral
ligands and the possibility for further derivatization via the unsaturation unit which
results from Heck products.
His initial model studies, designed to provide functionalizable truncated
morphinans, led to the development of a total synthesis of racemic desoxycodeine.13o
The key strategy of Cheng's synthesis is the elaboration of isoquinoline, which
constitutes the ring-C and D carbon and nitrogen framework, to a Heck cyclization
precursor, the product of which reaction provided the C-12, C-13 bond closure. An
attempted Pd-mediated olefin cyclization yielded, unexpectedly, gave instead the
corresponding N-benzylation product. This advanced intermediate was salvaged by a
Stevens rearrangement to give racemic desoxycodeine.
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Reagents and Conditions: a) Mel, CH2C12; b) NaBH4, MeOH, (85% over two
steps); c) ethyl ch1oroformate, KHC03, C1CH2CH2C1; d) NaOH, MeOH, (86%
over two steps); e) 2-bromoisovanillan, PBU3, DEAD (85%); 1) NaBH4, MeOH
(88%); g) TBDMS-C1, imid (84%); h) Pd(OAc)2, MeCN (62%); i) TBAF, THF
(95%); j) NCS,PPh3, THF (96%); k) Pd(PPh3)4, MeCN (59%); 1) Mel, CH2C12;
m) PhLi, Et20.
Scheme 34. Cheng's synthesis of desoxycodeine 285.
Hudlicky (2001)7
Hudlicky realized an elegant approach to the morphine skeleton, whose key step
involved a rare Heck cyclization to establish the C-13 quaternary center. A
retrosynthetic disconnection shows that the aromatic A ring would be derived from
bromoguaicol, Scheme 21. The advanced isoquinoline synthon would ultimately be
derived from homochiral bromophenethyl dienediol, available from whole-cell
fermentation of the phenethyl bromide. The key Heck coupling precursor 286 would
arise from opening of the isoquinoline epoxide 288 with the phenolate anion of
bromoguaicol 287.
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Figure 17. Retrosynthetic analysis of Hudlicky' s Heck approach.
The isoquinoline synthon, which makes up the B-C ring systems of morphine, had
previously been employed as a 9-carbon carrying unit in the 1996 and 1998 radical
cyclization studies directed toward the synthesis of ent-morphinans.
Phenethylbromide 222 was subjected to whole-cell fermentation with E. coli JM
109 (pDTG601) to provide the corresponding chiral diene diol 104. The diol was
converted in several steps cyclization precursor, 290. Treatment of 290 with aluminum
trichloride afforded the isoquinoline scaffold through an imimiun ion cycloaddition, the
product of which was subjected to dehydration under basic conditions (DBU, 100°C).
At this stage, a key issue is the attachment of the aryl unit at C-5. An initial inversion
step was necessary to provide the correct stereochemistry following attachment of the
aromatic A-ring by a Mitsunobu reaction.
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Reagents and Conditions: (a) Escherichia coli JM109 (pDTG601);· (10 gIL); (b) potassium
azodicarboxylate (PAD), AcOH, MeOH (52%); (c) benzoic acid, DCC, DMAP, (95%); (d)
oxazolidine-1,4-dione, tetramethylguanidine, THF (79%); (e) NaBH4, MeOH, THF (quant); (t)
AlCI3, CH2CI2, anti (16%), syn (40%); (g) DBU, DMSO, 100°C, (16%); (h) NaOMe, THF,
(87%); (i) pTsOH, py, DMAP, (45%); G) benzoic acid, nBu3P, DEAD, THF, (79%); (k) NaOMe,
THF, (68%).
Scheme 35. Synthesis of Hudlicky's B,C-ring -isoquinoline synthon.
Opening of the epoxide 288 with the potassium salt of bromoguaicol gave the Heck-
cyclization precursor having all the necessary carbons in the morphine skeleton. The
remaining alcohol functionality was protected as its silyl ether prior to palladium-
catalyzed cyclization. Treatment of 295 with Pd(PPh3)4 in toluene and employing proton
sponge® as base gave the cyclized Heck product 106 in 74% yield.
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288
Reagents and Conditions: a) DME, 18-Crown-6, reflux (80%); b) TBS-OTf,
CH2CI2, iPr2EtNH (77%); c) Pd(PPh3)4, proton sponge™, toluene, reflux (74%).
Scheme 36. C-13 closure facilitated by palladium catalysis.
The oxazolidinone was reduced to give the N-methyl functionality in the natural product.
A total synthesis of condeinone, and by extension, a formal synthesis of morphine will
require closure of the CIO-CII bond, isomerization of the olefin, and inversion of C-6.
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Scheme 37. Final transformations toward (-)-codeine.
Trost (2005)6
Trost developed a divergent approach in which the key intermediate cyano aldehyde 309
could be transformed into the galanthamine or morphine derivatives. The general
strategy relies on two well-developed palladium-catalyzed reactions: the asymmetric
allylic alkylation reaction (AAA), which was used to introduce asymmetry, and the Heck
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cyclization, through which the C-13 quaternary center was established in both series of
natural products.
·149
(-)-Morphine
OMe
OH
297
(-)-galanthamine
OMe
298
Heck
OHC~
ljOMe
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OHC~
xyoMe
OH
300
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301
Figure 18. Retrosynthetic analysis of Trost's divergent approach to morphine and
galanthamine.
The aryl ether 305 was synthesized by a palladium-catalyzed asymmetric allylic
alkylation of allylic carbonate 303 with bromo-isovanillin 302, affording the aryl ether in
72% yield and 88% ee facilitated by bis-phosphino ligand 304 shown below, Scheme 31.
OHCyIh- +Br OMe
OH
302
COOMe(yoTroc
303
cat PdL*
Br~CHO
COOMe I)-yo ~o OMe
305
304
Scheme 38. Synthesis of aryl ether 305.
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The ester in aryl ether 305 was reduced to its alcohol after protection of the aldehyde as
its acetal. The alcohol was then activated toward displacement with acetonecyanhydrin
under Mitsonobu conditions. Treatment of this material with a catalytic amount of p-
toluenesulfonic acid regenerated the cyano aldehyde, which was subjected to a Heck
closure to establish the C-13 quaternary center as detailed in Scheme 40.
CHO M;QMe CHO OMeBr~ o Br ~ NC Br~COOMe I a,b Hao ~I c,d a ~I e0°~ II II ~ 0 ,.~ OMe ~ OMe . OMe
305 306 307 308
Reagents and Conditions: a) 1.5 mol % pTsOH, CH(OMe)3, MeOH; b) DIBAL-H, toluene, -
78°C; 85% (over two steps); c) Ph3P, acetonecyanhydrin, DIAD, Et20; d) 2.2 mol % pTsOH,
THF, H20, 76% (over two steps); e) 15 mol % Pd(OAc)2, 15 mol % dppf, 3 equiv Ag2C03,
toluene, 107°C, 91 %.
Scheme 39. Heck closure to key intermediate 308.
A Corey-Fuchs homologation of the aldehyde 308 to its dibromide, and reduction of the
dibromide to its Z-vinyl·bromide set the stage to perform a second Heck closure, which
furnished the phenanthrofuran core of the alkaloid.
OMe
.. NC
h
OMe
9
..
OMe
Br
Br ~
OMe
308 309 310 311
Reagents and Conditions: t) CBr4, PPh3, CH2C12, 91 %; g) 5 mol % Pd(PPh3)4, nBu3SnH,
toluene, 88%; h) 15 mol % Pd(OAc)2, 15 mol % dppp, Ag2C03, toluene, 65%.
Scheme 40.
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Scheme 41 details the final transformations to morphine, which involved a selenium-
dioxide mediated allylic oxidation of C-7 to its enone and subsequent reduction of the
enone to its allylic alcohol. Reductive amination of the nitrile was carried out in a one-
flask operation by allowing the imine complex to form by reduction of the nitrile in
methylene chloride. Ammonium bromide in dry methanol was then added to quench any
excess hydride and liberate the free imine. Transamination was effected by addition of
excess methylamine and the secondary imine reduced in situ to its methylamine
derivative by addition of sodium borohydride. The penultimate step in the synthesis of
morphine involved a unique photochemical closure of the methylamine anion onto the
allylic C-14 center. This step was ultimately carried out by treating compound with 6
equivof LDA in THF in the presence of a 150-W tungsten bulb. Codeine was converted
to· morphine by demethylation with BBr3 according to the procedure of Rice.131
OHOMe OMs OMe
i,j k I,m III
NC
III ~
NC
OH OH
311 312 313 149
(~)~morphine
Reagents and Conditions: i) Se02' dioxane, sand, 75°C; j) DIBAL-H, THF, Et20, 99%; k)
DIBAL-H, CH2C12IEt20, then NH4Br, MeNH2, and then NaBH4 (quant); 1) LDA, THF, 150-W
tungsten bulb, 57%; m) BBr3 " CH2C12.
Scheme 41. Trost's final transformations in the synthesis of morphine.
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Throughout the 19th and early 20th century, experiments aimed at the structural
elucidation of morphine have been closely associated with the development of the
discipline of organic chemistry. Today, 54 years after the first synthesis by Gates,
morphine remains a formidable target for the synthetic chemist, and new contributions to
organic synthesis continue to be made as a result of these pursuits. Now that over thirty
formal or total syntheses of morphine have been reported, the next remaining challenge
may be even more difficult to attain- a fully synthetic route to morphine that would
compete economically with its isolation. To date the most efficient synthesis is that of
Rice, which provides a relatively direct route in morphine in 29% overall yield. 126
The complexity of morphine alkaloids has inspired a number of creative
approaches which address the difficult steps common to many syntheses- C-12,C-13
bond connection, the aryl ether formation, etc. The preceding chapter highlights some of
the important contributions which feature Diels-Alder, radical cascade, or palladium-
catalyzed bond-forming reactions as key strategies in the rapid construction of morphinan
alkaloids. .However elegant, most of these syntheses are far from ideal. Many suffer
from non-selective bond formation at C-9, require either tedious protectionldeprotection
sequences, and! or difficult, late-stage C-ring oxygenation protocols. Some of these
problems may be addressed in part through judicious choice of starting material.
The arenedihydrodiols which have found application in a variety of
enantioselective synthesis are particularly well-suited to morphine synthesis. Not only
are the starting material chiral (obviating tedious enantio-enrichment protocols), they are
functionally rich. The natural 1,2-disposition of the diol functionality allows easy
adaptation of these substates as C-ring morphine synthons, having naturally correct
69
configuration at C-6, and ent-configuration at C-5. This particular arrangement is well
suited for Mitsunobu-type coupling of aromatic halides, substrates which may be
exploited in radical or Heck-type cyclization reactions. Moreover, the aromatic A-ring
may also arise from fermentation of aromatics, as substituted bezenes are readily
converted to their corresponding catechols by oxidation with E. coli JM 109 (pDTG601).
Radical cascade and Heck reactions, some of which were highlighted by
application to morphine synthesis in the previous section, will be re-visited in a
chemoenzymatic approach, with the ultimate goal of greatly shortening the length of
morphine synthetic sequences. Athough all dienediols harvested from fermentation are
functionality rich, we continue to isolate new diol metabolites which may constitute
important intermediates in the synthesis of complex molecules, such as the morphine
alkaloids.
III Discussion
111-1 Introduction
The present research addresses, as a primary goal, our recent efforts toward the
chemical synthesis of morphine alkaloids; several unique approaches to the target
molecules are presented. Despite its being one of the oldest drugs on record, morphine
(and its derivatives) continue to find new applications in the medical field, such as in
open heart surgery and pain control.132,133 However, only a few specific geographic areas
produce opium poppies having usable amounts of these important natural products. The
problem is further compounded by the fact that many of these countries suffer from
political turmoil. The ultimate goal of the Hudlicky research group is to design a
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synthesis of morphine, beginning from enzymatically generated starting materials, which
would rival the cost of isolation from its natural source. Such a goal would ensure access
to steady supplies of the natural product without dependence on the isolation from its
natural source.
As target molecules have become increasingly complex, chemists have enlisted a
variety of "borrowed" technologies that have resulted in greatly shortened and improved
overall efficiency of many syntheses. For example, the incorporation of enzymatic
reactions (traditionally of interest to the biochemist or biologist) into synthetic sequences
can provide chiral synthons that may be further converted into a variety of beneficial
products. Among these materials are natural products which are known to possess
medicinal properties. A major component of our program is aimed at the synthesis of
morphine alkaloids and other medicinally useful natural products starting from materials
which are obtained through oxidative fermentation of aromatic compounds. Two
approaches to the synthesis of morphine alkaloids will be discussed. The first approach
targets thebaine, and the key strategy hinges on the ability to chemically or enzymatically
oxidize the divalent sulfur in substituted thiophenes. Fittingly, this approach will be
discussed only after the work involving enzymatic oxidation of aromatic substrates,
including a series of compounds bearing divalent sulfur functionalities. The second
approach to morphinans is based on radical and palladium-mediated bond-fonning
reactions. The common thread to this work is the use of the dienediol nucleus derived
from oxidation of aromatics. Preceding the discussion of these two major approaches
will be a summary of the research addressing the substituent tolerance and substrate
specificity by the enzyme toluene dioxygenase.
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A cursory glance at Table 1 reveals that the diols derived from benzene,
chlorobenzene, bromobenzene, and toluene have enjoyed broad .application in the
synthesis of structurally-diverse natural products. Although these four synthons remain
important building blocks, we continue to search for ·new metabolites with increased
functional content. It is because the enzyme toluene dioxygenase exhibits a high
tolerance for functionally diverse substrates that we are able to access new metabolites
from fermentation. Part of the present work is devoted to the isolation and rigorous
characterization of new metabolites from fermentation. To this end, a series of
bromothioanisoles was ·prepared and subjected to oxidation. Diene-diols such as 316
may be amenable to further manipulation. Elaboration of metabolite 316 by attachment
of olefinic tethers would allow investigations into radical or Heck-cascade reactions onto
the vinylbromide. Additionally, the vinyl sulfone may be used in conjugate addition
reactions. Specifically,our efforts to use derivatives of metabolites such as 316 in Diels-
Alder studies will be described in 111-2.0. The oxidation of this series of thioanisoles,
thus, served as a model for the tandem oxidation of thiophene-Diels-Alder approach
toward thebaine.
S~E+
SMa SMa ~OH¢ TOO ¢XoH NU-(::::'" 0!a •~ OH ChSr Sr
R
315 316 317
Figure 19. Reactive options in dienediol317.
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m-Dibromobenzene is unique in that its corresponding aromatic diol is the only
m-substituted arenediol to have been used in a total synthesis effort.3 The results of
whole-cell oxidation of the remaining isomers comprising this series, the ortho- and para-
substituted dibromides, are the next to be presented. Figure 20 highlights the synthetic
utility of the o-dibromobenzenediol in the projected synthesis of cyclitols and
carbohydrates.
CXOHHO"" =. OH
OH
.--------
Br~oxHO\"'~O
OH
--------~
C02H
HO H
HO H
H OH
H OH
C02H
6 (-)-conduritol E 318
~
Br'6
4
319 D-mannaric acid
Figure 20. Access to sugars and cyclitols from halobenzenes.
The outcome of oxidation for each substrate will be discussed with regard to its
symmetry. Additionally, the opportunities for selective conversion of 0-
dibromodienediol to either sugars, such as D-mannaric acid, or cyclitols, such as
conduritol E, will be highlighted.
The epoxide and aziridine derivatives of cyclitols are invaluable synthons for
natural product synthesis. As shown in Table 1, the cyclitol or aminocyclitol moiety is a
feature common to many natural products, and one readily accessible from the
fermentation of aromatic substrates. The nucleophilic opening of cyclitol epoxides or
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aziridines thus provides a means to elaborate these useful synthons. We initiated a
program directed at using silica gel as a replacement technology to metal or acid-
mediated opening of strained heterocycles, such as epoxides and aziridines. The results
of our research in this area will be presented in Chapter 111-5.0.
Cyclopropylbenzene, previously shown to be excellent substrates for the enzyme,
was originally investigated as part of a mechanistic study of toluene dioxygenase. 134 As
part of our ongoing interest in the mechanism of this enzyme, the results of oxidation of a
series of cyclopropylbenzenes will be presented. The study, which includes a number of
cyclopropylbenzenes bearing remote chiral centers, is aimed at answering the important
question of whether or not toluene dioxygenase is capable of resolving pro-chiral centers
proximal to the site of oxidation on the ring. In addition to the provision of chiral
vinylcyclopropanes, often used in tandem cycloaddition processes, the study should
present a clearer picture of the specificity of the enzyme for its substrates.
In connection with our long-standing interest in the oxidation of aromatic and
sulfur-containing compounds, we present a new morphine approach whose key step
would rely on a tandem enzymatic sulfoxidation-Diels-Alder sequence. Chiral
sulfoxidation of thiophenes, which occurs with concomitant loss of aromaticity, is a
reaction that is unique to the world of enzymes.
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Figure 21. Retrosynthetic analysis of thebaine synthesis.
As only ·limited examples of such enzymatic reactions are described in the
literature, we initially embarked on a model study directed at establishing the feasibility
of such tandem reaction. Our efforts toward the construction of this skeleton based on
simple model studies are detailed in Chapter 111-6.1.
X=O, NMe
[0] ~x 0 heat
sulfur oxidation!
extrusion of 802
2i(\~ Model C-13. quaternary centerX 0
Figure 22. Model approach involving tandem sulfoxidationlDiels-Alder cyclization.
This approach would allow rapid construction of the pentacycle from relatively simple
achiral precursors. In connection with our interest in aromatic sulfur oxidations, we
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examined the oxidation of a variety of substrates bearing a divalent sulfur functionality;
the results of these general studies are detailed in Chapter 111-3.1.
The second major approach to the morphinan skeleton is aimed at the introduction
of the aromatic A-ring through palladium catalysis. This new approach promises several
advantages over previous routes. As discussed in the historical section, a number of
morphine syntheses rely on a Mitsunobu alkylation for introduction of the aromatic A-
ring to an oxygenated C-ring. This disconnection necessitated a number of lengthy
inversion and/or protection and deprotections steps when applied to chiral diols from
fermentation. By direct alkylation with an aromatic piece, we may avert lengthy
inversion steps and correctly set the C- 14 stereocenter with complete control. The
discussion section will end with a description of this approach to the current stage of the
project.
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Figure 23. Palladium-catalyzed bond-formation in morphine synthesis.
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111-2 Oxidation of Sulfur-containing Aromatic Substrates by Toluene
Dioxygenase
The dioxygenase enzymes capable of converting aromatics to their corresponding
arene-dihydro dienediols have shown extraordinary selectivity in the oxidation of sulfur-
containing aromatics to their chiral sulfoxides, in many cases without accompanied over-
oxidation or dihydrodiol formation. Although the exact mechanism for theoxidation is
unknown, oxygen uptake experiments with purified dioxygenase enzymes have shown
unambiguously that these enzymes are responsible for this transformation.135
323
-,
toluene dioxygena:e 0 (SA
324
Figure 24. Oxidation of thioanisole to give R-sulfoxide.
Although chiral oxidations at sulfur are common to many microorganisms,
dioxygenases are known to have an increased level of specificity. Toluene dioxygenase
shows a preference for the formation of the R-isomer, whereas naphthalene dioxygenase
gives predominantly the S-isomer.
Outside active site
Inside active site
0+---" ::x5all
Large
Figure 25. Apparent difference in mechanism for ring vs. sulfur oxidation.
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Boyd has proposed a general empirical model for the oxidation of substituted
aromatics, which indicates that the larger of the two groups lies distal to the iron center in
the active site.4 While this working model is applicable to a vast number of substituted
aromatic substrates, the picture is somewhat more complicated for compounds bearing
sulfur functionalities as shown in Figure 25. In cases where divalent sulfur is oxidized to
its sulfoxide by dioxygenase enzymes, the thi0 ether must necessarily occupy a position
proximal to the iron center of the active site of the enzyme. That sulfur-containing
compounds are oftentimes oxidized to chiral sulfoxides with such specificity is more
remarkable.
Table 3. Selected Examples of Dioxygenase -mediated Divalent Sulfur Oxidation.
Entry Aromatic Metabolite Organism (Ref)
substrate
1 s-- 0 Pseudomonas
6 ·· .....8...- putita UV41416 E. coli JM 109(pDTG601)136
323
324
2 s-- .. Neill 8859
6 0,1...-6 (NDO)137
323 325
3 s-- s-- Pseudomonas
¢ HO ••¢ putita UV4138HO,'1 ~ E. coli JM 109(pDTG601)136
Br Br
315 316
78
4 8-- . q E. coli JM 1098-- · .......8-- (pDTG601)136Q HO"Q
h- Br
HO \' h- Br
Q
h- Br
326 327 328
5 O's,,-,s,-
., ,0 Pseudomonas
Ih- putita UV4139O's,,-,s,-
329 Ih-
330
6 (1 0,(1 (1 Pseudomonas
6 : ",...SyS 8 8 putita UV4
140
I~ 0 HO",·Oh- HO'\" ~
331 332 333
minor major
7 Co cexOH Pseudomonash- 8 I ~ S OH putita UV4141
334 335
8 0 H OH Pseudomonass ~ + ~OH putita UV4142336 ~ H
0
337 338
9 R-s-fJ R-s-fJ Pseudomonasputita UV41428 I S
0
339 340 R=Me
341 R= Ph
342 R = 2-Thiophene
10 ces> ces> Pseudomonash- 8 h- S putita
\ 9816/11(NDO)1430343
344
79
11 ceS> ces> Pseudomonasputita UV4143~ S ~ ~
343 0
345
12 cr:) cr:) Pseudomonasputita
1 9816/11(NDO)143
346 0
219
13 cr:) cr:) Pseudomonasputita UV4143
6
346
348
Despite the overwhelming number of examples in which aromatic thioethers are
processed to sulfoxides, there are also many cases in which dioxygenases prefer to give
ring-hydroxylated products, without attendant oxidation at sulfur. An interesting case is
encountered in thioanisoles. The parent compound, thioanisole, gives exclusively the R-
sulfoxide in greater than 90% optical purity when subjected to oxidation with toluene
dioxygenase, in contrast to p-halothioanisoles, which give dihydroxylated products.
In 2004, Boyd published138 the results of a toluene dioxygenase-mediated oxidation study
involving series of para-substituted thioanisoles. In all cases, the oxidation proceeded
with high ee's (>90%) to give the corresponding diene diols.
We were initially interested in the specificity of oxidation with respect to
substitution patterns on the ring. Our study began with p-bromothioanisole 315, which
was converted to its corresponding diene diol 316 in a high yield (3.2 gIL) without any
indication of accompanied sulfoxide formation, Scheme 42. We then set out to establish
the absolute configuration of the new metabolite. Our initial hope was that we could
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isolate a small amount of the corresponding diene diol from the oxidation of thioanisole.
This compound was specifically chosen because mono-substituted compounds give
exclusively the 2,3-diol with p-stereochemistry, with exception paid to benzoic acids,
which give ipso-substitution.
chemical match for comparison.
s"""'" s"""'"¢ TOO ¢roH.. ~ OH
Br Br
315 316
Dehalogenation of metabolite 316 would provide a
0
s"""'" s"""'" :~ .........SCc°H 6 TOO 6.. • X ..~ OH
349 323 324
Scheme 42. Initial approach for determination of absolute configuration.
Fermentation of thioanisole 323 gave, instead, exclusively 92% optically pure R-
sulfoxide 324 and the initial approach was abandoned. The second chemical matching
strategy relied on a 1998 report from the Boyd group, which describes the displacement
of bromide by treatment with sodium thiomethoxide in HMPA, Scheme 43.144 We opted
to initially reduce diene 72, whose absolute configuration is well established, to its more
stable mono-ene with diimide and subsequently displace the bromide functionality based
on analogy to Boyd's experiment.
~OH
U OH
72
Scheme 43.
NaSMe/
HMPA
..
SMe
h OH
U OH
349
In preparation to make a chemical match, the vinyl bromide functionality on diene diol
316 was reduced electrochemically by Dr. Petr Cankaf, and the crude product from
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electrochemical reduction submitted directly to diimide reduction, giving vinyl thioether
350.
SMe SMe SMe
<XoH -2.72 v aOH diimide (x0H.. ..~ OH Hg cathode ~ OH OH
Br
316 349 350
Scheme 43. Electrochemical reduction of diol metabolite 316.
Bromodiene diol 72 was reduced with diimide to vinyl bromide 351, which was subjected
to the conditions (NaSMe, HMPA, 60°C) employed by Boyd in the synthesis ofthioether
349. We were surprised to find that the physical and spectral properties of vinyl thioether
350 made by electrochemical reduction and subsequent diimide reduction did not match
those of the compound prepared from bromodiene diol. Their elemental compositions
were, however, identical.
Br Br NaSMe/ MeSa(xoH Cx°H HMPA OHPAD/AcOH.. )( II
~ OH OH OH
72 351 352
Option b I Option a
B;jH BrMes~ MesDoH -HBr •MeSUOH
OH OH OH
353 354 355
~ S~ I(H OH
}:OH
UOH
350
MeS 356
Figure 25. Mechanistic options for rearrangement of compound 351.
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Careful analysis of the COSY NMR spectra of both compounds revealed that a
rearrangement had taken place in the course of the sodium thiomethoxidelHMPA
displacement of bromide 351. Two plausible mechanistic options are offered in Figure
25. One can easily assign the structure of the rearrangement as compound 355 based on
an analysis of the IH NMR and COSY spectrum.
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Figure 26. COSY-spectrum of rearrangement product 355.
The IH NMR spectrum reveals that the vinyl proton B 5.35 ppm is a doublet with
coupling constant, J =4.3 Hz. It exhibits a strong coupling with its neighboring proton,
which appears at B4.15 ppm. The proton at 4.15 ppm, in tum, couples strongly with its
neighboring proton at B3.67 ppm. The assignment of compound 355 was based of the
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characteristic coupling pattern of three contiguous protons, as shown in Figure 26.
Assignment of the regioisomeric structure having identical elemental composition
derived from p-bromothioanisole is again based on analysis of the IH NMRand COSY
spectra. The vinyl proton at B5.61 ppm is a clean triplet with coupling constant J =3.9
Hz. While the proton at B4.10 ppm couples strongly to its neighbor at B3.65 ppm, its
coupling to the vinyl proton at 5.61 ppm cannot be detected. This characteristic coupling
pattern is indicative of structure 350, in which coupling from the proton at 5.61 ppm to
the proton at 4.10 ppm is insulated by the thiomethyl group.
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Figure 27. COSY spectrum of compound 350.
The determination of absolute configuration of diol metabolite 316 was ultimately
made by conversion of this compound and bromodiene diol 72 to a common
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intermediate, mono-protected silyl ether 358. Diimide reduction of bromodiene dial 72
and subsequent protection of the distal hydroxyl as a THS silyl ether gave compound
357, which was subjected to hydrogenation over Adams' catalyst to give mono-protected
silyl ether 358. This intermediate was alternatively synthesized from diol metabolite 316
by electrochemical reduction, and treatment of the crude electrochemical reduction
product with diimide to give compound 350. Diene diol 349 was quickly purified by
chromatography on deactivated silica gel for the purpose of characterization, however,
the half-life of this compound in pure state at room temperature is less than 20 minutes
and it is recommended that it be directly converted to its more stable derivative 350.
Br Br
6 0H 1) PAD, AcOH 6 0H Pt02 , H2" '"~ OH 2) THSCI, imido OTHS
72 357
toluene dioxygenase
•(TOO) ¢cSMe OH~ OH
R
PAD, AcOH
'"
(X0H
OTHS
358IRaney Ni
aOHOR
o Ph
NEta. DM:P (Xo-ay.~ OMe
Mosher's acid CF3
chloride OTHS
359
315
Scheme 44.
316 R= Br
349 R= H :J -2.7 V 350 R= H ~ THSCI, imido360 R= THS ~
Thioether 350 was similarly protected as its silyl ether, and the resulting compound 360
subjected to reduction by Raney nickel to give the mono-protected dio1358. Spectral and
physical properties of compound 358 prepared by both routes were in agreement. The
absolute configuration was determined to be the same for both compounds based on their
having the same sign of specific rotation. Determination of ee was carried out by
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acylation of compound 358 with Mosher's acid chloride. A racemic standard of 359 was
initially prepared by treating rac-358 with Mosher's acid chloride. Comparison of the
respective acylation products 359 derived from bromodiene diol 72 and diol metabolite
316 revealed that both exist as single diastereomers, indicating that both had been
oxidized enzymatically to give a single enantiomeric product.
Having. established the absolute configuration and ee of compound 316, we were
prompted to undertake a specificity study of the remaining two members of the
bromothioanisole series. The ortho-substituted thioanisole was subjected to small-scale
fermentation with E. coli JM 109 (pDTG60l) to give a mixture of the chiral diol and (R)-
sulfoxide, with a preference for the diene diol. m-Bromothioanisole was also oxidized
with the same organism, which gave, in this case, primarily the (R)-sulfoxide along with
a small amount of chiral diene diol. We required a larger amount of this diene diol for a
chemical proof of absolute configuration and repeated the oxidation on fermentor scale,
however, ·in this case, the oxidation resulted solely in the formation of the sulfoxide,
Table 4.
Table 4. Comparison of yield and distribution of products from shakeflask and
fermentor transformations.
Fermentor Shakeflask
sulfoxide diol sulfoxide diol
mgIL (mgIL) mgIL (mgIL)
s"""" 0 2300 -* -*¢C0H
~ OH
Br
316
86
s"""'" 50 175 47 117
BrU
OH
~ OH
364
s"""'" 150 0 130 7
tx°HBr ~ OH
327
*Not perlormed.
The corresponding chiral sulfoxides are known compounds, and their optical
purities were calculated relative to specific rotations reported in the literature.145,146,147 A
chemical proof of absolute configuration of the .diene diols was ~carried out according to
Scheme 45.
Br~e
U
362
toluene
dioxygenase
•
SMe
+ Br~OH 1) PAD, ACO~U 2) DMP, TsOH
1 : 2.5 OH
364 365
SMe SMe SMe SMe¢x 50/0Pd/C, (x0H Cx:><'9' OH HCOOH, NEt3 (x0H PAD, AcOH DMP, TsOH:::-.. OH -or -2.7 V (~g) • •~ OH OH
Br
316 349 350 366
toluene
dioxygenase
•
. 0
• ,-: 1) 50/0 Pd/C, HCOOH, NEt3j)S-Me ~ 2) Potassium azodicarboxylateI: + M OH__..... AcOH
Br Br OH
328 327
18: 1
Scheme 45. Proof of absolute configuration for diol metabolites 327 and 364.
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241
Figure 28. Various reactive options in sulfur-containing diols.
We chose initially to investigate the possibility of Diels-Alder reactions in which the
vinyl sulfone would serve as the ene component. These studies were performed with the
help of graduate student Jon Collins (Brock University). To this end, thioether 316 was
chemically oxidized to its more stable sulfone. Having found conditions which allow
oxidation of the thioether directly to the sulfone, we reduced the vinyl bromide of diol
316 by hydrogenation over Adams' catalyst and the resulting compound 350 was
subsequently protected as an acetonide, Scheme 46. Oxidation of divalent sulfur to its
sulfone was accomplished by treatment with aq hydrogen peroxide and ammonium
molybdate. The vinyl sulfone would allow us to investigate Diels-Alder reactions with
various diene components.
SMa SMa SMa
a:><¢CoH pta! H2 (x0H DMP, TsOH Cr:>< H20! NH4Mos024.. .. ..~ OH OH
Br
316 350 366 367
Scheme 46. Synthesis of vinyl sulfone 367.
Ultimately, the sulfone would serve as a prelude to the tandem oxidation-Diels-Alder
sequence that was planned for the synthesis of thebaine. Several dienes were enlisted for
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the Diels-Alder studies, however, starting material was quantitatively recovered in each
reaction and further elaboration of diol metabolite 316 was abandoned.
Table 5. Attempted Diels-Alder reactions of sulfone 367.
Dienea Dienophile Solvent Temperature Result
0 5:>< 120 U recovery of 8M#,:=.o0 neat
368
OSiMea 5:>< toluene 120
uC recovery of 8M~OMe -or-
369 neat
0 5:>< 40 Uc to 120°C recovery of 8Mneat370
a Or diene equivalent
In conclusion, a substrate specificity study with regard to outcome of enzymatic
oxidation has been conducted on a series of thioanisoles. The product distribution seems
to be highly influenced by the distance between the substituents. In the case of p-
bromothioanisole, the dienediol 316, obtained as a single enantiomer, was the exclusive
product of oxidation. Moreover, the fermentation of p-bromothioanisole with E. coli JM
109 (pDTG601) provides useful amounts of the bacterial metabolite, which may be
amenable to further application in asymmetric synthesis. Conversion of this metabolite
to sulfone 367 has permitted a preliminary Diels-Alder study featuring several
commercially available diene components. While these substrates failed to react under
our conditions, future work might include a study of substrates having an intramolecular
dienyl tethers. The conditions used to effect both chemical and enzymatic oxidation at
sulfur will be re-applied to the tandem oxidationlDiels-Alder study toward the synthesis
of thebaine.
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111-3 Oxidation of 0- and m-Dibromobenzene- Synthesis of (-)-Conduritol E.
As an extension to our continued studies concerned with the relationship with the
specificity and mechanism of oxidation of aromatics by toluene dioxygenase, we became
interested in the fate of oxidation for all isomers of disubstituted aromatics- ortho, meta-,
and para. Table 6 lists such a series for which the metabolites are known for all three
isomers.
Table 6. Known arene diol metabolites listed by complete series.
Substrate Products (references)
I I I I
© F'(x0H aOH ¢C0H~ OH F ~ OH ~ OHF
371 F
372149 373149 374149,150
I I I I
© BrUOH b OH ¢CoH~ OH Br ~ OH ~ OHBr
375 Br
376149 377149 378149,151
6 CI£OH Lc -9'-7 OH -7 OHCIQ ~ OH CI ~ OH ~ OH
379 CI
380152,153 381152 382152
62H F(j02H F C02H C02H-7 OH 'Ct0H U OH~ OH ~ OH F ~ OHF
* * *383
384154,155,156 385157 386154,155,157
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~e
Sr
SMa
BrVvOH
U OH
J:OH
BrAAOH ¢cSMe OH~ OH
Sr
364136,158 327136,158 316136,158
387
388159,160
CI
389159,160
OH
OH
390159,160
*Absolute stereochemistry not determined.
Meta-substituted aromatics are generally poor substrates for the enzyme, if they are
oxidized at all. A notable exception is m-dibromobenzene, which gives up to 4 gIL of the
corresponding diene diol and was used as chiral starting material in the synthesis of
narciclasine.161 The inherent symmetry in this molecule allows the formation of only a
single diene diol, Figure 16.
We decided to investigate the oxidation of the two remaining members of this
series of di-bromobenzenes. p-Dibromobenzene 392 was oxidized to its corresponding
diene diol 393 in 55 mgIL in a small-scale shakeflask fermentation. Although this
particular compound is meso, it may find application in asymmetric synthesis through
further lipase resolution and desymmetrization.162 Such procedures have been used to
enrich enantiomeric excesses of those diols that are produced as scalemic mixtures.
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ortho-
Sr Sr
Br~6J ~r~OH~\ U OH
4 5
1 regioisomer
2 enantiomers
meta-
-_& _ LOH
BrN -- BrA)..oH
391 113
1 regioisomer
2 enantiomers
para-
--$--- ~::
Sr Sr
392 393
1 meso compound
Figure 29. Symmetry of di-bromobenzenes and possible modes of oxidation.
The o-dibromo isomer 4 was oxidized by E. coli JM 109 (pDTG601) in a 15-L fermentor
to give diene diol 5 in 4.1 gIL. Following a literature precedent, compound 5 was
protected as its acetonide 394 and the more electron-rich olefin subjected to
dihydroxylation to afford tetrol 318. Removal of the both bromine atoms was
accomplished smoothly using tri-n-butyl tin hydride to give the known compound 395.
According to a literature prodecure, the acetonide functionality was removed using 3%
cone Hel in MeOa to give the natural product (-)-conduritol E in 81 % yield. The optical
purity of (-)-conduritol E 6 was compared to a literature value163 and found to be within
3% error, Scheme 47.
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Br~OH
UOH
5
2,2-DMP,
pTsOH
..
394
OS04, NMO,
acetone-H20
..
710/0
Br
Br~O><HO\"'~O
OH
318
InBu3SnH,AIBN, THF640/0
(X0H
HO"" ~ OH
OH
3% cone Hel, (X0
MeOH -9' \./
.. A
6 (-)-conduritol E
[a]D21 -285 (c 1.0, H20)
lit: [a]D20 -294 (c 1.0, H20)ref 163
395
Scheme 47. Stereochemical correlation by conversion to (-)-conduritol E.
The absolute configuration of 5 was established by its conversion to conduritol E, as
shown in Scheme 47, and its enantiomeric excess was conveniently determined by 19p_
NMR evaluation of the Mosher ester derived from mono-protected diol 360, Scheme 48.
The Mosher ester 361 was previously prepared from homochiral and racemic alcohols
360 in connection with our studies on the oxidation of bromothioanisoles. Analysis of
the crude 19p_NMR spectrum indicated the prescence of a single diastereomer,
corresponding to an enantioselectivity of greater than 95% in the enzymatic oxidation of
o-dibromobenzene.
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Br potassium Br BrBr"C:coH azodicarboxylate, Br'C::coH Br'C::coHAcOH THSCI, imidazole
)II )It
~ OH 95% OH 86% OTHS
5 396 397
1H2o52% Pt02, NEt3
0
cco~Ph Mosher's acid
MeO /CFs chloride, NEts CCOH..OTHS OTHS
359 358
Scheme 48. Determination of ee for metabolite 5.
D-mannaric acid would easily be accessed from enantiomerically pure diol318 by
ozonolysis according to established procedures for the conversion of vinyl bromides to
this type into hexoses.31 The provision of isomeric sugars D-glucaric acid and D-altaric
acid is also possible, as all four diastereoisomers at C-4 and C-5 are accessible by
directed hydroxylation or epoxidation procedures. Diol 118 would appear to be suitable
for synthesis of such acids.
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This type of programmed approach has been extended to the synthesis of
inositols,41 aminoconduritols,57 and aza-sugars. 164 In this manner, diastereomeric
analogues can be generated by either osmylation, or alternatively, epoxidation followed
by nucleophilic opening of the epoxide in trans-diaxial fashion. Apart from the
biological properties that aminoconduritols possess,165 they are shown to be important
builing blocks in a variety of natural products. Conduritols and aminoconduritols can be
easily accessed through the intermediacy of their epoxide and aziridine precursors,
respectively. Our reliance on epoxide and aziridine precursors derived from homochiral
dienediols, therefore, prompted us to investigate new methods for selective opening of
these intermediates which complemented our program in green chemistry.
111-4 Nucleophilic Opening of Strained Heterocycles Facilitated by Silica Gel
In connection with our interest in the generation of analogues of the powerful
anti-tumor agent pancratistatin, we set out to synthesize such a derivative in which the
aromatic nucleus was replaced by indole. We imagined that nucleophilic attack. of a 2-
substituted indole onto a vinyl aziridine would occur at C-3. Aziridines, however, are
known to be more resistant to opening than their epoxide analogues,166 and often require
Lewis or protic acid catalysis in order to effect opening. Although a single report from
the Yadaf group suggests that indoles readily undergo nucleophilic attack at C-3 under
InCl3 catalysis,167 all attempts to carry out this transformation in our hands led to
decomposition of the indole nucleus, with only trace amounts of the product arising from
nucleophilic opening byC-3 of indole. Under strongly acidic conditions indoles are
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known to dimerize, forming indigo or indirubin.168 A notable exception to the
incompatibility is Wenkert and Hudlicky's use of 10% aq HOAc as a mild protic acid in
the synthesis of aspidosperma alkaloids from indole nuclei.
Our investigations into the use of silica gel as a mild acid catalyst stem from the
incompatibility of indoles with many protic and Lewis acids. We envisioned that a ~-
carboline-I-one analogue of pancratistatin may arise from nucleophilic opening of a vinyl
aziridine at the C-3 position of indole. Gratifyingly, Dr. Uwe Rinner discovered that the
nucleophilic reaciton of indole derivatives with the requisite vinyl aziridine is facilitated
on solid silica surface at 70°C in the absence of solvent.
rT----n _=~\oOv~~JyOMe + ~, ~
H 0 NTs
silica 70 QC
•
Scheme SO.
401 402 403
Moreover, indole-2-methyl ester, which may be considered deactivated toward attack by
C-3 owing to resonance through the ester functionality, was found to exhibit superior
reactivity relative to indole.
Vinyl epoxides 13 and 14 were synthesized according to the methods of
Crandall169 and Hudlicky,27 respectively. Aziridines 402,44 408,170 410,171 and and were
prepared as described in the published procedures. A general procedure was developed
for the activation of silica gel, which required washing with THF, ether, and finally
pentane. The silica was further activated by drying under high vacuum (ca 1 mm Hg) for
a period of 12-24 h. The electrophile (1 equiv) and nucleophile (3 equiv) were suspended
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in a minimal amount of methylene chloride and poured over activated silica gel. The
methylene chloride was removed under reduced pressure and the silica gel containing the
adsorbed reactants heated under argon atmosphere at 70 °C until consumption of the
starting material was observed by TLC control. Following the precedent of the Yadaf
group, who reported success using 10% InCl3 in CH2CI2, we originally hoped that silica
gel catalysis in conjunction with a Lewis acid such as InCl3 would promote the ring
opening at or slightly above rt. Several hybrid silica! acid catalytic systems were
investigated, .but none proved superior to solid silica gel at elevated temperature.
Reactions of Lewis acid doped silica gel were difficult to purify owing to the tendency
for these reactions to produce a variety of degradation products. The reactivity of an
alternative InCl3/silica surface (entry d in Table 7) was examined by pre-treating silica
gel with 10% aq. InCl3prior to the standard activation protocol and the yield found to be
equal to that for 5% InCl3-doped silica surface reactions in the case of epoxide 406. The
results of the un-optimized ring-opening reactions promoted by silica gel are summarized
in Tables 7 and 8.
Table 7. Reaction of Epoxides and Aziridines with Indole on Silica and in Solution.
Electrophile Condensation product Yield*
0 ~ a) 32% b) 22%0 c) 51%N
H
404 405
~>< ~ o~I~ I 0 a) 51% b) 8%0 OH~ N c) 17% d) 17%
H
406 407
98
0 ~ a) 38% b) <5%NTs I h I ~HTS c) 26%N
H
408 409
0 wf2~ . a) 76% b) 25%NTs I h I ~HTSN c) 66%H
410 411
~>< a) 48% b) 8%NTs
c) 31% d) 70%;
402 403
rt, tIc plate
((>< a) 29% b) not
=" °NC02Me NHC02Me determined
c) not determined
413 414
*Yields are isolated.
a) silica gel surface at 70°C
b) 0.1 eq. InCl3 in CH2Cl2
c) InCl3-doped silica at 70°C
d) 10 % aq. InCl3-treated silica at 70°C
Table 8. Reaction of 2-substituted Indoles with Aziridine 402.
Indole
nucleophile
Condensation product Yield*
a) 68% b) NR
c)NR
401 403
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rIT-n~~~
H OAe
415 416
a) 24% b) NR
c) not determined
*Yields are isolated.
a) silica gel surface at 70°C
b) 0.1 eq. InCl3 in CH2Cl2
c) InCl3-doped silica at 70°C
The reactions of N-t-butoxycarbonyl and N-carbomethoxy-protected aziridines
with indole was briefly examined. The Boc-protecting group was found to be labile
under optimized reaction conditions (70°C) and this substrate was un-reactive at rt. N-
carbomethoxyaziridine was un~reactive at rt and the reaction not investigated at elevated
temperatures.
To the best of our knowledge, not a single general report describing the reactions
of azirdines and epoxides with indole nucleophiles on silica surface was known at the
time that this work was carried out. Satisfied that we had developed a general protocol
for the nucleophilic opening of strained heterocycles by acid-labile compounds, Dr.
Rinner and Prof. Hudlicky turned their attention to completion of the target molecule. A
retrosynthetic disconnection to the key precursors in shown below.
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73 X = OH pancratistatin
74 X =H 7-deoxypancratistatin
75 B-carboline-1-one mimic
OH
o
OH :;> C9YOMe cr:><+ N\
H 0 I
Ts
401 402
Figure 30. Retrosynthetic analysis of ~-carboline-1-onemimic of pancratistatin.
With multigram quantities of intermediate 403, the synthesis of the ~-carboline-1-
one mimic of pancratistatin was completed according to Scheme 51.172 Silica gel plays a
critical role in several late-stage steps of the synthesis. Heating bis-Boc derivative 421
on silica· surface allowed a thermal deprotection of the carbamates, and subsequent
closure of the resulting amine to give the amide 422. Further heating of 422 on silica
surface installed the remaining hydroxyl functionality by acid-catalyzed epoxide opening,
and finally, deprotection of the acetonide protecting group was accomplished to provide
the target molecule 75.
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OH
422
Scheme 51. Completion of ~-carboline-l-onemimic of pancratistatin.
75
A detailed NMR study was initiated in cooperation with Dr. Ion Ghiviriga (The
University of Florida) to assess whether the opening of vinyl epoxides proceeded in a
SN2' fashion at the distal olefinic center (producing 407-alt) or in the expected SN2
manner to yield 407. Analysis of long-range couplings in the HMBC NMR spectrum
established that carbon 40.8 ppm is connected to the indole ring. Dr. Ghiviriga writes,173
"One can easily make three arguments for assignment of structure 407, as opposed to
407-alt: i) the proton at 3.89 ppm displays two large couplings, 9.0 and 10.0 Hz,
therefore it is axial and its vicinal protons at 3.54 and 4.22 ppm are also axial, which
would imply a trans relationship of the protons in the acetonide moiety in 407-alt. ii) the
chemical shifts of the protons at 4.22 and 4.76 ppm and their coupling constant of 6.6 Hz
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are expected for the acetonide moiety represented in 407. iii) the proton at 1.45 ppm
displays an nOe with the protons at 4.76, but not with that at 3.89 ppm."
407
Figure 8. NMR assignment of compound 407.
407-all
The present study provides an excellent example of the generality and mildness of
silica gel as a Lewis-acid catalyst. Indole nuclei, which are notoriously unstable toward
even mildly acidic conditions, are readily reacted with a variety of strained heterocycles
on the surface of silica gel. The reactions facilitated by silica gel provide a mild
alternative to Lewis- or protic acid catalysis. Such reactions could provide an entry to a
variety of indole-based natural products containing oxygen or nitrogen functionalities.
The reactivity of other aromatic nucleophiles, however, is largely unexplored. A single
experiment in which pyrrole was reacted with vinyl aziridine 410 was examined, giving
the coupled product tentatively assigned as 424, Scheme 52. Future work will include a
series of heteroaromatic nuclei, such as furans, benzofurans, thiophenes, etc. which will
further demonstrate the generality of this methodology.
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Scheme 52. Reaction of pyrrole and vinyl aziridine 410.
111-5 Oxidations of Aromatics Containing Remote Chirsl Centers. Studies
on Aromatic Cyclopropanes.
The products arising from oxidation of aromatic compounds containing racemic
or chiral centers account for less than 10 percent of all the known diene diol metabolites.
Substrates in which the chiral center lies proximal to the site of oxidation on the ring
present an opportunity for resolution of pro-chiral centers by the enzyme. Studies on the
oxidation of I-phenethyl alcohol using Pseudomonas putida expressing toluene
dioxygenase by Ribbons resulted in a slight preference for the formation of the (S)-
enantiomer in the diastereomeric oxidation products, Figure 32.
6H & &I~ PpF39D -9" OH -9" OH• +~ ~ OH ~ OH
425 426 427
4 6
Figure 32.
The work was later repeated using E. coli which over-express the enzyme toluene
dioxygenase and surprisingly, they found that oxidation with this organism resulted in an
equal distribution of diasteromeric diols. A collaborative effort between the Hudlicky
and Ribbons groups undertook a general study of substrate specificity and product
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distribution in which a variety of substrates having chiral or racemic benzylic centers
were subjected to oxidation with both E. coli JM 109 and Pseudomonas putida F39D.
(SH E. coli JM1 09I ~ _(p_DT_G_6_O_1)~..
~
425
Figure 33.
&H~ OH~ OH
426
1
+ &'\'OH~ OH~ OH
427
1
With the exception of l-phenethyl alcohol 425, which was consistently found to give a
preference for the (S)-isomer by oxidation with Pseudomonas putita, all substrates were
oxidized to give equal mixtures of diasteremeric products. We became interested in the
oxidation of substituted cyclopropanes because they represent a series of substrates in
which a racemic center lies proximal to the site of oxidation. Such a series would allow
us to investigate the possibility of performing a resolution of chiral centers through
enzymatic oxidation.
Cyclopropylbenzene was initially investigated in connection with a study
focusing on elucidation of the mechanism of oxidation.134 We were encouraged by the
high yield of the diol from oxidation and the possibilities for further fuctionalization of
the metabolites as shown in Figure 34.
R
[5+2] {
cycloadditions
~+~ ~
cycloadditions .. ~
radical cyclizations J
epoxidation 428
nucleophilic tether
attachment
OH~
electrophilic
OH tether attachment
V
Figure 34. Reactive options of homochiral dienylcyclopropanes obtained from
enzymatic oxidation of the corresponding arenes.
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We synthesized a series of cyclopropylbenzenes, which were subjected to
oxidation with E. coli JM 109 (pDTG601). The products of fermentation were extracted
from the fermentation broth into ethyl acetate, purified, and fully characterized. The
absolute configuration of each metabolite was proven unambiguously by chemical match
with synthetic material derived from diol 72, whose absolute stereochemistry has been
firmly established,7 except in the case of metabolite 434, whose match was made from
known dio1452.174
Table 9. Results of Enzymatic Oxidation of Cyclopropylarenes by E. coli JM 109
(pDTG601)
Entry Substrate Product Yield (mglL)
1a 6 &OH 2500~ OH
429 428
6 &OH2 ~ OH 56
430 431
3 Q ~OH~ OH 32
Br Br
432 433
~..• " ...." '74 bOH (x0H 90
434 ~ OH ~ OH
435a (1 :1) 435b
5b if' --- ---
436
106
~""O ",0 ~60H6 aOH 140437 :::::.... OH :::::.... OH
438a (1 :1) 438b
7b ~ --- ---b b
439
gc I~
--- ---b
440
a Biotransformation of substrate 429 was performed in a 15-L fermentor.
b 1H NMR spectra of the crude residue from biooxidation of cis configured cyclopropanes
revealed the presence of only trace amounts of the corresponding diene-diols.
c Only starting material was recovered.
Oxidation of cyclopropylstilbene 437 gave diene-diols 438, which were reduced
with potassium azodicarboxylate/acetic acid. The diol was protected as its acetonide to
afford 445, Scheme 52. Analysis of IH and 13C NMR spectral data for compound 445
revealed an approximate 1: 1 ratio of diastereoisomers. The absolute configuration was
proven by conversion of phenylacetylene 443 to the corresponding cyclopropylboronic
acid 445, which was subjected to a Suzuki coupling protocol with vinyl bromide 446,
prepared from homochiral bromodienediol 72. Spectral data and optical rotation of 442,
synthesized from compound 72, provided the proof of absolute configuration of the trans
isomer 438.
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~ B-O ~B-OHif~ ??' 1) borane ~I~ 1) Pd(OAc)iCH2N2 '::::: IIPd(0)"--------.. • I •~ 2) 2,3-butanediol ~ 2) NaOH ~ 446
443
Scheme 52.
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+
Br
• Ch><II:
446
442
1:1 diastereomers
byNMR
By analogy to the sequence shown in Scheme 52, we imagined that the
configuration of compound 435 could be proved by a Suzuki coupling reaction in which
racemic methylcyclopropyl boronic acid would undergo palladium catalyzed coupling
with vinyl bromide 446. To this end, the cyclopropylbromide 448 was prepared from
acid 447 by a Hunsdiecker reaction in the presence of mercuric acetate and bromine,
Scheme 53. The bromide was converted to its Grignard reagent, which was directly
quenched with freshly distilled trimethyl borate and acidified to give the corresponding
boronic acid 449.
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448
2) B(OMeh, H+
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Scheme 53. Synthesis of Suzuki coupling precursor 449.
A variety of unsuccessful conditions were investigated to effect coupling of vinyl
bromide 446 to the boronic acid 449 by a Suzuki protocol. Alternative coupling
procedures involving the Grignard or cuprate derivative of cyclopropyl with vinyl
bromide 446 met with limited success; in most cases, the vinyl bromide was re-isolated.
Relatively few reports of successful Pd-reactions involving cyclopropanes are known,
probably owing to the ease of opening and polymerization of cyclopropanes in the
presence of palladium.
JY Pd (0)
R XII 0><Br
6::><
0
449 R =B(OH)2 452450 RI =MgBr
451 RII =cuprate
446
Scheme 54. Attempts to introduce cyclopropane by coupling reactions.
Proof of absolute configuration of compound 435 ultimately relied on correlation with a
known diol, 454, which results from fermentation of trans-~-methylstyrene453, and was
initially reported by Boyd and co-workers.174 Fermentation of trans-~-methylstyrene
gave the corresponding chiral trienediol 454, which was reduced with diimide to its more
stable diene. The diol functionality was protected as its acetonide 455 and the less-
substituted olefin converted to its corresponding cyclopropane 456, formed as a single
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diastereoisomer whose sign of optical rotation matched that of compound 435 prepared
by fermentation of cyclopropyl benzene 434.
h- h-
OH 1) Potassium~ TOO azodicarboxylate, AcOH
JIll JIll
~ Boyd OH 2) 2,2-0imethoxypropane
453 454
pTsOH
TOO
(rac)-434
Scheme 55.
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ex= OH~ OH
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1) Potassium
azodicarboxylate, AcOH
JIll
2) 2,2-Dimethoxypropane
pTsOH
455
IEt~n/ trifluoroacetic acidCH2 '2
456
The configuration of metabolite 433 was determined by conversion to
vinylcyclopropane 457 by hydrogenation with Adams' catalyst in triethylamine. The
configuration of diol 457 was correlated to diol 428, as shown in Scheme 56. The
absolute configuration of diol 428 had been previously matched to diol 72.134 While
oxidation of cyclopropylbenzene proceeds to give essentially enantiomerically pure
dienediol, enzymatic oxidation of p-bromocyclopropylbenzene provides material of only
27% optical purity, bearing the absolute configuration shown in Scheme 56.
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Scheme 56.
Chiral dioxygenase metabolites bearing a cyclopropyl unit represent a new class
of arene diene diols which may find application in asymmetric synthesis. Two general
types of these substrates were investigated with respect to their tendency to undergo
oxidation and respective stereochemical outcome: (1) mono-substituted aromatic
cyclopropanes bearing a racemic benzylic center; (2) di-substituted aromatic compounds
bearing an unsubstituted cyclopropane. Mono-substituted compounds having cis-
stereochemistry·were not found to be accepted as substrates for the enzyme and starting
material was recovered from these fermentations, whereas their trans-substituted
counterparts were found to be good substrates for the enzyme and gave mixtures of
diastereomers. In accordance with Boyd's explanation for rationalization for
stereochemistry in mono-substituted systems, we propose that it is the larger of the two
groups, i.e., the one which bears asymmetry which must lie outside the active site during
oxidation and therefore is unable to be recognized by the enzyme, Figure 35. Such a
hypothesis would support our finding that no diastereoselectivity was observed in the
oxidation of racemic cyclopropanes.
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Figure 35. Cartoon representation of substrate in active site of enzyme.
111-6 Approaches to the Chemical Synthesis of Morphine
111-6. 1 Diels-Alder Approach Using Thiophene as a Latent Diene
In the last several years, Diels-Alder reactions involving heteroaromatic systems
have witnessed broad application. Padwa has utilized furan cycloadditions as an entry to
the Amaryllicidacae and vindoline families of natural products.175 Similar heteroaromatic
cycloadditions· have been employed in the synthesis of various indole-containing natural
products by Boger.176 An extention to this cycloaddition chemistry involves the use of
thiophene-1,I-dioxide or thiophene-I-oxide as a latent diene synthetic equivalent. 177 By
occupation of the lone pairs in bond formation, the thiophene is rendered far less
aromatic, and therefore less stable, and the diene portion of the molecule has proven to be
susceptible to Diels-Alder chemistry. Unlike its furan counterpart, the sulfone or
sulfoxide functionality present in the Diels-Alder adduct can be excised by thermal
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cheleotropic extrusion on heating. The application of such chemistry in the construction
of natural products has not yet been realized and there is still much to learn regarding the
scope and mechanism of these reactions.
Our proposed synthesis of thebaine would take advantage of the pseudo-C2
symmetry present in the target. Indeed, a strategic intermediate is the symmetrical alkyne
12. The key step, which would simultaneously construct the complete pentacycle, relies
on a tandem enzymatic sulfoxidation-Diels-Alder sequence.
o
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S
Meo-()-I
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OMe OMe
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Figure 36. Retrosynthetic analysis of thebaine.
In connection with our interest in the oxidation of aromatic compounds using bacterial
enzymes, the key strategy in our approach to thebaine would rely on a tandem
sulfoxidationl intramolecular Diels-Alder reaction to establish the C-13 quaternary center
in the natural product. The oxidation at sulfur could be mediated enzymatically, or by
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standard chemical oxidants. Failing the thiophene-oxide cycloaddition, an alternative
strategy for the construction of the pentacycle could be established by an analogous
intramolecular Diels-Alder with furan (IMDAF) reaction.
458 14-hydroxycodeinone
~
o
459
o
Me0-(Jj-I
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Figure 37. An alternative retrosynthetic analysis of morphinan I4-hydroxycodeinone.
Several examples describing the chemical oxidation of the divalent sulfur atom in
thiophenes have been reported. 178 The oxidation of sulfur to its thiophene-I-oxide
renders the sulfur more susceptible to oxidation than its precursor. Thiophene-I-oxides
are highly-reactive, transient species which undergo dimerization reactions by Diels-
Alder cyclization in the absence of an external olefinic or alkynyl cycloaddition partner.
Sterically-congested thiophenes are readily oxidized to their corresponding dioxides, and
several examples of isolable thiophene-I, I-dioxides have been reported. 179
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Scheme 57. Oxidation of divalent sulfur in thiophenes.
Table 10. Synthesis of thiophene-1,1-dioxides by dioxirane oxidation.180
Entry Thiophene Thiophene-1,1-dioxide Yield (%)
1 H3C~CH3 0" //0 93~ !J H3C~CH3~ !J
465
466
2 Ph~Ph 0" I/O 93S
467
Ph~Ph
468
3 Ph*Ph 0" I/O 99
Ph*Ph
Ph Ph
469 Ph Ph
470
4 (rCH3 0" 110 0
(rCH3
471 472
5 Br--(yBr 0" //0 27
Br--(yBr
473
474
6 ~COPh 0" 110 73S~COPh
475
476
Entry 4 of Table 10 is noteworthy; attempted oxidation of 2-ethylthiophene did not
produce the corresponding dioxide. Although the authors did not offer an explanation for
this lack of oxidation, van Tilborg reportsI80 that oxidation of 2-methylthiophene with
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mCPBA produces, apart from the expected dioxide (18.7% yield) at least 32 by products
from oxidation (determined by analysis of the crude reaction mixture by HPLC). The
decomposition of 2-methyl-subsitituted thiophenes may be attributed, in part, to its
tendency to undergo oxidation at the methyl group, eventually leading to ring opening
processes. Thiophene itself is too unstable to be isolated as its 1, I-dioxide, but the
dimerized products have been well characterized. Boyd has reported the enzymatic
oxidation of thiophene and several derivatives by enzymatic oxidation with the mutant
strain Pseudomonas putida UV4, a strain which over-expresses the enzyme toluene
dioxygenase.14o Once oxidized, these unstable thiophenes undergo Diel-Alder
dimerization. Interestingly, the enzymatic pathway is the only example of selective
thiophene oxidation to its corresponding sulfoxide, without over-oxidation to the sulfone.
so
S mCPBA ~0 .,
'is" 477
336 o 0
S So0 P. putida UV4 ~., 478
336 SII
0
Scheme 58. Divergent modes oxidation of thiophene by chemical and enzymatic means.
In a 1976 Acta Chemica Scandinavica publication, Kurt Torssell wrote:
"It therefore seemed reasonable to anticipate the formation of Diel-Alder adducts when
the sulfoxide was generated in presence of suitable enes."
With Professor Torssell's words in mind, we embarked on a synthesis of symmetrical
alkyne 12. We hoped to install the methylamino functionality through a Ti-catalyzed
hydroamination reaction. Acylation of the amino group with the appropriate furanyl
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tether would set the stage to carry out the tandem oxidationlDiels-Alder reaction. The
synthesis began with commercially available 2-iodothiophene, which was converted to its
2-methoxy derivative by treatment with sodium methoxide and cupric oxide in refluxing
methanol, according to the procedure of Sice,.181 2-Methoxythiophene is readily
converted to its 5-lithio species by treatment with n-butyllithium, and the resulting anion
quenched with iodine. Installation of iodine at the 5-position provided a functional
handle for Sonagashira chemistry, and 2-iodo-5-methoxythiophene 13 was subjected to a
variety of standard conditions in order to effect Pd-catalyzed cross coupling to give
alkyne 12. Compound 12 could be prepared in a single step,182 albeit in low yield.
Additionally, the procedure was not amenable to scale-up and the yields were capricious.
Although the 2-bromo-5-methoxythiophenecould also be readily prepared, the bromide
proved resistant to coupling. A less direct route was realized by stepwise introduction of
the alkynyl portion, removal of the silyl protecting group, and exposure of this material to
another coupling reaction with 2-iodo-5-methoxythiophene.183
((Syl NaOMe, CuO~ .
600/0
479
((SyOMe 12, HgO~ .
480
I"«SyOMe
~
13
Pd(PPh3)4' TEBAC, Cui
TMS == NaOH
Pd(PPh3)2CI2' ,Pr2NH, Cui
TMS ==
SR~OMe
t _
I"«SyOMe
~
13
481 R =TMS
482 R =H .:JTBAF. THF
41 % (over two steps)
Scheme 59. Preparation of hydroamination precursor 12.
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With acetylene 12 in hand, the Doye's Ti-based hydroamination catalyst was
prepared from bis-indenyl titanium dichloride by treatment with 2 equiv of methyllithium
in diethylether. 184
MeLi
)II:
~~T··Me 800/0~1'Me
~
483 484
Scheme 60. Preparation of Doye's hydroamination catalyst.
At that time, there were no reports which described the application of hydroamination to
small molecule amines and several sets of conditions were attempted to introduce the
methylamine functionality. Initially, a toluene solution of alkyne 12 was introduced to a
Teflon-sealed Schlenk tube, degassed under a positive pressure of nitrogen, a THF
solution of methylamine was -added, and the tube sealed and heated to 120°C. After
heating the reaction mixture for several days, the starting alkyne was returned unchanged.
Professor Doye, who was at that time extending his hydroamination research to include
methyl- and ethylamine, suggested185 that we use employ gaseous methylamine and treat
the crude product with sodium cyanoborohydride to reduce the resulting imine to its
stable methylamine derivative. These modified conditions, again, resulted in recovery of
the starting alkyne.
118
MeO"\(S~S')y/OMeu- 'L!I~ Ii
12
120 deg
)( .
H2Me
NMe
MeO,/S,A /S, -OMe
\J ~
485
Scheme 61.
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We decided to change our strategy synthesizing an olefinic thiophene dimer, such as 489.
Such a strategy would allow introduction of the requisite methylamine by reaction of
methylamine with its epoxide derivative, or more directly, by conversion of the olefin to
its aziridine, followed by treatment with a source of hydride.
480
1)IBuLi, Cui
•
2) ~
EtO-P~1
Eta 480
NaH, DMSO, 481
19°!c>
MeO,,«S~S'iY0Me
>-----.. U U
489
Scheme 62.
481
NatOAmyl, 481
27%
In this manner, the olefin 489 was prepared in low yield by condensation of Homer-
Wadsworth-Emmons derivative 488 with the aldehyde 481. The cis-olefin was also
prepared by hydrogenation with Lindlar catalyst, and several unsuccessful attempts were
made to introduce an aziridine functionality. The approach was soon abandoned in favor
of testing the key step in the form of a model substrate.
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Scheme 63.
Chloramine T, 12
..
Chloramine T, NBS
25% SM recovery, 30% unknown
66°!c> SM recovery
We decided to focus our attention on several model studies which would allow us to
quickly assess the feasibility of the tandem oxidationlDiels-Alder sequence. Several
generations of model system were synthesized; each model system increased
progressively in complexity.
x~X 0
X=O, NMe
[0]
.. ~x 0 heat ..
sulfur oxidation!
extrusion of S02
2\(\~ Model C-13quaternary centerX 0
Figure 22. Model study for assessment of tandem oxidationlDiels-Alder sequence.
The first, and simplest, model was synthesized from commercially available 2-
acetylthiophene 491 by borohydride reduction of the ketone to alcohol 492 and DeC
coupling of the alcohol with vinyl acetic acid 493.
o
<r
491
Scheme 64.
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tr
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o
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The ester was screened for its tendency to undergo oxidation by Escherichia coli JM 109
pDTG061, a recombinant strain which over-produces the enzyme toluene dioxygenase.
Oxidation of the simplest model 494 produced a small amount of a bicyclic compound,
tentatively assigned as the mixture of diastereomers 495.
o
o~
cr
494
Scheme 65.
E. coliJM 109
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tentative assignment
OH
495
(5:1 mixture of isomers)
Compound 495 proved to be unstable and eluded attempts at rigorous purification. This
may be attributed to its tendency to undergo air oxidation to its aromatic analogue.
Analysis of the the IH NMR spectrum clearly shows a characteristic AB splitting pattern
(in a 5:1 ratio) as one would expect to from bicyclic derivatives. IR spectroscopy reveals
the absence of the ester functionality and the appearance of the hydroxyl functionality.
All attempts to repeat this experiment gave the product of ester hydrolysis. We chose to
reinvestigate the enzymatic oxidation of the model.compounds which bear additional
substitution on the olefinic side chain, a feature which would prevent re-aromatization.
2-Acetylthiophene was reduced with sodium borohydride, and the alcohol esterified with
one of two acids having an appropriate olefinic tethers, Scheme 66. Similarly, the Schiff
base prepared by condensation of methylamine with 2-acetylthiophene was reduced with
sodium borohydride, and a similar activated ester coupling protocol was used for
synthesis of the analogous amide. Acid 496 was prepared by a solid carbon dioxide
quench of the Grignard reagent prepared from 2-methyl-3-bromopropene.
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Scheme 66.
2-Furanyl acetic acid 498 was prepared in four steps from furan-3-carboxaldehyde
according to a published procedure. 186
oQ 1. NaBH4, IPro~
CHO 2. SOCI2, Pyr
503
o
VCh 1. NaCN, H20, DM~O2.20% aq KOHCI
504
o~O
OH
498
Scheme 67. Synthesis of 3-furanyl acetic acid.
A more direct route to the requisite esters and amides was developed by in situ formation
of the ketene187 derived from 2,2-dimethylacryllic acid chloride and trapping with either
the alcohol or amine, respectively.
122
XH
<:r
492 X=O
501 X =NMe
elM
505 497 X= 0
502 X= NMe
Scheme 68. Alternative route to deconjugated esters and amides.
Esters 497 and 499 were subjected to enzymatic oxidation with Escherichia coli JM 109
pDTG06l, Scheme 69. Both experiments resulted in nearly quantitative cleavage of the
ester functionality, presumably by non-specific proteolytic enzymes, based on the fact
that enzymatic reactions were carried out at neutral pH.
aU OHE. coliJM 109 <:r<:r ..
497 492
Jlf}1,-9 OH0
<:r<:r E. coli JM 109..
499 492
Scheme 69. Proteolytic cleavage of esters by Escherichia coli JM 109.
We turned our attention to oxidation of the analogous tethered amides, as the amide
functionality is known to be more resistant toward enzyme-mediated cleavage. The
amide was, indeed, stable to hydrolysis, but the amide was also resistant to enzymatic
oxidation.
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Table 11. Enzymatic Oxidation of Olefin-tethered Thiophene Amides and Esters.
Conditions Result
'NU JM 109 (pDTG601A) Recovery of starting materialJM 109 (pDTG141) Recoverynsomerization of()A starting materialChloroperoxidase Persistence of starting material by
TLC
502
Conditions Result
aU JM 109 (pDTG601A) Recovery of hydrolysis product(10%)()A
497
JM 109 (pDTG141) Recovery of hydrolysis product
The difficulties encountered in enzymatic oxidations prompted us to investigate
chemical oxidation of divalent sulfur. Owing to the aromatic nature of thiophene, the
conditions reported for oxidation are more limited than those used for standard oxidation
of divalent sulfur. By far the most common conditions reported for synthesis of
thiophene sulfones is the treatment of thiophene derivatives with mCPBA in
dichloromethane as reaction medium. In our hands, these conditions led to selective
oxidation olefin rather than sulfur, Scheme 70.
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Table 12. Chemical Oxidation of Olefin-tethered Thiophene Esters and Amides.
502
497
Conditions
BF3·OEt, mCPBA syringe
pump addition, -60 DC to rt
mCPBA syringe pump
addition, 0 DC
Oxone, acetone, NaHC03, rt
30% H20 2, ammonium
molybdate, water/acetone
RuCI3·3H20, NaI04, H20,
CCI4, acetonitrile
Conditions
mCPBA syringe pump
addition, 0 DC
Oxone, acetone, NaHC03, rt
30% H20 2, ammonium
molybdate, water/acetone
10% (aq) bleach
Result
Recovery of starting material
Decomposition of starting material
Epoxidation product- 50%
conversion
Persistence of starting material by
TLC
Decomposition of starting material
Recovery of starting material-60%,
trace of aromatic
Persistence of starting material by
TLC
Recovery of starting material +
isomerization of olefin
25% isomerization of olefin
Result
Recovery of starting material
Epoxidation product- 62%
conversion
Persistence of starting material by
TLC
Decomposition of starting material
Recovery of starting material
Persistence of starting material by
TLC
25% isomerization of olefin
Persistence of starting material by
TLC
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Scheme 70.
At this point we turned our attention to the application of IMDAF chemistry
toward the construction of model systems. Furan was acetylated by treatment with a
mixture of acetic anhydride and catalytic borontrifluoride etherate188 and the resulting 2-
acetylfuran converted to its corresponding Schiff base. The imine was reduced with
sodium borohydride and the amide formed by activated ester coupling mediated by EDC.
0 NHMe WEDC, DMAP, 1//0 BF30Et, (AchO if 1. NH2Me, TiCI4 0 CH2CI2 --N0 .. .. .. 02. NaBH4 , IPrOH 0
508 509 510 fZ 511CO H2
498
Scheme 71.
Bis-furanamide 511 was subjected to a variety of conditions with the hope of effecting an
intramolecular Diels-Alder closure. The molecule was stable up to greater than 200°C.
Compound 511 was also screened for possible reactivity promoted by Lewis acid
catalysis. Lanthanide triflates, which are known to lower the LUMO and thereby
facilitate Diels-Alder cyclizations, did not promote reaction in our case. Stronger Lewis
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acids, such as dimethylaluminum chloride and aluminum chloride, resulted in complete
decomposition of the bis-furan. We surmised that the constrained nature of the amide
bond may force the molecule in such a conformation that the renders the Diels-Alder
reaction unfavorable. Reduction of the amide to its amine would allow us to test this
hypothesis. Amide 511 was reduced by LAH in ether to give the expected amine, which
was subjected to several thermal Diels-Alder reactions without success.
511
Scheme 72.
LAH, ether
II
512
220 deg
)( II recovery of starting material
The tandem oxidation-Diels-Alder sequence would have provided one of the most
expedient routes to the core of thebaine. Though there is some precendent for thiophenes
undergoing oxidation-mediated cycloadditions, the work described in this section is to the
best our knowledge, the only attempts at intramolecular thiophene-based Diels-Alder
reactions. Incomplete as they may be, these studies may provide a basis for further
exploration in this area.
By examination of the early studies on chemical oxidation of thiophene by van
Tilborg,180 it would seem that the tendency of thiophines to undergo oxidative
dearomatization is a strongly dependent on the nature of substitution on the ring. This
work is summarized by the entries in Table 3. Moreover, mono-substituted thiophenes
are not known to undergo oxidation without attendent decomposition. It is suspected that
oxidation of mono-subsituted thiophenes may give rise to oxidation on the ring and
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mixtures of subsequent ring-opened products. The stablest thiophene-I, I-dioxides are
the most sterically congested; the dioxide corresponding to 2,5-di-tert-butylthiophene
may even be handled in pure form. A number of chemical oxidation experiments (see
Table 3) yielded complete decomposition of the starting material, and we speculated that
this was probably due, at least in part, to the mono-substituted nature of the molecule and
its tendency to decompose in the presence of strong oxidants.
The nature of the divalent sulfur in thiophene is altogether different than that of
other sulfur-containing molecules. Thiophene is aromatic; its calculated resonance
stabilization is slightly higher than that of furan or pyrrole. 189 As such, the divalent sulfur
functionality is more difficult to oxidize than its non-aromatic analogues because its
results eventually in dearomatization, a high energy process. To the best of my
knowledge, only two reagents have been reported to carry out this transformation in
thiophenes: dioxirane and mCPBA. In our hands, dioxirane (generated in situ) resulted
in the re-isolated of unchanged starting material, while treatment of 497 or 502 with
mCPBA gave the corresponding epoxides, isolated in 62 and 70% yields, respectively.
Less reactive oxidants, such as NaI04 or NaCI02 returned starting material unchanged.
Finally, using oxidants in conjunction with acids, such as RuCI3, NaB04, or Mn02, often
resulted in isomerization of the olefin into conjugation with the amide or ester.
The problems attributed to chemoselectivity in the oxidation of thiophene led us
to adopt an alternative approach in which a furan nucleus would serve as a latent diene in
an intramolecular furan Diels-Alder (IMDAF) approach toward thebaine. Gratifyingly,
the bis-furanyl model system 511 was constructed in 8 steps in a strait-forward manner.
We initially carried out a series of Lewis-acid promoted Diels-Alder reactions using
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AIC3, Me2AICI, TiC4, Sc(OTf)3, Yb(OTF)3, CeCI3. Lanthanide triflates proved to be
ineffective catalysts, while stronger acids, such as AICl3and TiCl4 resulted in destruction
of the starting material. We decided at this stage to explore thermal cycloadditions of
bis-furan 511 in the absence of Lewis-acid catalysts. Heating dilute (0.086 mmol)
solutions ·of the amide failed to produce even trace amounts of the Diels-Alder adduct.
We wer~ concerned that the prescenceof the amide functionality restrict the rotation of
the molecule thereby causing it to adopt a conformation in which reaction could not take
place. In order to test this hypothesis, the amide was reduced to its amine 512, and the
thermal Diels-Alder experiments were repeated. However, cyclization failed to occur
even in excess of 200°C! Future experiments may benefit from the use of a high
pressure reaction vessel.
The original goal of the thiophene-based approach was to allow rapid access to
the core of the morphinan skeleton based on our knowledge of enzymatic oxidations of
aromatic and sulfur-containing compounds. The approach promised not only a viable
entry into the morphine skeleton, but also an elegant solution to the generation of the C-
13 quaternary center common to morphinan alkaloids. The failure of our original
approach to deliver the target molecule prompted us to explore other routes which also
have the potential to rapidly assemble the target molecule through Diels-Alder and
palladium catalysis.
111-6.1.1 Alternative Diels-Alder Approach to Morphine
Despite the popularity of the Diels-Alder reaction, the analogous benzyne Diels-
Alder reaction has seen little application in total synthesis efforts and relatively few
examples of the intramolecular benzyne reaction exist. There are however, several
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examples of the application of the benzyne Diels-Alder reaction as a key step in a total
synthesis.190
Me0(2)
Ih-
o
~
403
Meo~
-~#
° I~
404
Me0:QI~
; ~,r
~05
Scheme 66. Retrosynthetic analysis of truncated morphinans by benzyne Diels-Alder
reaction.
An initial model study was directed at determining the feasibility of. a benzyne
Diels-Alder reaction to establish the A, B, and D ring systems of morphine, Scheme 66.
We envisioned that deprotonation of 405 at the position ortho to the bromine would allow
generation of the benzyne 404, which would be trapped in intramolecular fashion with
the pendant dienyl tether. The benzyne precursor 405 was readily available through
Mitsunobu alkylation of bromoguaicol with sorbyl alcohol.
Me0:Q Me0:Q MeoXlPh3P, DIAD I~ LOA, THF
HO ~ • ~r • HO h-Sr HO~ Sr36% I _ 405 520/0 406406
Scheme 67.
Exposure of the material to LDA resulted in dealkylation to regenerate the starting
phenolic compound. The approach was then abandoned in favor of the well-developed
Heck and radical cyclizations previously carried out by the Hudlicky group.
130
111-6.2 Radical-Based Approaches to the Morphinan Skeleton
A new radical-based strategy was briefly investigated which would rely on a radical
cascade closure to generate the C-13 quaternary center and "zip up" the A,B,and C ring
system in a single operation. Following radical generation by heterolytic cleavage of the
aromatic bromide, we imagined the possibility to establish the complete phenanthrofuran
skeleton in a one-pot reaction by a radical cascasde terminating onto the aromatic alkyne.
17
MeO
513
Meo~Ih-
~
====;:» 0 Br ~
~~ NMeTsHO'~
514
Meo~
. 1.0
HO ~
Br
515
HOI",C)- NMeTs
HO'"
516
Figure 38. Retrosynthetic analysis of a radical-based approach to codeine.
In the event that the C-13 closure proceeded smoothly, a concern was the
possibility for 5-exo vs. 6-endo closure onto the tethered alkyne. In cooperation with
Dr. Takeo Omori, a model system was constructed to allow the investigation of this
closure. The aromatic alkyne was available through bromination191 of commercially
available iso-vanillan, Corey-Fuchs homologation,192 and elimination of the geminal
dibromide to the corresponding alkyne.193
MeO~
HOVCHO
517
NBS
)II
Meo~
HO¥CHO
Br
302 518
Scheme 74. Synthesis of aromatic alkyne.
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The lower (C-ring) of the model system was synthesized in 3 steps from 2-methyl
cyclohexanone, Scheme 75.
2,4,6-collidine
•
519
520 ~.
2,4,6-collidine =~A
521 522
Scheme 75. Synthesis of allylic alcohol as C-ring analogue.
The first two steps of the sequence, an a-chlorination step, followed by a base-promoted
elimination of the chloride to give the corresponding enone were described by W.S.
Johnson.194 A Luche reduction of the enone provided the requisite allylic alcohol 522,
which was ultimately coupled with the aromatic phenol by a Mitsunobu alkylation to
provide a precursor for radical-promoted C-13 bond closure.
Meo~
1 0 +
HO Br ~
518 522
PBu3 , DIAD
•
Meo~1-&0\5 ~
523
Scheme 76. Assembly of morphine model via Mitsunobu coupling.
Compound 523 was subjected to Parker's radical conditions (nBu3SnH, AIBN, 0.012 M
in toluene at 130 °C),121 which gave a complex distribution of products. At least part of
this mixture consisted of a bromine atom transfer across the alkyne. We did not,
however, detect the product from 6-endo closure as we had originally hoped. The use of
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samarium diiodide as a source of radical initiation was evaluated; this reaction resulted in
recovery of 96% starting material.
Although radical cascade reactions are shown to be powerful tools in the multi-
step fonnation of carbon-carbon bonds, they have several drawbacks. Many reactions
require the use of tributyltinhydride, giving rise to alkyltin by-products which can be
difficult to separate from the desired reaction products. The radical closures onto alkynes
are also complicated by 5-exo vs. 6-endo closures. The complicated reaction mixture
resulting from radical-induced cascade reactions impelled us to re-visit anold theme-
palladium catalysis as a strategic carbon-carbon bond forming reaction.
111-6.3 Palladium-Catalyzed Cyclization Studies in the Morphine Series
Owing to the non-stereospecific nature of radical closures in combination with
complex product mixtures, the radical approach was abandoned in favor of Pd-catalyzed
cyclizations. Such reactions have been employed in the construction of C-13 morphine
centers previously (vide supra), and have the added advantage of generating a new site of
unsaturation. Additionally, the model system 523 could be re-investigated using
palladium to effect cyclization at the C-13 center.
Using Pd(OAc)2 in conjunction with triphenylphosphine and potassium carbonate
in DMF, compound 523 gave the corresponding bis-alkyne dimer 524 in 92% yield. A
solution to the undesired coupling product could be realized by protection of the terminal
alkyne, however, attempts to introduce a silyl protecting group onto the terminal position
of the alkyne led to elimination of the phenol, Scheme 77.
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The Heck reaction was re-investigated with the corresponding alkene derivative 525,
which was prepared by Mitsunobu alkylation of the analogous alkene-substituted phenol.
In these cases, the C-13 closure was accomplished, albeit in low yield, Scheme 78. A
possible explanation to account for the low yield may be attributed to metallation of the
allyl species, followed by elimination of the phenol. The phenol would have been
washed away on work-up, and the cyclohexene moiety lost in evaporation with toluene.
Pd(O)
..
a -or- b
525
Scheme7S.
526
Reagents and Conditions: a) Pd(PPh3)4 0.1 equiv, Proton Sponge® 2.0 equiv, PPh3, 0.3
equiv, benzene 11% yield, 19% starting material; b) Pd(OAc)2 0.1 equiv, PPh3 0.3
equiv, K2C03 3.0 equiv, DMF, trace of 526, 15% starting material.
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Encouraged by these initial results, we embarked on a more advanced model which
would allow us to investigate a second Heck closure by Corey-Fuchs homologation of a
pendant aldehyde, as detailed in Scheme 79. Recall that the requisite aldehyde is
available by bromination of commercially available iso-vanillin. The allylic alcohol was
synthesized from toluene in three steps by fermentation with E. coli JM 109 (pDTG601),
reduction with diimide, and protection of the distal alcohol as its TBS-silyl ether.
Meoll1
HOYCHO
Br
302
+
HO",.A
TBSO"'U
527
Meo~
trCHO
a.. 0Yh
TBSO\"V
528
b CHO
ria
TBSO\"
529
Reagents and Conditions: a) PBU3 1.1 equiv, diisopropyl azodicarboxylate 1.1 equiv,
44%; b) Pd(OAc)2 0.15 equiv, dppf, 0.15 equiv, Ag2C03 3.0 equiv, toluene, 62% yield.
Scheme 79. Optimized conditions for Heck closure.
We were now confident that the C-13 closure could be effected through an
intramolecular Heck-type closure. An old problem soon presented itself- how to inv~rt
the C-5 center to pennit synthesis of the natural enantiomer of morphine? Unwilling to
lengthen the synthesis with tedious protection and inversion protocols, we looked for a
route which would avoid inversion of the C-5 center of the starting diol. At this point,
we turned again to palladium catalysis for the solution to the problem.
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111-6.3.1 Allylic Displacement Approaches to Morphine Skeleton
Undoubtedly the most common criticism laid upon enzymatic chemistry is that it,
in many cases, fails to deliver chiral synthons in either enantiomeric series. In the case of
the enzyme toluene dioxygenase, however, Boyd and Hudlicky have independently
developed routes to both enantiomers of the commonly-used bromodiene diol. 195,196
Unfortunately, this protocol has yet to be extended to the vast number of more
sophisticated dienediols, which are largely available as single enantiomers only. While
diene diols have shown great promise as synthons in morphine syntheses, previous
syntheses have shown that the diol unit must be subjected to laborious inversion
sequences in order to attach the requisite aromatic A-ring with correct stereochemistry.
We attempted to circumvent this problem through either a Pd-promoted allylic acetate
displacement,· or alternatively through SN2' displacement of an allylic carbonate.
530
R = OAe, CONHPh
RO",
TBSO\\\
~Nu: ?'" \\\ Nu
14
TBSO\\\~
531
Figure 39.
Such a displacement, if amenable to aromatic malonates or phenylacetylides, would
provide easy access to morphine precursors in which the C-lO-C11 bond had already
been formed. As we had shown in our earlier model studies, the Heck reaction may then
be used to forge the C-13 quaternary center. Finally oxidation of the alcohol at C-6
would permit installation of the benzofuran bridge using Gates protocol.111
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Figure 40. Retrosynthetic analysis of an allylic displacement approach toward
morphinans.
Several groundwork experiments were carried out in order to establish the
feasibility of the allylic acetate displacement approach. Allylic acetate 534, prepared by
acylation of allylic alcohol 522, was treated with the anion of malonate 536, or aromatic
~-ketoester 533 in the presence of palladium (tetrakis)-triphenylphosphine in THF with
triphenylphosphine as a supporting ligand. These conditions, originally reported by
Trost,197 provided the alkylated products in 54 and 60% yields, respectively. Encouraged
by this initial result, a more elaborate allylic acetate was synthesized for further study.
o 0
~OMeU -Na+
533
Pd(PPh3)4'
PPh3 , THF
..
o o
535
OMe 600/0
o 0
MeoVOMe
Na+
536
534
Pd(PPh3)4'
PPh3 , THF
•
534
o 0
MeO OMe
54%
537
Scheme 80. Model studies involving allylic acetate displacements.
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Dienediol 121, which carries the 8 carbons present in the lower portion of the
natural product, was synthesized by enzymatic oxidation of azidoethylbenzene 538 with
E. coli JM 109 (pDTG601). The cis-olefin in 121 was selectively reduced with diimide,
and the diol functionality protected as its acetonide. The azide was converted to its amine
by Staudinger198 reduction with triphenylphosphine in aq THF. Next, the methylamine
functionality was introduced by acylation of the primary amine with methyl
chloroformate, and reduction of the resulting carbamate with lithium aluminum hydride
in THF. After the nitrogen was protected as its acetate, we turned our attention to
cleavage of the acetonide.
63 a &OH b,c &~ d t~~.. .. ..~ OH
538 121 539 540
0
NMeAc NMeAc HNJLOMe60H~ h &~ • f,9 &~ eOH
543 542 541
Reagents and Conditions: a) E. coli JM 109 (pDTG601A) (3.5 gIL); b) potassium
azodicarboxylate, AcOH (60%); c) 2,2-dimethoxypropane, pTsOH, (quant); d) Ph3P,
H20, THF (78%); e) NEt3' methyl chloroformate (52%); t) LAH, THF (quant); g) AC20,
DMAP, py (92%); h) 3:2:2 glacial AcOH/ H20/THF (74%).
Scheme 81. Initial synthesis of the C-ring.
Despite the number of existing protocols for facile removal of the acetonide protecting
group, our attempts to effectively liberate the diol met with little success. Initially, the
best results were obtained by treatment of compound 542 with 3% conc HCI in MeOH,
which gave 45% yield (70% by conversion) in a single best experiment. Dowex-50-8
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acidic resin gave complex mixtures and low yields of the free diol; treatment with silica
gel in water at 150 °C returned only starting material. Ultimately, the protecting group
was cleaved by treatment with 60% aq glacial acetic acid in THF (containing 1 drop of
conc HCI) at refluxing temperature for 10 h, providing diol 543 in 74% yield. The diol
was either elaborated to its carbamate 544 by protection of the distal hydroxyl as its TBS-
silyl ether and subsequent treatment of the resulting alcohol with phenyl isocyanate in
pyridine, or, simply converted to its corresponding triacetate 14 under standard
conditions (Ac20, DMAP, TEA), Scheme 82.
NMeAc NMeAc NMeAc
{c01.NHPh .. a,b {c0H c {c0AC
•
OTBS OH OAc
544 543 14
Reagents and Conditions: a) TBS-Cl, imidazole, DMF (40%); phenyl isocyanate,
DMAP, py (47%); c) AC20, NEt3' DMAP, CH2C12 (95%).
Scheme 82. Synthesis of allylic carbonates or acetates.
The allylic acetate displacement described by Trost was then re-investigated by Dr.
Omori using the more advanced triacetate derivative 14, whose synthesis is depicted in
Scheme 82. Treatment of this substrate under Trost's conditions in the presence of the ~-
ketoester returned only starting material; decomposition to an unidentified mixture
accompanied returned starting material in the case of attempted malonate displacement.
In an attempt to further probe the displacement reaction, ~-ketoamide 548 was
synthesized, the anion was generated and allowed to react with palladium, according to
standard conditions. In this case 65% starting material was recovered.
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starting material
545
Scheme 83.
547 548
By consideration of Overman's SN2' silylcuprate displacement of carbamates, and
similarity between "softness" of acetylide anions and cuprates, we hoped the carbamate
544 would.undergo displacement by the anion of phenylacetylene. This hypothesis was
tested by reacting carbamate 544 with both the lithium and sodium anions of
phenylacetylene, according to Scheme 84. No reaction was observed in either case at, or
below, room temperature. In the case of the sodium anion, heating above 60°C resulted
in diminished yields of the recovered carbamate.
NMeAcIOJLNHPhCXOTBS
544
conditions
a or b
starting material recovered
Scheme 84. Attempted carbamate displacement.
Reagents and Conditions: a) nBuLi, phenylacetylene, THF, -25°C to rt, then
15 (75% recovered SM); b) NaH, phenylacetylene, THF, then 15, O°C to 60°C
(33% recovered SM)
Now convinced that the problem with the displacement is somehow related to the amide
functionality, we set out to prepare a synthetic equivalent of the amide to test in the
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allylic displacement reaction. Surprisingly, the triacetate 549 reacted to give the the
tetrahydrobenzofuran 550 in 31% isolated yield, Scheme 85.
549
Pd(PPh3)4'
PPh3 , THF
o 0
~OMeU -Na+
533
550
Scheme 85.
A plausible mechanism for this unique transformation is outlined in Scheme 86. Initial
complexation of the metal to the olefin leads to an ionized intermediate 553, which is
then attacked by the anion of the ~-keto-ester, 533. An insertion of Pd(O) into the carbon
acetate bond gives 554, which is prone to cyclization to furnish tetrahydrobenzofuran
550a or 550b as a single diastereomer and regenerating the active palladium catalyst in
the process. The ring-junction stereochemistry of 550 is tentatively assigned as trans-
based on the coupling constant (J = 8.4 Hz) and both possible trans-isomers are shown.
Compound 550a may result from initial 1t-complexation on the face opposite to the
hydroxyl functionality, followed by an equilibration to the form a 1t-allyl complex
occuping the same face as the hydroxyl. The equilibration step would lead to alkylation
of the ~-keto-ester with net inversion of configuration (note the initial stereochemistry of
the triacetate). Diastereomer 550b may result from initial1t-allyl complex formation the
less hindered face, permitting nucleophilic attack of the ~-keto-ester to give net retention
of configuration.
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Scheme 86. Proposed mechanism for formation of tetrahydrobenzofurans under
palladium catalysis.
IV. Conclusions and Future Work
Though unexpected, the isolation of compounds such as 550 is encouraging, as
this route shows promise as a potential new entry into the morphine alkaloid family by
forming the C-9/C-14 bond via palladium-mediated allylic acetate displacement and thus
introducing carbons 9, 10, and the incipient ring A of morphine. When Pd(allyl)2CI2 was
used as a catalyst, compound 555 (Ar = dimethoxybromophenyl) was obtained along
with recovered starting material. This is significant because such material may be used in
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a Heck reaction to create the 'C-13 center. Future work may be divided into two
categories. First, allylic acetate displacements by ~-keto-ester nucleophiles will be re-
investigated for compounds such as 560, in which the distal hydroxyl functionality has
been excised.
&OH 60H g:H NHAc60AC.. .. ..~ OH OTs
538 558 559 560
current status
rMeo=QyyPd(O) 1-
MeO ~ OEt
Br 0 0
MeO 561
MeO MeO
MeO
MeO
• 0• 0 ..Me
NMeAc
17 codeine 563 562
Scheme 87. Projected allylic acetate displacement and completion of codeine synthesis.
Removal of the distal hydroxyl should circumvent the formation of the benzofuran
resulting from cyclization of the ~-keto-ester. The requisite allylic acetate 560 was
prepared from azidoethylbenzene according to Scheme 87. It is noteworthy to mention
that compound 560 is quite similar to the allylic carbonates such as 303 used by Trost6 in
a palladium-mediated arylation reaction which comprised the enantioselective step in the
synthesis of (-)-galanthamine and (-)-morphine (see Section 11.3).
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Second, the Heck reaction which succeeded in closing the C-13 center in
previous model studies will be re-applied to a synthesis of unnatural (+)-morphine. This
convergent approach will rely on a Mitsunobu alkylation to introduce the aryl fragment
with inversion of configuration at C-5, thus allowing entry into the unnatural series of
morphinan alkaloids via Heck reaction to establish the C-13 center. The homochiral C-
ring, whose preparation has been detailed in Scheme 81, will be reacted with the
appropriate aryl bromide, according to Scheme 88. The salient features of the proposed
synthesis will entail a Heck closure to install the C-13 center, homologation of the
aldehyde, and a subsequent Heck closure to form the phenanthrene core. Given the
similarity between aldehyde 565 and Trost's aldehyde 308, a concise asymmetric
synthesis of synthesis of (+)-morphine should result from elaboration of the Heck product
565. These projects are in progress and their current status as of this writing is indicated
in Schemes 86, 87, and 88.
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Scheme 88. Projected synthesis of (+)- morphine through Mitsunobul Heck strategy.
v. Experimental Section
General Experitnental SecUon
All non-hydrolytic reactions were carried out under an argon atmosphere. Glassware
used for moisture-sensitive reactions was flame-dried under vacuum and subsequently
purged with argon. THF was distilled from potassium/benzophenone. Methylene
chloride and acetonitrile were distilled from calcium hydride. Electrochemistry supplies
and apparatus were purchased from EG&G Princeton Applied Research. Flash column
chromatography was performed using Kieselgel 60 (230-400 mesh). Analytical thin-
layer chromatography was performed using silica gel 60-F254 plates. Melting points
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were measured on a Thomas-Hoover melting point apparatus and are reported
uncorrected. IR spectra were obtained on a Perkin-Elmer FT-IR 1600 Series Spectrum
One instrument and were recorded as neat samples. IH and 13C NMR spectra were
obtained on either a 300-MHz Bruker or a 600 MHz Varian instrument. Specific rotation
measurements are given in deg cm3 g-l dm-1and were recorded on a Perkin-Elmer 341
Polarimeter. Ultraviolet spectroscopy was performed using a Perkin-Elmer 8452 A diode
array spectrophotometer. Large-scale fermentation was performed in a 15-L B. Braun
Biostat C-15 fermentor. All biological media was purchased through Sigma-Aldrich
Canada. Combustion analyses were performed by Atlantic Microlabs, Norcross, Georgia,
USA, and ISAR Laboratories, Guelph, Ontario, Canada.
General Experimental Procedures for Biotransformations
Small-scale fermentation with E. coli.JM 109 (pDTG601)
Growth of colonies. Agar plates consisted of bactotryptone (10 g L-1), yeast extract (5 g
L-1), NaCI (5 g L-1), agar (30 g L-1) and ampicillin (100 mg L-1). E. coli JM 109
pDTG601 cells were streaked onto a plate and were incubated at 35°C for 12-24 h. A
single bacterial colony was selected for the preculture preparations described in the
following section.
Preparation of preculture. Luria Bertani (LB) liquid medium consisted of bactotryptone
(10 g L-1), yeast extract (5 g L-1), NaCI (5 g L-1) and ampicillin (100 mg L-1). The
preculture medium (3 mL) was inoculated with a single colony of E. coli JM 109
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(pDTG601) and the resulting inoculum was grown at 35°C on an orbital shaker (200
rpm) for 6 h.
Fernbach flask preparation. LB liquid medium consisted of bactotryptone (10 g L- I ),
yeast extract (5 g L- I ), NaCI (5 g L- I ), glucose (5 g L- I ) and ampicillin (100 mg L- I ). 500
mL of LB medium was inoculated with 1 mL of E. coli JM 109 (pDTG601) preculture
medium. This inoculum was grown at 35°C on an orbital shaker (180 rpm) for 5 h. A
chemical inducer, isopropyl-l-thio-~-D-galactopyranoside (IPTG ) (10 mg L- I ), was
added via sterile filter and the cells were grown for additional 7 h at 35°C on an orbital
shaker (200 rpm).
Substrate Addition. The cells were separated from the supernatant by centrifugation at
7000 rpm for 15 min and the supernatant was decanted. The cell pellet wasre-suspended
in 500 mL of 0.1 M phosphate buffer consisting of KH2P04 (6.8 g L-I), K2HP04 (8.7
gILl) and glucose (2 g L-I). The aromatic substrate (400 mg L-1) was added as a solution
in isopropyl alcohol. Product formation was monitored by thin-layer chromatography
(hexane-ethyl acetate, 1: 1).
Product Isolation. After 5 h of incubation with substrate the pH of the culture medium
was adjusted with 6 M NaOH to 8.5, and a cell pellet was obtained by centrifugation at
7000 rpm and 4 °C for 20 min. The supernatant liquid was extracted with acid-free ethyl
acetate (prepared by stirring with a saturated solution of Na2C03) and separation of the
organic from the aqueous layer. The extract was dried over anhydrous MgS04, filtered
and the solvent was removed under reduced pressure. The crude material was purified by
crystallization or flash column chromatography (silica gel deactivated with 10% distilled
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water) immediately after concentration of the solvent in order to minimize decomposition
of the unstable dienediols.
Large-scale fermentations were carried out in a 15-L (8-L working volume) B. Braun
Fermentor according to a published procedure.25
Extraction of Products
Dienediols obtained from large-scale (8-L fermentation) were extracted from the aqueous
fermentation broth into ethyl acetate either by standard manual extraction or by
continuous extraction. The diene diols derived from small-scale fermentations «I-L)
were extracted manually. Progress of either manual or continuous extraction was
monitored by thin layer chromatographic analysis of the aqueous layer.
General Procedure for the Acitivation of Silica Gel:
Silica gel (1.5 g, 230-400 mesh) was poured onto a sintered glass Buchner funnel and
washed with reagent grade THF (2 x 15 mL) and diethyl ether (2 x 15 mL). The silica
gel was transferred to a round-bottomed flask and heated externally at 140 °C under
vacuum (1 mm Hg) for 24 hours.
General Procedure for Opening of Aziridines and Epoxides on Silica Gel
Surface:
A flame-dried 25-mL round-bottomed flask was charged with indole (1.2 mmol, 3 eq.),
aziridine or epoxide electrophile (0.40 mmol, 1.0 eq.), and previously activated silica gel
(500 mg). The starting materials were suspended in 3 mL freshly distilled methylene
chloride and the solvent removed under reduced pressure. The silica gel supporting the
adsorbed reactants was heated externally at 70 °C under argon atmosphere for 48 hours,
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after which time the silica gel was loaded onto a flash silica gel column and the
condensation product eluted with 4: 1 hexanes/ethyl acetate.
(IS,2R)-3-Bromo-6-(methylsulfanyl)cyclohexa-3,5-diene-l,2-diol (316)
The biooxidation of 4-bromo-l-(methylsulfanyl)benzene 315 was performed according to
the general procedure for large-scale fermentation. 4-bromo-l-(methylsulfanyl)benzene
(35 g) was added as a slurry in a minimal amount of DMSO to a 15-L fermentor
containing a growing culture of E. coli JM 109 (pDTG601) over a 2 h period. After
stirring the media for an additional 2 h, the cell broth was separated from the cells by
centrifugation. The broth was then extracted with equal volumes of ethyl acetate (20L x
2) until TLC analysis of the aqueous layer revealed that the extraction was complete. The
combined organic were layers washed twice with 10 % (by volume) of saturated sodium
carbonate solution to remove any residual phenol. The organic extracts of the
fermentation broth were concentrated in vacuo and diol 316 precipitated by addition of
pentane. Recrystallization from ethyl acetate/pentane provided the title compound as a
white solid (18 g, 2.25 gIL): mp 59-63°C; [aJ I9D -10.0, (c 1.08, CHCI3); Rf 0.26
(hexanes-ethyl acetate, 1:1); IR (film) v 3197, 2921, 1626, 1548, 1416, 1340, 1306, 1036
em-I; IH NMR (300 MHz, CDCI3) 3: 6.37 (d, J= 6.1 Hz, IH), 5.35 (d, J= 6.3 Hz, IH),
4.43 (dd, J =9.0, 3.2 Hz, IH), 4.32 (dd, J =7.5, 1.4 Hz, IH), 2.63 (d, J =9 Hz, IH), 2.26
(s, 3H), 2.24 (d, J = 7.6, IH); I3C NMR (75 MHz, CDCI3) 3: 142.8, 127.8, 120.3, 112.7,
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73.6, 72.5, 14.4; MS (EI) mlz (%): 238 (8), 236 (8), 220 (100), 218 (98), 205 (41), 203
(39), 177 (24), 175 (24), 157 (20), 142 (25), 109 (33), 96 (24), 45 (41); HRMS-EI calcd
SCHsBr~OH
UOH
(lS,2S)-4-Bromo-3-(methylsulfanyl)cyclohexa-3,5-diene-1,2-diol (364)
Diol 364 was prepared according to the general procedure for shake-flask fermentation
described above. 2-Bromophenyl methyl sulfide 363 (0.6 g, 2.97 mmol) was added to the
E. coli JM 109 (pDTG601) culture, and product formation was monitored by TLC (Rr
0.3,1:1, hexanes-ethyl acetate) and UVNis (Amax 288 nm, 100X dilution, distilled H20 as
blank). The resulting yellow-white crystalline material was purified by column
chromatography (96:4, CH2CI2-MeOH), and the title compound (0.117 g, 16 %) was
isolated as off-white solid: mp 70°C; [a]D22 +130 (c 1.0, MeOH); [a]D22 +123 (c 1.0,
MeOH)]; Rr 0.2 (96:4, CH2CI2-MeOH); IR (film) v 3258, 2924, 2871, 1259, 1101, 1095,
1005 cm-1; IH NMR (300 MHz, CDCI3) 3: 5.9 (dd, J = 9.83,2.56 Hz, 1H), 5.5 (d, J = 9.7
Hz, 1H), 4.4 (s, 1H), 4.1 (d, J = 5.3 Hz, 1H), 2.5 (s, 1H), 2.3 (s, 3H), 2.1 (s, 1H); 13C
NMR (75 MHz, CDCI3) 3: 135.9, 129.8, 129.0, 116.6, 70.1,68.7, 15.0; MS (EI) mlz (%):
238 (46.1), 236 (46.4), 220 (68.4), 218 (67.4), 111 (100), 109 (69.1), 81 (87.3); HRMS-
EI calcd for C7HgBr02S (M+): 235.9506, found: 235.9501.
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(IS,2S)-5-Bromo-3-(methylsulfanyl)cyclohexa-3,5-diene-1,2-diol (327)
3-Bromophenyl methyl sulfide 326 (0.4 g, 1.97 mmol) was added to a growing culture of
E. coli JM 109 (pDTG601) according to the general procedure for shake-flask
transformation described above. Product formation was monitored by TLC (Rr 0.5, 1:1,
hexane-ethyl acetate). A yellow oily material was purified by column chromatography on
10% deactivated silica gel (hexane-ethyl acetate, 1: 1), and the title compound was
isolated as off-white solid, (7 mg, 1.6 %). Mp 87-89 °C; [a]D23 +26.6 (c 0.88, acetone) Rr
0.5 (hexane-ethyl acetate, 1:1). IR (film) v 3350, 3019, 2917, 1603, 1551, 1435, 1384,
1216, 1112, 1043 em-I. IH NMR (300 MHz, CDCI3) 3: 6.0 (d, J = 2.7 Hz, 1H), 5.4 (s,
1H), 4.1 (m, J = 9.8,6.2,4.4 Hz, 2H), 2.2 (s, 3H); 13C NMR (75 MHz, CDCI3) 3: 146.7,
124.8,118.9,116.3,70.7,69.5,13.0; MS (En mlz (%): 238 (10.2),236 (10.3), 220 (100),
218 (97.2),205 (42.2), 203 (40.8),177 (18.8),175 (18.4),111 (40.5),95 (25.1); HRMS-
EI calcd for C7HgBr02S (M+): 235.9507; found, 235.9509.
(18,28)-3-(methylsulfanyl)cyclohexa-4,6-diene-l,2-diol (349)
a) Preparation from diol316 by electrochemical reduction:
Electrolysis was performed in a 150 mL beaker with a mercury pool cathode and AglAg+
(silver wire in a solution of 0.1 M AgN03 in acetonitrile) as reference electrode. A Pt
anode was placed in a chamber separated from the rest of the cell by a sintered-glass frit.
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Dienediol 316 (237 mg, 1 mmol) was dissolved in a minimum amount of acetonitrile and
transferred to the beaker containing 100 mL of 0.15 M Et4NBr solution in acetonitrile
(previously degassed under positive pressure of argon for 20 min) followed by
tetrabutylammonium hydroxide (1 mL of 40% aqueous solution). Electrolysis was
performed at -2.75 V. A charge of 2 Flmol was delivered over approximately a 1 h
period; progress of the reaction was monitored by TLC. Following electroreduction, the
crude reaction mixture was decanted, and 10 mL of saturated sodium carbonate solution
was added to neutralize any phenolic residue formed as a byproduct of the reaction. The
organic solvent was evaporated under reduced pressure, and the residue diluted with 20
mL of distilled water. The aqueous layer was extracted with 5x50 mL of diethyl ether.
The combined ethereal layers were washed with 2x3 mL of saturated sodium carbonate,
10 ml of brine and dried over anhydrous MgS04. After filtration to remove the drying
agent, the solvent was removed under reduced pressure, and the crude product was
immediately purified by flash chromatography on deactivated silica gel (hexanes-ethyl
acetate, 6:4). Purification afforded the title compound as. a white crystalline solid, 31.1
mg (20%). The crystalline product decomposes completely to its phenolic derivative at
room temperature in less than 30 min; however, in dilute dichloromethane solution the
decomposition is significantly slowed and the dienediol is stable for several days. Mp 61-
62°C; [a]24n +81.3, (c 0.27, MeOH); (lit: 199 [a]n +37 (c 0.7, MeOH)); Rf 0.4 (hexanes-
ethyl acetate, 30:70). IR (film) v 3247, 2915, 2858, 1551, 1545, 1431, 1420, 1321, 1292,
1106 cm-I ; IH NMR (300 MHz, CD30D) 0: 5.99 (dq, J = 5.5,2 Hz, IH), 5.72 (dd, J =
9.5,3.6 Hz, IH), 5.58 (d, J = 5.6 Hz, IH), 4.25 (m, 1H), 4.02 (d, J = 5.5 Hz, IH), 2.31 (s,
3H). I3C NMR (75 MHz, CD30D) 0: 141.7,125.4,124.5,114.0,71.3,69.1,13.0. Note:
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b) Preparation from diol316 by Heck reduction:
To a thick-walled reaction vessel equipped with magnetic stirring bar and Teflon seal was
added dienediol 316 (300 mg, 1.27 mmol, 1 equiv), 5% palladium on activated carbon
(60 mg), and freshly distilled triethylamine (500 JlL, 3.8 mmol, 3 equiv). The reaction
vessel was flushed with argon before addition of formic acid (120 JlL, 2.8 mmol, 2.2
equiv). The vessel was sealed and the reaction mixture stirred at rt for 1 h and then
heated for 2 h at 55°C. The crude mixture was filtered through Celite and washed with 5
mL of methanol. The crude product, which is unstable, was used directly in the
subsequent reaction without further purification.
c) Preparation from diol 327 by Heck reduction:
To a thick-walled reaction vessel equipped with magnetic stirring bar and Teflon seal was
added dienediol 327 (25 mg, 0.11 mmol, 1 equiv), 5% palladium on activated carbon (15
mg), _and freshly distilled triethylamine (87 JlL, 0.63 mmol, 5.7 equiv). The reaction
vessel was flushed with argon before addition of formic acid (8 JlL, 0.46 mmol, 4 equiv).
The vessel was sealed and the reaction mixture was stirred at rt for 10 min and then
heated for 1 h at 55°C. The crude mixture was filtered through Celite and washed with 5
mL of methanol. The crude product, which is unstable, was used directly in the
subsequent reaction without further purification.
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J:OH
UOH
(IS,2S)-3-(methylsulfanyl)cyclohex-3-ene-l,2-diol (350)
a) By diimide reduction of diene 349:
The crude product (1 mmol) from electroreduction was chromatographed on 10%-
deactivated silica (hexanes-ethyl acetate, 30:70). Fractions containing the pure dienediol
(TLC analysis) were transferred to a round-bottomed flask containing 10 mL methanol,
and the hexanes/ethyl acetate mixture was evaporated with continuous addition of
methanol. When the solvent volume was reduced to approximately 30 mL, the flask was
placed in an ice/salt bath. Potassium azodicarboxylate (580 mg, 3.0 mmol, 3 equiv) was
added in portions to the methanolic solution. Upon complete addition of the PAD
reagent, the yellow slurry was stirred for 10 min. Acetic acid, (400 f.lL, 7 mmol, 7 equiv)
in 15 mL methanol was added dropwise over a two hour period to the slurry at 0 °C. The
reaction mixture was allowed to warm to room temperature overnight. The pH of the
mixture was brought to neutral by addition of 4 mL of saturated solution of sodium
hydrogencarbonate. Methanol was removed under reduced pressure and the residue
diluted with 5 mL of distilled water followed by 20 mL of ethyl acetate. The layers were
separated, and the aqueous layer extracted three times with 20 mL portions of ethyl
acetate. The combined organic layers were dried (anhydrous MgS04) and the solvent
removed under reduced pressure to afford the title compound as a white crystalline solid,
37 mg (16 % yield over two steps). The crude product may be further purified by
recrystallization from methylene chloride/pentane. Mp 91-93 °C; [a]D24-104, (c 0.75,
CHCI3); Rf 0.4 (hexanes-ethyl acetate, 30:70); IR (film) v 3249, 2944, 2913, 2890, 2829,
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1623, 1434, 1356, 1327, 1100 cm-I; IH NMR (300 MHz, CDCI3) 8: 5.57 (t, J =4 Hz,
1H), 4.05 (s, 1H), 3.82 (d, J =4.2 Hz, 1H), 2.55 (d, J =4.1 Hz, 1H), 2.40 (s, 1H), 2.19 (s,
3H), 2.15-2.10(m, 1H), 1.85-1.60 (m, 3H); I3C NMR (75 MHz, CDCI3) 8: 134.6, 124.8,
69.4,69.1, 25.7, 24.8, 15.1; MS (EI) mlz (%): 160 (50), 142 (22), 127 (31), 116 (100), 95
(47), 87 (58), 68 (40, ), 55 (30), 45 (54); HRMS-EI calcd for C7HI20 2S (M+): 160.0554,
found: 160.0558; Anal. Calcd for C7H1202S: C, 52.47; H, 7.55; Found C, 52.74; H, 7.39.
b) An alternative procedure for the reduction of unstable diene diol 349 from the
Heck reduction product 349:
A 50-mL round-bottomed flask fitted with an addition funnel was charged with the crude
debrominated material 349 dissolved in 5 mL of methanol. The reaction 'flask ·was placed
in an ice bath and PAD reagent (730 mg, 3.8 mmol, 3 equiv) added in 2 portions. After
10 min, a solution of acetic acid (493 ilL, 8.89 mmol, 7 equiv) in 10 mL of methanol was
added to the yellow slurry over a 45 min period. The reaction mixture, whose yellow
color gradually faded to tan, was allowed to warm to rt overnight. The reaction mixture
was neutralized with a saturated solution of sodium hydrogencarbonate. After
neutralization, the volume of the reaction mixture was reduced to approximately half
under reduced pressure. The contents of the reaction flask were extracted with several
portions of ethyl acetate. The combined organic layers were washed with brine and dried
over anhydrous MgS04. Removal of the organic solvent under reduced pressure
provided a tan solid (57 mg, 28 % over two steps), whose spectral data were consistent
with that previously published.
c) Preparation from diol 349 (prepared by Heck reduction of m-bromothioanisole
dioI327):
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To a 25-mL round-bottomed flask equipped with an addition funnel and magnetic
stirring bar was added crude debrominated material 349 dissolved in 5 mL of methanol.
The reaction flask was placed in an ice bath and potassium azodicarboxylate (73 mg, 0.38
mmol, 3 equiv) added in 2 portions. After 10 min, a solution of acetic acid (53 JlL, 0.88
nunol,7 equiv) in 3 mL of methanol was added to the yellow slurry over 30 min. The
reaction mixture was allowed to warm to rt overnight and neutralized with a saturated
solution of sodium hydrogencarbonate. After neutralization, the volume of the reaction
mixture was reduced to approximately half under reduced pressure. The content of the
reaction flask was extracted with several portions of ethyl acetate. The combined organic
layers were washed with brine and dried over anhydrous MgS04. Removal of the
organic solvent under reduced pressure gave the crude dial 5, which was purified by flash
column chromatography to furnish 1 mg of the title compound; [a]n21 -35, (c 0.1,
CXOHOTHS
(lR,2S)-2-[(Hexyldimethylsilyl)oxy]cyclohexan-l-ol (358)
a) Preparation from vinyl bromide 357 (derived from homochiral bromodienediol
72)
A hydrogenation flask was charged with bromide 357 (1.0 g, 2.9 mmol, 1 equiv),
triethylamine (0.40 mL, 2.9 nunol, 1 equiv), platinum oxide (Adams catalyst, 65 mg, 0.29
mmol, 0.10 equiv) and 5 mL of methanol. The flask was placed in a Parr hydrogenation
apparatus, slowly evacuated, and the headspace filled with hydrogen gas. The flask was
shaken for 2 h under 3 atm hydrogen. When the reaction was complete by TLC analysis,
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the catalyst was removed by filtration through a short plug of Celite and sand. The
solvent was evaporated, and the residue diluted with 1 mL water, 10 mL ethyl acetate,
and extracted. The organic layer was washed with water (2 mL x 2), sat. NaHC03 (2 mL
x 2), brine, (2 mL x 2), and dried (anhydrous MgS04). Removal of the solvent provided
the title compound as a clear and colorless oil (735 mg, 98 %); [a]D23 +10.6, (c 1.0,
CHCI3); Rf 0.55 (hexanes-ethyl acetate, 9:1); IR (neat) v 3580, 3487, 2938, 2866, 1463,
1447, 1377, 1252, 1078 cm-I; IH NMR (300 MHz, CDCI3) 0: 3.62 (dt, J = 7, 3 Hz, IH),
3.51 (m, IH), 2.05 (bs, IH), 1.7-1.3 (m, 8H), 0.77 (dd, J = 6.8, 2 Hz, 6H), 0.72 (s, 6H), 0
(s, 6H); I3C NMR (75 MHz, CDCI3) 0: 74.4, 73.0, 36.6, 32.9, 32.5, 24.4, 22.7, 22.5,
21.0, 20.9, 0, -0.5; MS (EI) mlz (%): 173 (19), 155 (2), 129 (2), 105 (6), 81 (13), 75 (35),
55 (4), 41 (6); HRMS-EI calcd for CgHI702Si (M+): 173.10195, found: 173.09933.
b) Preparation of 358 from thioether 350:
A 5-mL round-bottomed flask was charged with diol 350 (75 mg, 0.46 mmol, lequiv),
imidazole (41 mg, 0.61 mmol, 1.3 equiv), and 400 JlL of anhydrous DMF. The flask was
cooled to -30°C, then THS-CI (87 JlL, 0.49 mmol, 1.05 equiv) was added. The mixture
was stirred at -30°C for 1 h and then the reaction flask was placed in a freezer (-18°C)
for 10 h. The mixture was diluted with 30 mL of ether, washed with 8 x 1 mL of aqueous
solution of 5% citric acid, 2 x 1 mL brine, and the ethereal layer dried over anhydrous
MgS04• The drying agent was removed by filtration, and the solvent was removed under
reduced pressure to afford the crude silyl ether, (120 mg, 90 % crude yield) which was
used directly in the subsequent reaction without further purification.
Commercially available Raney nickel 2400® was activated by swirling with 10% NaOH
solution and decanting the supernatant. The procedure was repeated with distilled water
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until neutral pH was attained (about 12 washes). The nickel was finally washed with
absolute ethanol three times. The crude THS-protected thioether 360 (60 mg, 0.199
mmol) was introduced into a 25-mL round-bottomed flask equipped with a magnetic
stirring bar and reflux condenser. The reaction flask was then charged with freshly
activated Raney Ni (spatula tip) and 5 mL absolute ethanol. The reaction flask was
heated to maintain steady reflux overnight. Reaction progress was monitored by TLC and
the reaction deemed complete after 11 h at reflux temperature. The reaction mixture was
filtered through a plug of Celite and washed with copious amounts of hot methanol. The
washings were passed through a plug of silica gel to remove residual impurities. The
product was obtained as yellow oil, 15 mg (29% yield). IH and 13C NMR spectral data
matched those of compound 358, prepared by hydrogenation of vinyl bromide 357.
ISUOH
OH
(IS ,2S)-4-(methylsulfanyl)cyclohex-3-ene-l,2-diol (355)
To a flame-dried flask containing a magnetic stirring bar was added bromide 351 (1.0 g,
5.18 mmol, 1 equiv), sodium methanethiolate (725 mg, 10.4 mmol, 2 equiv), and 3 mL of
HMPA under argon atmosphere. The reaction flask was heated to an external
temperature of 65°C for a period of 16 h. The crude reaction mixture was taken up in 50
mL of diethyl ether and washed with water (ImL x 10 ) and brine (ImL x 2). The
ethereal layer was dried (anhydrous MgS04), the drying agent filtered, and the solvent
removed under reduced pressure to provide a brown oil which was purified by silica gel
flash chromatography (hexanes-ethyl acetate, 30:70). The title compound was isolated as
a crystalline white solid (24%). Mp 83°C; [a]24n -74 (c 0.75, CHCI3); Rf 0.32 (hexanes-
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ethyl acetate, 30:70); IR (film) v 3247, 2914, 1432, 1294, 1123, 1100, 996 cm-I ; I H NMR
(300 MHz, CDCI3) 0: 5.25 (d, J =4.1 Hz, 1H), 4.12 (m, 1H), 3.78 (m, 1H), 2.75-2.4 (bs,
2H), 2.30-2.05 (m, 2H), 2.17 (s, 3H), 1.85-1.65 (m, 2H); I3C NMR (75 MHz, CDCI3) 0:
141.1, 116.2, 68.9, 67.3, 28.3, 26.7, 14.4; MS (EI) mlz (%): 160 (39), 142 (64), 127 (31),
116 (72), 109 (30), 101 (100), 85 (24), 69 (49), 53 (22), 41 (41); HRMS-EI calcd for
7.55, Found, C, 53.02; H, 7.82.
(lS,2S)-4-Bromo-3-(methylsulfanyl)cyclohexa-3-ene-l,2-diol
Diol 364 (0.63 g, 3.0 mmol) was dissolved in 35 mL MeOH, and the round-bottomed
flask containing the solution was subsequently placed into an ice/NaCI bath. PAD reagent
(1.8 g, 9.0 mmol) was added in portions to the methanolic solution. The resulting yellow
slurry was stirred for 15 min, at which point acetic acid (1.2 mL, 21 mmol) in 25 mL
MeOH was added dropwise via addition funnel over a period of 3 h. The reaction mixture
was allowed to warm to rt overnight. The pH of the reaction mixture was brought to
slightly alkaline by adding 20 mL of saturated NaHC03 solution. Methanol was removed
under reduced pressure and the residue diluted with ethyl acetate. The layers were
separated and the aqueous layer was extracted with several portions of ethyl acetate. The
combined organic layers were washed with a saturated NaCI solution, dried over
anhydrous MgS04, filtered, and solvent was removed under reduced pressure. The crude
residue was purified by flash column chromatography (CH2CI2-MeOH, 96:4) yielding the
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title compound as white solid, 0.321g (51 %). Mp 135°C; [a]n -104.3 (c 0.5; acetone);
Rf 0.2 (96:4, CH2CI2-MeOH). IR (film) v 3401, 2977, 2400, 1604, 1521, 1476, 1424,
1216, 669. IH NMR (300 MHz, CDCI3) 0: 4.3 (s, 1H), 3.9 (s, 1H), 2.4 (s, 3H), 2.3 (s,
3H), 1.9 (m, 2H), 1.8 (m, 2H); 13C NMR (75 MHz,CDCI3) 0: 134.7, 121.4, 69.1, 68.7,
36.4, 26.9, 13.4; MS (EI) mlz (%): 240 (17.5), 238 (18.4), 196 (30.0), 194 (30.1), 149
(100); HRMS-EI calcd for C7HIIBr02S (M+): 237.9663; found: 237.9661; Anal. Calcd
for C7HIIBr02S: C, 35.16; H, 4.64, Found: C, 35.48; H, 4.30.
(3aS,7as)-2,2-Dimethyl-4-(methylsulfanyl)-3a,6,7a-tetrahydro-l,3-benzodioxole
(366)
a) Preparation from diol 350:
Diol350 (55 mg, 0.35 mmol, 1 equiv) was transferred to a 10-mL round-bottomed flask
and dissolved in 1 mL of acetone. 2,2-DMP (250 J!L, 2.0 mmol, 5.7 equiv) was added
followed by 1 crystal of pTsOH. The solution was stirred at rt for 24 h before the
reaction was quenched with 1 mL of a saturated NaHC03 solution. The cloudy mixture
was diluted with 15 mL ethyl acetate and 2 mL of distilled water. The layers were
separated and the aqueous layer back-extracted with ethyl acetate. The combined organic
layers were washed with brine and dried over anhydrous MgS04• The solvent was
removed under vacuum to provide a tan oil (24 mg) which was purified by flash column
chromatography (10% ethyl acetate in hexanes) to afford the title compound as a clear
oil, 16 mg (23 %). [a]n22 +20.1 (c 0.8, CHCI3); Rf 0.38 (10% ethyl acetate in hexanes).
IR (film) v 2984, 2924, 1624, 1438, 1379 cm-I; IH NMR (300 MHz, CDCI3) 0 5.56 (s,
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IH), 4.40 (s, IH), 4.29 (s, IH), 2.20 (8, 3H), 2.20 (m, IH), 2.0-1.8 (m, 2H), 1.75-1.60 (m,
IH), 1.36 (s, 3H), 1.30 (s, 3H); 13C NMR (75 MHz, CDCI3) 0 134.0, 123.8, 109.2,74.5,
74.1,28.1, 26.6, 25.9, 22.0, 14.9; HRMS-EI (M+) calcd for CloH1602S, 200.0871; found,
200.0864; Anal Calcd for CloH1602S: C, 59.97; H, 8.05, Found: C, 60.11; H, 7.78.
b) Preparation from the partially reduced diol derived from o-bromothioanisole
364:
(IS,2S)-4-Bromo-3-(methylsulfanyl)cyclohexa-3-e~e-l,2-diol (0.020 g, 0.084 mmol, 1
equiv) was dissolved in 2,2-DMP (1 mL, 8.4 mmol, 10 equiv), to which one crystal of
pTsOH was then added. The reaction mixture was stirred at room temperature under a
positive pressure of argon until the complete consumption of starting material was
observed by TLC analysis (ca 1 h). Rf 0.9 (1:1, hexane-ethyl acetate). The solvent was
removed under reduced pressure and the residue diluted with 0.5 mL of saturated
NaHC03. The aqueous portion was extracted into ethyl acetate, washed with a saturated
solution of NaCI, and dried over anhydrous MgS04• The solvent was removed under
reduced pressure and residual white-yellow solid dried under·high vacuum. The protected
diol365 was used directly in the subsequent reaction without further purification.
The crude material from the previous reaction was dissolved in 1 mL of anhydrous THF
in a flame-dried 25-mL round-bottomed flask and cooled to -60°C. nBuLi (195 JlL of 1.6
M in hexanes, 0.25 mmol, 3 equiv) was added dropwise and the reaction mixture stirred
at -60°C under positive pressure of argon for 45 min. Reaction progress was monitored
by TLC. The reaction mixture was quenched with 0.5 mL of distilled water and 1 mL
saturated aqueous solution of ammonium chloride. The mixture was extracted several
times with ether and the ethereal layer then washed with brine and dried over anhydrous
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MgS04. The drying agent was removed by filtration and the solvent removed under
reduced pressure to provide a crude oil which was purified by flash column
chromatography (hexanes-ethyl acetate, 9:1), affording the title compound as a clear,
colorless oil (3 mg, 18 %). [a]D +20.3 (c 0.3, CHCI3). IR (film) v 3368,2984,2924,1625,
1576, 1439, 1368, 1219 cm-I; IH NMR (300 MHz, CDCI3) b: 5.5 (s, 1H), 4.4 (s, 1H), 4.2
(s, 1H), 2.2 (s, 3H), 2.2 (m, IH), 1.9 (m, 2H), 1.7 (m, 2H), 1.35 (s, 3H), 1.31 (s, 3H).
(+)-(R)-2-Bromophenyl methyl sulfoxide (363)
Sulfoxide 363 was prepared according to the general procedure for shake-flask
fermentation described above. The crude material isolated after extraction was purified
by column chromatography (CH2CI2-MeOH, 96:4,) to give 2-bromophenyl methyl
sulfoxide 363 (0.047 g, 7 %) as a brown oil. Further elution gave starting material (0.070
g, 0.346 mmol, 11%) and the chiral diene diol364 (0.210 g, 0.890 mmol, 33%). [a]D23
+32.5 (c 1.8, CHCI3); lit.146 [a]D +35 (c 1.8, CHCI3)]; Rf 0.4 (CH2CI2-MeOH, 96:4); IR
(film) v 3400,3059,2996, 1447, 1093, 1058,755 cm-I. IH NMR (300 MHz, CDCI3) b:
7.9 (dd, J =7.6, 1.3 Hz, IH), 7.5 (t, J = 17.2, 8.6 Hz, 2H), 7.2 (td, J =7.8, 1.4 Hz, IH),
2.7 (s, 3H). I3C NMR (75 MHz, CDCI3) b: 144.3, 131.9, 131.3, 127.7, 124.7, 117.4, 40.9;
MS (En mlz (%): 220 (81.6), 218 (84.4), 205 (100), 203 (98.7), 96 (33.8). HRMS-EI
Calcd for C7H70SBr (M+): 217.9401; found: 217.9398.
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(+)-(R)-3-Bromophenyl methyl sulfoxide (328)
m-Bromothioanisole 326 (0.4 g, 1.97 mmol) was added to E. coli JM 109 (pDTG601)
culture according to the general procedure described for shake-flask fermentation.
Progress of the reaction was monitored by TLC. The crude material was purified by
column chromatography (1:1, hexane-ethyl acetate) to provide 3-bromophenyl methyl
sulfoxide 328 (0.130 g, 0.6 mmol, 28%) as a yellow oil. [a]n23 +39.8 (c 1.2, acetone);
lit. 147 [a]n +116.3 (c 1.2, acetone)]; Rf 0.2 (hexane-ethyl acetate, 1:1). IR (film) 3440,
3054,2998,2912,2856,2094,1959,1885,1709,1643, 1567, 1460, 1402, 1080, 784cnf
1. IH NMR (300 MHz, CDCI3) 0: 7.8 (s, 1H), 7.6 (td, J =9.2, 1.1 Hz, 2H), 7.4 (t, J =
15.7,7.9 Hz, 1H), 2.6 (s, 3H); 13C NMR (75 MHz, CDCI3) 0: 150.3, 133.9, 131.5, 126.5,
123.2, 122.9,43.7; EI-MS m/z (%): 220 (83.4), 218 (83.3), 205 (100), 203 (97.6), 177
(10.4), 175 (12.0), 157 (24.8), 155 (25.4), 139 (21.0), 108 (22.2), 96 (23.0), 50 (44.4). EI-
HRMS calcd. for C7H7BrOS (M+): 217.9401; found: 217.9396.
2,2-Dimethyl-7-methylsulfone-3(S)a,4(S),5,7a-tetrahydro-benzo[1,3]dioxole (367)
Protected sulfide diol 366 (220 mg,1.14 mmol, 1 equiv) was suspended in a minimal
amount of 50% (aq) acetone. To 0.4 mL 0.3 M aqueous ammonium molybdate solution
was added 2.5 mL 30% (aq) hydrogen peroxide, and the resulting yellow solution was
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immediately added to the suspension of sulfide. Within seconds the reaction mixture
became homogenous. The progress of the reaction was monitored by TLC and deemed
complete after 3 min, at which time the reaction was quenched by addition of 3 mL
saturated solution of sodium bisulfite until the reaction mixture confirmed a negative
potassium iodide starch paper. The organic solvent was removed under reduced pressure
and the aqueous portion extracted with chloroform (5 x 20 mL). The extract was dried
(MgS04) and the solvent removed in vacuo to provide a crude oil. Purification by flash
column chromatography (ether-pentane, 1:2) gave the title compound as a white
crystalline solid (167 mg, 59% yield). Mp 84/85 0 C; [a23D] +98.1 (c 0.72, CHCI3) Rf 0.27
(pentane-diethyl ether, 2:1); IR (film) v 2986, 2935, 1642, 1298 cm-1; IH NMR (300
MHz, CDCI3) b: 7.10 (dd, J =6,3 Hz, IH), 4.98 (d, J =6 Hz, IH), 4.50 (m, IH), 3.01 (s,
3H), 2.42 (m, IH), 2.25 (m, IH), 2.05 (m, IH), 1.73 (m, 1H), 1.37 (s, 6H); 13C NMR (75
MHz, CDCI3) b: 142.4, 139.2, 109.6, 73.0, 69.7, 44.0, 27.7, 26.1, 24.5, 20.6; HRMS-EI
Calcd for C9HI30 4S: 217.0534; Found, 217.0541; Anal. calcd for C9H1304S C, 51.71; H,
6.94; found C, 51.58; H, 6.99.
Br
Br~OH
UOH
(18,28)-3,4-Dibromo-cyclohexa-3,5-diene-l,2-diol (59)
The biooxidation of o-dibromobenzene was performed according to the general
procedure for large-scale fermentation. o-Dibromobenzene 311 (60 g) was added
dropwise over 45 min to a 15- L fermentor containing a growing culture of E. coli JM
109 (pDTG601). After stirring the media for an additional 1 h, the cell broth was
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separated from the cells by centrifugation. The broth was extracted with 3 L of ethyl
acetate using a rotary evaporator-driven continuous extractor over a three-day period.
The combined organic layers were washed twice with approximately 10% by volume
saturated sodium carbonate solution to remove any phenolic residue. The organic
extracts of the fermentation broth were concentrated in vacuo and the dienediol
precipitated by addition of pentane. Recrystallization from ethyl acetate/pentane provided
the title compound as a white solid (32.8 g, 4.1 gIL): mp 144-146 °C (from ethyl acetate-
pentane); [a22D] +104, (cO.15, diethyl ether); Rf 0.36 (hexanes-ethyl acetate, l:l);IR
(film) v 3175, 1621 em-I; IH NMR (300 MHz, acetone d6) 3: 6.03 (dd, J = 9.9,2.1 Hz,
1H), 6.00 (dd, J = 6.6, 2.4 Hz, 1H), 4.62 (d, J = 6.9 Hz, 1H), 4.55 (m, 1H), 4.28 (m, 2H);
I3C ~. .NMR (75 MHz, acetone d6) u. 133.4, 126.5, 126.2, 120.6, 74.2, 69.0, HRMS-EI calcd
2.24; Found C, 27.04; H, 2.32.
(3as,7as)-2,2-Dimethyl-4,5-dibromo-4,6-benzo[I,3]dioxole (315)
Diene diol59 (3.0 g, 11.1 mmol, 1 equiv) was transferred to a 100-mL round-bottomed
flask and suspended in 5 mL acetone and 15 mL of 2,2-DMP. A few crystals of pTsOH
were added, and the reaction mixture was stirred at rt for 3 h. The reaction was
quenched with 12 mL of 10% aq sodium hydroxide solution, and the acetone was
removed under reduced pressure. The residue was diluted with ethyl acetate, and the
layers were separated. The aqueous layer was then extracted with several portions of
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ethyl acetate. The combined organic layers were washed with brine and dried over
anhydrous MgS04• The solvent was removed under vacuum to provide a light oil (3.21
g, 95%), which was essentially pure. An analytical sample was obtained after
chromatography over 10% deactivated silica gel, affording the title compound as a clear
oil. [a]n22 +101 (c 0.75, CHCI3); Rf 0.50 (50% ethyl acetate in hexanes); IR (film) v
2988, 2933, 2896, 1634 em-I; IH NMR (300 MHz, CDCI3) b 6.14 (d, J = 9.9 Hz, IH),
5.93 (dd, J = 9.9, 3.6 Hz, IH), 4.82-4.72 (m, 2H), 1.45 (s, 6H); 13C NMR (75MHz,
CDCI3) b 128.7, 125.6, 123.8. 120.3, 106.9, 77.3, 71.3, 26.6, 25.0; HRMS-EI Calcd for
C9HIOBr202, 307.9047; Found, 307.9037.
(3aS,4R,5S,7as)-2,2-Dimethyl-6,7-dibromo-4,5-dihydroxybenzo[I,3]dioxole (316)
The protected dienediol 315 (3.1 g, 10 mmol, 1 equiv) was suspended in 60 mL of 8:1
(by volume) mixture of acetone/ water. N-Methylmorpholine-N-oxide (2.34 g, 20 mmol,
2 equiv) was added followed by 4 crystals of osmium tetraoxide. The reaction mixture
darkened slightly and was stirred for 18 h until consumption of starting material was
complete as evidenced by TLC. The reaction mixture was quenched by addition of 5 mL
sat aq sodium bisulfite, followed by a further addtition of 2 g solid sodium bisulfite, and
the pH of the mixture was adjusted to approximately 2 by addition of cone HCI. The
mixture was stirred for 15 min, and the acetone was removed under reduced pressure.
The remaining aqueous portion was extracted repeatedly with ethyl acetate, and the
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combined organic extracts were washed sequentially with IN HCI, 20% aq solution of
KOH, and brine before being dried over anhydrous MgS04• The organic solution was
filtered through a short column of silica gel and the solvent evaporated to furnish 2.4 g of
a white crystalline solid, 71 % yield which required no further purification for the
subsequent reaction. An analytical sample was obtained from a portion of the solid,
recrystallized from ethyl acetate/ pentane. Mp 155/156 °C; [a]n22 +5.47 (c 0.75, MeOH);
Rf 0.3 (50% ethyl acetate in hexanes); IR (KBr) v 3435, 3360, 2994, 2905, 1606 em-I; IH
NMR (300 MHz, CDCI3) b 4.77 (dd, J = 1.2,5.4 Hz, 1H), 4.50-4.45 (m, 2H), 4.34 (m,
1H), 2.68 (bs, 2H), 1.43 (s, 6H); I3C NMR (75 MHz, CDCI3) b 127.6, 125.6, 77.6, 75.3,
70.9, 69.1, 27.6, 26.1; HRMS-EI calcd for CgH90 4Br, 326.8867; found, 326.8863; Anal
Calcd for C9H12Br204: C, 31.42; H, 3.52, Found: C, 60.11; H, 7.78.
~OH
HO"'yOH
OH
(-)-Conduritol E (60)
Dibromide 316 (0.50 g, 1.4 mmol, 1 equiv) was dissolved in 50 mL distilled THF and
transferred to a flame-dried 100-mL round-bottomed flask equipped with a reflux
condenser. The solution was degassed in an ultrasound bath and under positive argon
pressure for 10 min. Azoisobutyronitrile (23 mg, 0.14 mmol, 0.1 equiv) was added, and
the solution heated to steady reflux (83°C external temp). At this time, tributyl tin
hydride (1.0 mL, 3.36 mmol, 2 equiv) was added in a single portion. Reflux was
maintained for 1.5 h until complete consumption of starting material was evidenced by
TLC analysis. The reaction mixture was cooled, and potassium fluoride (2 g) was added.
The resulting preciptitate was filtered, and the filtrate concentrated under reduced
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pressure. The residue was purified by flash column chromatography, eluting with 4:1
hexanes/ethyl acetate to 100% ethyl acetate to provide 170 mg (64%) of the de-
brominated material. The solid was dissolved in 5 mL of methanol and to this solution
was added 2 mL of a 3% (by volume) solution of conc HCI in methanol and the resulting
solution stirred for 40 h after which time the solvent was removed under reduced pressure
to provide a crude white solid. The solid was purified by flash column chromatography
(4: 1 chloroform/methanol) to give conduritol E as a white crystalline solid (78 mg, 81 %).
Mp 194/195 °C (litI63 mp 193 °C); [a]D20 -285 (c 1.0, H20), litI63: [a]D20 -294 (c 1.0, H20)
; Rf 0.18 (chloroform-methanol, 4:1); IR (film) v 3434, 1634 cm-I; IH NMR (300 MHz,
MeOD) b 5.79 (d, J = 2.1 Hz, 2H), 4.27 (s, 2H), 3.93 (d, J = 0.9 Hz, 2H); I3C NMR (75
MHz, MeOD) b 130.7, 70.9, 67.6; HRMS-EI Calcd for C6HI004, 146.0579; Found,
146.0577.
(IS,2S)-3,4-Dibromo-cyclohexa-3-ene-I,2-diol (396)
Diol 5 (0.384g, 1.47 mmol, 1 equiv) was dissolved in 6 mL MeOH, and the round-
bottomed flask containing the solution was subsequently placed into an icelNaCI bath.
Potasium azodicarboxylate (0.93g, 4.27 mmol, 3 equiv) was added in two portions to the
methanolic solution. Acetic acid (0.85 mL, 12.78 mmol, 9 equiv) in 2 mL MeOH was
added dropwise over 40 min. The reaction flask was allowed to warm to room
temperature overnight (15 h). The reaction was quenched by adding 2 mL saturated
Na2C03 solution and stirring for 20 min. Methanol was removed under reduced pressure
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and the residue diluted with 10 mL EtOAc. The layers were separated and the aqueous
phase was extracted with EtOAc (10 mL x 3). The combined organic layers were washed
with brine, dried over MgS04, and treated with activated charcoal. Filtration and
subsequent concentration of the filtrate under reduced pressure afforded 318 as a white
crystalline solid (0.367g, 95%). Mp 175-176 °C; [a]n2I -50.4 (c 0.75, MeOH); Rf 0.23
(Hex: EtOAc, 1:1); IR (KBr pellet) v 3246,1626 cm-I; IH NMR (300 MHz, acetone d6) b
4.61 (d, J = 6 Hz, 1H), 4.26 (s, 1H), 3.96-3.84 (m, 2H), 2.79-2.51 (m, 2H), 2.05-1.92 (m,
1H), 1.85-1.73 (m, 1H); I3C NMR (75 MHz, acetone d6) b 127.1, 124.9, 73.5, 68.25,
35.2, 26.9; HRMS-EI Calcd for C6HgBr202, 271.8872; Found, 271.8871; Anal calcd for
C6HgBr202; C, 26.50; H, 2.97; Found C, 27.34; H, 3.16
Br
Br~OH
OTHS
(IS,2S)-I-[(Hexyldimethylsilyl)oxy]-3,4-dibromocyclohexa-3-ene-2-o1 (397)
A 5-mL round-bottom flask was charged with diol 396 (200 mg, 0.74 mmol, 1 equiv),
imidazole (65 mg, 0.96 mmol, 1.3 equiv) and 1 mL anhydrous DMF. The flask was
cooled externally to -30°C, then hexyldimethylsilyl chloride (0.15 mL, 0.78 mmol, 1.05
equiv) was added. The mixture was stirred at -30°C for 1 h then placed in a freezer (-18
°C) for 21 h. The mixture was allowed to warm to room temperature and diluted with 50
mL ether, washed with 10 xl mL distilled H20, brine, and then dried over MgS04• After
filtration the filtrated was concentrated under reduced pressure. The crude silyl ether was
purified by flash column chromatography (pentane: Et20, 10:1) to give 397 as a clear and
colorless oil (0.26 g, 86%). [a]n2I -41.1 (c 0.75, MeOH); Rf 0.23 (Pentane: Et20, 10:1);
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IR (film) v 3547,2958,2868, 1628 cm-I; IH NMR (300 MHz, CDCI3) b 4.26-4.17 (m,
IH), 4.03-3.93 (m, IH), 2.84 (d, J = 4, IH), 2.77-2.64 (m, IH), 2.63-2.48 (m, IH), 2.10-
1.9 (m, IH), 1.77-1.57 (m, 2H), 0.95-0.84 (m, 13H), 0.17 (s, 6H); I3C NMR (75 MHz,
CDCI3) b 130.8, 127.8, 122.9, 74.1, 73.6, 69.6, 35.1, 34.1, 27.2, 24.8, 20.2, 20.0, 18.5,
18.4; HRMS-EI Calcd for C14H26Br202Si, 328.9032; Found,328.9026; Anal calcd for
C14H26Br202Si; C, 40.59; H, 6.33; Found C, 40.96; H, 6.36.
CXOHOTHS
(lR, 2S)-2-[(Hexyldimethylsilyl)oxy]cyclohexan-l-ol (360)
A flask containing a magnetic stirring bar was charged with dibromide 397 (0.219 g, 0.53
mmol, 1 equiv), triethylamine (0.5 mL, 3.56 mmol, 7 equiv), platinum oxide (Adam's
catalyst, 24 mg, 0.11 mmol, 0.2 equiv) and 0.5 mL MeOH. The reaction flask was
evacuated, flushed with hydrogen via a filled balloon (1 atm), and stirred until total
consumption of starting material was observed by TLC (6h). The crude mixture was
filtered through a short plug of Celite, and the solvent was removed under reduced
pressure. The crude residue was purified by flash column chromatography (pentane/
Et20, 10:1) to give the title compound as a clear and colorless oil (71 mg, 52%) having
spectral data matching that of previously reported. [a]D23 + 3.4 (c 1.0, CHCI3); litl36:
23[a]D + 3.3 (c 1.0, CHCI3).
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oJ.l /CFs
ceo '(-'''PhOMeOTHS
Mosher ester derivative 361.
Alcohol 360 (20 mg, 0.076 mmol, 1 equiv) was transferred to a flame-dried round-
bottomed flask containing magnetic stirring bar under argon atmosphere. Anhydrous
triethylamine (17~L) was added followed by DMAP (4.8mg, 0.038mmol, 0.5 equiv). (R)-
(-)-a-Methoxy-a-trifluoromethyl-phenylacetic acid chloride (23~L, 0.11 mmol, 1.5
equiv) was added dropwise. Within minutes a white precipitate was observed. The
reaction was stirred overnight. The reaction mixture was then diluted with 5 mL
methylene chloride, transferred to a separatory funnel and washed with 5 mL saturated
solution of sodium bicarbonate. The layers were separated and the organic layer dried
(MgS04) and the solvent evaporated to provide the ester as a crude oil. The ester was
purified by flash column chromatography (pentane: Et20, 10:1) to afford the ester as a
clear and colorless oil (20 mg, 57%). Rf 0.46 (pentane: Et20, 10:1); IR (film) 2948,
2867, 1745, 1463, 1450, 1379, 1263, 1169 cm-I; IH NMR (300 MHz, CDCI3): 3: 7.60
(m, 2 H), 7.40 (m, 3 H), 5.12 (m, 1H) 3.80 (m, 1H), 3.55 (m, 3H), 1.75-1.55 (m, 7H), 1.5-
1.2 (m, 2H) 0.88 (dd, J =6.8, 5.2 Hz, 6 H), 0.81 (d, J =4.1 Hz, 6H), 0 (s, 3 H), -0.10 (s,
3 H) I9p NMR (188 MHz, CDCI3) 3: -72.4 ppm. Lit:136I9p NMR (188 MHz, CDCI3) 3: -
72.8pprn.
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2-(lH-Indol-3-yl)-cyclohex-3-enol (404).
Indole (367 mg, 3.12 mmol, 3 eq.) and vinyl epoxide 405 (100 mg, 1.04 mmol, 1.0 eq.)
were heated on a previously-activated silica-gel surface (1.0 g) at 70 °c for 27 hours as
described in the general procedure. The silica gel supporting the reaction mixture was
cooled to rt and chromatographed directly on flash silica (hexanes/ethyl acetate; gradient
elution, 4:1 to 1:1), providing the title compound as an off-white crystalline solid (68 mg,
32%); The crystalline material was recrystallized from methylene chloride/pentane. Rf
0.5 (hexanes-ethyl acetate, 1:1); mp (sealed tube) 121-122 °C; IR (film) v 3543, 3410,
3056, 3022, 2922, 1618, 1456, 1433, 1339, 1054 em-I; IH NMR (300 MHz, CDCI3) 0:
8.03 (s, 1H), 7.61 (d, J = 7.8 Hz, 1H), 7.29 (d, J = 8.0 Hz, 1H), 7.15 (m, 1H), 7.00 (m,
2H), 5.77 (m, 1H), 5.66 (dd, J =9.7, 1.2 Hz, 1H), 3.91 (ddd, J =10.3, 7.3, 2.9 Hz, 1H),
3.48, (m, 1H), 2.2 (m, 2H), 1.98 (m, 1H), 1.84 (bs, 1H), 1.65 (m, 1H); 13C NMR (75
MHz, CDCI3) 0: 137.3, 129.0, 127.4, 127.0, 122.9, 122.6, 120.0, 119.8, 117.2, 111.7,
72.3, 43.4, 29.4, 24.8; HRMS-EI Calcd for C14H15NO 213.1153, Found: 213.1148.
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5-(lH-Indol-3-yl)-2,2-dimethyl-3a,4,5,7a-tetrahydro-benzo[1,3]dioxol-4-o1 (407).
Indole (211 mg, 1.8 mmol, 3 eq.) and vinyl epoxide 406 (100 mg, 0.60 mmol, 1.0 eq.)
were heated at 70 °C on a previously-activated silica-gel surface (600 mg) for 20 hours as
described in the general procedure. The reaction mixture on silica gel was purified by
chromatography on flash silica gel (hexanes/ethyl acetate; gradient elution, 4: 1 to 1:1),
providing a foamy solid (86 mg, 51%);Rf 0.28 (pentane/ethyl acetate, 1:1); [a ]D28
+35.45; (c 0.35, MeOH); IR (film) v 3407, 2927, 1456, 1379 cm-I; IH NMR (300 MHz,
CDCl3) 3 8.21 (s, 1H), 7.55 (d, J = 8.0 Hz, 1H), 7.25 (d, J = 8.0 Hz, 1H), 7.12 (m, 1H),
7.05-6.95 (m, 2H), 5.93 (s, 2H), 4.66 (d, J = 6.2 Hz, 1H), 4.12 (m, 1H), 3.80 (t, J = 9.3
Hz, 1H), 3.45 (d, J =9.8 Hz, 1H), 2.21 (bs, 1H), 1.45 (s,3H), 1.37 (s, 3H); I3C NMR (75
MHz, CDCl3) 3: 137.0, 135.6, 126.8, 123.9, 123.2, 122.7, 119.9, 119.8, 114.5, 111.0,
79.4, 74.0, 73.2, 40.9, 28.7, 26.2; HRMS-EI Calcd for CI7HI9N03 285.1364, Found
285.1364; Anal. Calcd for CI7HI9N03: C, 71.56; H, 6.71. Found: C, 70.25; H, 7.03.
N-[2-(lH-Indol-3-yl)-cyclohexyl]-4-methyl-benzenesnlfonamide (409).
Indole (95 mg, 0.81 mmol, 3 eq.) and N-tosylaziridine 408 (68 mg, 0.27 mmol, 1.0 eq.)
were heated on a previously-activated silica-gel surface (800 mg) at 70 °C for 22 hours
according to the general procedure. The silica gel supporting adsorbed reaction mixture
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was loaded onto a flash silica column and eluted with hexanes/ethyl acetate; (4: 1 to 2: 1)
to give the title compound as a white foam (38 mg, 38%); RrO.22 (hexanes/ethyl acetate,
2:1); IR (film) v 3404,2930, 1598, 1457, 1316, 1157,1093 cm-I; IH NMR (300 MHz,
CDCI3) 0 8.05 (s, 1H), 7.27 (m, 2H), 7.16 (m, 3H), 6.90 (m, 3H), 6.75 (d, J =2.5 Hz,
1H), 4.51 (d, J = 3.3 Hz, 1H), 3.17 (m, 1H), 2.65 (dt, J = 11.2,3.5 Hz, 1 H), 2.50 (m,
1H), 2.33 (s, 3H), 1.95 (m, 1H), 1.75 (m, 3H), 1.25 (m, 3H); I3C NMR (75 MHz, CDCI3)
0: 143.0,136.9,136.5,129.4,126.9,126.4,122.2, 122.1, 119.4, 116.7, 111.7,57.5,42.0,
35.1, 33.7, 26.4, 25.3, 21.8; HRMS-EI Calcd for C2IH24N202S 368.1558, Found
368.1553; Anal. Calcd for C2IH24N202S-H20: C, 65.26; H, 6.25. Found: C, 65.88; H,
6.44.
N-[2-(IH-Indol-3-yl)-cyclohex-3-enyl]-4-methyl-benzenesulfonamide (411).
Indole (141 mg, 1.2 mmol, 3 eq.) and vinyl aziridine 410 (100 mg, 0.40 mmol, 1.0 eq.)
were heated on a previously-activated silica-gel surface (1.0 g) at 70°C for 20 hours as
described in the general procedure. The silica gel supporting the starting materials was
directly loaded onto a flash silica gel column and the product purified by flash
chromatography (hexanes/ethyl acetate; gradient elution, 4:1 to 2:1), providing the tosyl
derivative 411 as an off-white solid (112 mg, 76%). RrO.2 (pentane/ethyl acetate, 3:1);
mp 158-160 °C; IR (film) v 3406,3285, 3027, 2924,2860, 1598, 1493, 1457, 1420, 1158
cm-I; IH NMR (300 MHz, CDCI3) 0 8.02 (s, 1H), 7.48 (d, J = 8.0 Hz, 1H), 7.35-7.20 (m,
2 H), 7.17-7.10 (m, 2H), 7.0 (d, J = 8.0 Hz, 2H), 6.97 (m, 1H), 6.82 (s, 2H), 5.88 (m, 1H),
5.65 (d, J =9.5 Hz, 1H), 4.85 (d, J =5.3 Hz, 1H), 3.50 (s, 2H), 2.33 (s, 3H), 2.20 (s, 2H),
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2.05-1.95 (m, 1H); I3C NMR (75 MHz, CDCI3) 0: 143.3, 137.1, 137.0, 129.7, 128.1,
127.6, 127.2, 123.3, 122.4, 119.7, 119.4, 166.5, 111.5, 53.4, 39.9, 26.3, 22.8, 21.9;
HRMS-EI Calcd for C2IH22N202S 366.1401, Found 366.1398; Anal. calcd for
C12H22N202S: C, 68.83; H, 6.05. Found: C, 68.14; H, 6.07.
0>(
o
3-Indolyl-l-H-3-(2,2-dimethyl-3a,4,5,7a-tetrahydro-benzo[I,3]dioxolyl-4-tosylamine
(412).
Indole (73 mg, 0.621 mmol, 2.0 eq.) and vinyl aziridine 402 (100 mg, 0.311 mmol, 1.0
equiv) were allowed to react on a previously-activated silica-gel surface (1.0 g) at 70°C
for 17 hours as described in the general procedure. The silica gel supporting adsorbed
reaction mixture was loaded onto a flash silica column and eluted with hexanes/ethyl
acetate; 4:1 to 2:1, to give the title compound as a brown crystalline solid (130 mg, 48%);
Rf 0.26 (hexanes/ethyl acetate, 1:1); [a]DI9 +59 (c 0.99, CHCI3); IR (film) v 3389, 3039,
2985, 2931, 1718, 1621, 1599, 1458, 1375, 1246, 1093 cm-I; IH NMR (300 MHz,
CDCI3) 0 8.0 (s, 1H), 7.30-7.15 (m, 4H), 7.10 (m, 1H), 6.97 (m, 2 H), 6.83 (d, J = 7.5 Hz,
2 H), 5.93 (s, 2H), 5.12 (d, J = 7.3 Hz, 1H), 4.65 (m, 1H), 4.19 (m, 1H), 3.75 (dd, J = 17,
8.4 Hz, 1H), 3.49 (d, J =9.8 Hz, 1H), 2.26 (s, 3H), 1.51 (s, 3H), 1.35 (s, 3H); I3C NMR
(75 MHz, CDCI3) 0: 142.3, 138.3, 136.8, 135.9, 129.0, 126.8, 126.6, 123.6, 123.5, 122.2,
119.7, 119.3, 114.1, 110.1, 72.7, 57.5, 39.4, 28.4, 26.4, 21.8; HRMS-EI Calcd for
H, 6.18. Found: C, 63.32; H, 5.95.
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OH
OH
(IS,2R)-3-(I-Methyl-cyclopropyl)-cyclohexa-3,5-diene-l,2-diol (431)
The diol was isolated from a crude mixture from biotransformation of the corresponding
cyclopropylbenzene by E. coli JM 109 (pDTG601) according to the general procedure for
shake-flask fermentation. After purification by flash silica gel chromatography (hexanes-
ethyl acetate, 2:1; 10% deactivated silica), the cis-dienediol was recrystallized from ethyl
acetate/ pentane to afford the cis-dihydroarene diol as a white crystalline solid, 56 mg/L;
mp 81-81.5 °C; [a]n26 +65.5, (c 1.0, MeOH); Rf 0.30 (hexanes-ethyl acetate, 1:1); IR
(film) v 3290, 1639, 1582, 1453 cm-I ; IH NMR (300 MHz, CDCI3) 0: 5.90 (d, J = 5.6
Hz, 1 H), 5.85 (d, J =6.0 Hz, 1 H), 5.63 (d, J =9.0 Hz, 1 H), 4.32 (s, 1 H), 4.10 (dd, J =
14, 10 Hz, 1 H), 3.72 (d, J = 5.0 Hz, 1H), 1.23 (s, 3 H), 0.92 (m, 2 H), 0.56 (m, 2H);
HRMS-EI calcd for CloH1402, 166.0994; found, 166.0995
OH
OH
Br
(IR,2R)-3-Bromo-6-cyclopropyl-cyclohexa-3,5-diene-l,2-diol (433)
The diol was isolated from a crude mixture from biotransformation of the corresponding
cyclopropylbenzene by E. coli JM 109 (pDTG601) according to the general procedure for
176
shake-flask fermentation. Purification by flash silica gel chromatography (hexanes-
ethyl acetate, 3:2; 10% deactivated silica) furnished the cis-dihydroarene diol as a white
crystalline solid, 32 mg/L; [a]D26 -17.5, (c 0.65, CHCI3); Rf 0.76 (hexanes-ethyl acetate,
1:1); IR (film) v 3290, 1631, 1550 cm-1; IH NMR (300 MHz, acetone d6) 3: 6.27 (d, J =
6.3 Hz, 1 H), 5.47 (d, J = 6.3 Hz, 1 H), 5.63 (d, J = 9 Hz, 1 H), 4.23 (d, J = 2.4 Hz, 2 H),
4.18 (m, 1 H), 3.92 (d, J =7.5 Hz, 1H), 2.88 (s, 1H), 1.65 (m, 1H), 0.76 (m, 2H), 0.60 (m,
2H); 13C NMR (75 MHz, acetone d6) b: 144.2, 126.6, 124.2, 115.6, 72.6, 70.3, 13.2, 6.4,
6.0.
OH
OH
+
V
0= OH~ OH
(lS,2R)-3-(2-Methyl-l-cyclopropyl)-cyclohexa-3,5-diene-l,2-diol (435a, 435b)
1: 1 mixture of diastereoisomers.
The crude mixture of diols was isolated from fermentation with Escherichia coli JM 109
(pDTG601) according to the general procedure for shake-flask fermentation. The
products were purified by flash column chromatography on 10% deactivated silica gel
(hexanes-ethyl acetate, 1:1) to provide the crystalline diols 435a and 435b as an
inseparable mixture of diastereoisomers, (90 mg/L). Mp 42-46 °C; [a]D22 +71.3 (c 0.5,
CHCI3); Rf 0.3 (hexanes-ethyl acetate, 1:1); IR (film) v 3350, 2951, 1585, 1384, 1074
cm-1; IH NMR (300 MHz, CDCI3) b 5.83 (m, 1H), 5.62 (d, J = 9.8 Hz, 1H), 5.55 (m, 1H),
4.25 (s, 1H), 3.78 (s, 1H), 2.30 (bs, 1H), 1.87 (bs, 1H), 1.20 (m, 1H), 1.05 (d ,J=2.8 Hz,
3 H), 0.97 (m, 1H), 0.65, (m, 1H), 0.45 (m, 1H); 13C NMR (75 MHz, CDCI3) 3: 143.5,
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128.0,127.9,124.9,124.8,120.7,117.4,117.3,70.3, 70.2,69.6.6,69.5,23.4,23.3,19.2,
16.4, 16.0, 15.2, 14.6, 14.5; HRMS-EI calcd for C1oHl402 (M+), 166.0993; found,
166.0994.
OH
OH
+ ce: OH~ OH
(lS,2R)-3-(2-Phenyl-cyclopropyl)-cyclohexa-3,5-diene-l,2-diol (438a, 438b)
1: 1 mixture of diastereoisomers.
The crude mixture ·of diols was isolated from fermentation with Escherichia coli JM 109
(pDTG601) according to the general procedure for shake-flask fermentation. The
products were purified by flash column chromatography on 10% deactivated silica gel
(hexanes-ethyl acetate, 1:1) to provide the title compound as a clear oil, which was an
inseparable mixture of diastereoisomers, (140 mg/L): [a]D22 +38.6 (c 0.89, CHCI3); Rf
0.28 (hexanes-ethyl acetate, 1:1); IR (film) v 3346, 2922, 1603, 1498, 1403 cm-l; IH
NMR (300 MHz, CDCI3) 0 7.24-7.19 (m, 2H), 7.13-7.01 (m, 3H), 5.86 (m, 1H), 5.67-
5.60 (m, 2H), 4.27 (s, 1H), 3.87 (d, J = 5.8 Hz, 1H), 2.58-2.41 (bs, 1H), 2.07 (m, 1H),
1.81-1.71 (m, 1H), 1.33 (m, 1H), 1.17 (m, 2H); 13C NMR (75 MHz, CDCI3) 0:142.4,
142.3, 142.1, 142.0, 128.9, 128.8, 128.6, 128.5, 128.2, 126.4, 126.3, 126.2, 126.2, 124.8,
124.7, 120.9, 118.5, 118.3, 70.3, 70.1,69.4, 27.1, 26.9, 26.5, 25.5, 25.3, 16.9, 16.2, 15.7;
HRMS-EI calcd for C1sHl602 (M+): 228.1150; found, 228.1139.
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3(R),7(8)-2,2-Dimethyl-7-(2-phenylcyclopropyl)-3a,4,5,7a-
tetrahydrobenzo[1,3]dioxole (442)
1:1 mixture of diastereoisomers
A mixture of diene diols 438a and 438b (140 mg, 0.61 mmol, 1 equiv) was dissolved in
5 mL methanol, and the solution transferred to a 25-mL round-bottomed flask equipped
with magnetic stirring bar and addition funnel. The flask was cooled externally to 0 °C at
which time PAD reagent (331 mg, 1.71 mmol, 2.8 equiv) was added to the reaction
flask. The yellow slurry was stirred for 10 min, then the addition funnel was charged
with acetic acid (236 JlL, 3.99 mmol, 6.5 equiv) dissolved in 5 mL methanol. The acetic
acid solution was added dropwise over a 1 h period and the yellow slurry was allowed to
warm to rt overnight. A saturated solution of sodium bicarbonate was used to adjust the
pH to approximately 8.5 and the reaction mixture was diluted with 20 mL ethyl acetate.
The layers were separated and the aqueous layer extracted with 3 portions of ethyl
acetate. The combined organic layers were washed with brine, dried (MgS04), and the
drying agent removed by filtration. The solvent was removed under reduced pressure to
provide 125 mg crude product which was used directly in the subsequent reaction without
further purification.
The crude product from diimide reduction was dissolved in a minimum amount of
acetone and transferred to a 25 mL round-bottomed flask equipped with magnetic stirring
bar. 2,2-DMP (471 JlL, 3.9 mmol, 6.4 equiv) was added as a neat solution followed by
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several crystals of pTsOH. The reaction mixture was stirred for 1.5 h at which time the
solvent was removed under vacuum. The residue was purified by flash column
chromatography (hexanes-ethyl acetate, 3:1), affording the title compound, which was as
a clear and colorless oil, as an inseparable mixture of diastereoisomers, (66 mg, 40%
yield over 2-steps); [a]D22 +30.2 (c 1.0, CHCI3); Rf 0.55 (hexanes-ethyl acetate, 5:1); IR
(film) v 2984, 2931, 1604, 1498, 1455, 1367, 1241 cm-I; IH NMR (300 MHz, CDCI3) 0:
7.16 (m, 2H), 7.05 (m, 3H), 5.72/5.50 (t, J = 3.8 Hz, IH), 4.35 (m, IH), 4.25 (m, IH),
2.20-2.05 (m, IH), 2.05 (m, IH), 1.90-1.75 (m, 2 H), 1.70-1.60 (m, IH), 1.35 (d, J = 3.5
Hz, 3H), 1.30 (d, J =3.2 Hz, 3H), 1.22 (m, IH), 1.05 (m, 2 H) ; I3C NMR (75 MHz,
CDCI3) 0: 142.0, 141.9, 135.3, 135.1, 127.5, 127.2, 124.9, 124.7, 124.4, 124.4, 123.0,
122.0, 119.4, 107.3, 73.3, 72.9, 72.4, 27.0, 26.9, 25.7,25.7, 25.5, 24.5, 24.1, 22.5, 19.6,
19.5, 14.2, 14.0; HRMS-EI calcd for CI8H2202 (M+): 270.1619; found, 270.1603; Anal.
Calcd for C18H2202: C, 79.56; H, 8.20, Found, C, 79.23; H, 8.15.
OH
OH
(IS,2R)-3-Prop-I-enyl-cyclohex-3-ene-I,2-diol
To a solution of dienediol454 (1.35 g, 8.8 mmol, 1.0 equiv) in 20 mL MeOH at 0 °C was
added portionwise PAD reagent (5.16 g, 26.6 mmol, 3 equiv) over 10 min. The yellow
slurry was stirred for 10 min before addition of AcOH (3.55 mL, 61.6 mmol, 7 equiv) in
20 mL MeOH over a 1 hour period. The reaction mixture was stirred overnight,
warming slowly to rt over 12 h. The reaction mixture was quenched by addition of 12
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mL saturated solution of sodium carbonate. MeOH was removed under vacuum and the
residue diluted with ethyl acetate. The layers were separated and the aqueous portion
extracted 3 times with 15 mL ethyl acetate. The combined organic layers were washed
with brine and dried over anhydrous MgS04• Removal of of the drying agent by
filtration and evaporation of the solvent under reduced pressure provided a solid which
was recrystallized to give 828 mg of the title compound as a tan solid (61 %). Mp 107-
108 °C (from methylene chloride-pentane); [a]D24 -133 (c 0.5, CHCI3); Rf 0.21 (hexanes-
ethyl acetate, 1:1); IR (film) v 3260, 2945, 2871, 1633 cm-1; IH NMR (300 MHz, CDCI3)
3 5.93 (d, J =16 Hz, 1H), 5.84 (m, 1H), 5.63 (t, J =3.9 Hz, 1H), 4.30 (d, J =3.6 Hz,
1H), 3.63 (m, 1H), 2.23 (bs, 2H), 2.15 (m, 2H), 1.72 (d, J = 5.9 Hz, 3H), 1.66 (m, 2H);
13C NMR (75 MHz, CDCI3) 3: 135.9, 131.5, 128.9, 123.7, 69.7, 65.9, 25.3, 25.1, 18.3;
HRMS-EI calcd for C9H140 2 (M+): 154.0993; found, 154.0994.
3(8),7(R)-2,2-Dimethyl-propenyl-3a,4,5,7a-tetrahydro-benzo[1,3]dioxole (455)
The diol derived from diimide reduction of trienediol 454 (828 mg, 5.37 mmol, 1 equiv)
was transferred to a 50-mL round-bottomed flask and dissolved in 5 mL acetone. 2,2-
DMP (1.2 mL, 10.1 mmol, 1.9 equiv) was added followed by 1 spatula tip of pTsOH.
The solution was stirred at rt for 2.5 h before the reaction was quenched with 10 mL of
saturated sodium carbonate solution, and the acetone removed under reduced pressure.
The cloudy mixture was diluted with 15 mL ethyl acetate and 2 mL of distilled water.
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The layers were separated and the aqueous layer extracted with ethyl acetate. The
combined organic layers were washed with brine and dried over anhydrous MgS04• The
solvent was removed under vacuum to provide a tan oil, purified by flash column
chromatography (98:2 hexanes-ethyl acetate) to afford the title compound as a clear and
colorless oil, 900 mg (86%): [a]D24 +68.1 (c 0.72, CHCI3); Rf 0.56 (10% ethyl acetate in
hexanes); IR (neat) v 2984, 2932, 1451, 1367 em-I; IH NMR (300 MHz, CDCI3) 0 5.96
(d, J =15.9 Hz, 1H), 5.83 (m, 1H), 5.73 (t, J =4.2 Hz, 1H), 4.58 (d, J =6.0 Hz, 1H), 4.22
(m, 1H), 2.15 (m, 1H), 1.96 (m, 1H), 1.71 (d, J =6.3 Hz, 3 H), 1.69 (m, 2H), 1.42 (s,
6H); 13C NMR (75 MHz, CDCI3) 0 134.3, 131.9, 129.3, 124.5, 108.3, 73.6, 71.4, 28.1,
26.3, 26.1, 21.6, 18.4; HRMS-EI Calcd for C12H1802, 194.1306; found, 194.1304 .
3(R),7(S)-2,2-Dimethyl-(2-methylcyclopropyl)-3a,4,5,7a-tetrahydro-benzo[1,3]dioxle
(456)
To a solution of diethyl zinc (16.5 mL of 1.0 M solution in hexanes, 16.5 mmol, 4 equiv)
in 16 mL anhydrous methylene chloride at 0 °C was added freshly distilled trifluoroacetic
acid (0.65 mL, 8.25 mmol, 2 equiv) in 8 mL methylene chloride very slowly (ca. 20 min).
The thick, white slurry was stirred at 0 °C for 20 min at which time diiodomethane (0.66
mL, 8.25 mmol, 2 equiv) in 8 mL was introduced to the reaction flask by cannulation.
The resulting gray slurry was stirred for 20 min before addition of propenyl protected diol
455 (800 mg, 4.06 mmol, 1 equiv) dissolved in 8 mL methylene chloride. The reaction
flask was removed from the ice bath and the slurry allowed to warm to rt over 30 min.
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Progress of the reaction was monitored by TLC (10% ethyl acetate in hexanes, KMn04
stain). When deemed complete, the reaction was quenched by addition of 20 mL
saturated solution of NH4CI and the layers were separated. The aqueous layer was
extracted with 2 portions of methylene chloride and the combined organic layers dried
over anhydrous MgS04. Evaporation of the solvent under reduced pressure provided an
oil, which was purified by flash column chromatography (10% ethyl acetate in hexanes)
to afford the corresponding cyclopropane as a clear and colorless oil, (567 mg, 67%).
[a]n24 +64.3 (c 0.4, CHCI3); Rf 0.44 (hexanes-ethyl acetate, 9:1); IH NMR (300 MHz,
CDCI3) b: 5.32 (m, 1H), 4.17 (m, 1H), 4.15 (m, 1H), 1.98 (s, 1H), 1.73 (m, 2H), 1.27 (m,
6H), 0.94 (m, 4H), 0.85 (2H), 0.42 (m, 1H), 0.21 (m, 1H); 13C NMR (75 MHz, CDCI3) b:
137.1, 122.4, 108.2, 74.2, 73.6, 28.0, 26.5, 25.7, 23.1, 20.7, 18.9, 14.2, 13.4 ppm (single
diastereomer).
+
3(R),'(S)-2,2-Dimethyl-'-(2-methyl-cyclopropyl)-3a,4,5,'a-tetrahydro-
benzo[1,3]dioxole (456)
1:1 mixture of diastereoisomers
A mixture of reduced diols 435a and 435b (40 mg, 0.24 mmol, 1 equiv) were transferred
to a 10-mL round-bottomed flask and dissolved in 2 mL acetone. 2,2-DMP (250 J.LL, 2.4
mmol, 10 equiv) was added followed by 1 crystal pTsOH. The solution was stirred at rt
for 24 hours before the reaction was quenched with 1 mL of saturated sodium bicarbonate
solution. The cloudy mixture was diluted with 15 mL ethyl acetate and 2 mL of distilled
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water. The layers were separated and the aqueous layer back-extracted with fresh ethyl
acetate. The combined organic layers were washed with brine and dried over anhydrous
MgS04• The solvent was removed under vacuum to provide a tan oil (24 mg) which was
purified by flash column chromatography (10% ethyl acetate in hexanes) to afford the
title compound as a clear oil and inseparable mixture of diastereoisomers, 16 mg (23%):
[a]n22 +47.5 (c 0.4, CHCI3); Rf 0.44 (10% ethyl acetate in hexanes); IR (film) v 3353,
2984, 2930, 1430, 1366 cm-I; IH NMR (300 MHz, CDCI3) 0 5.43/5.37 (t, J = 3.8 Hz,
1H), 4.47 (m, 1H), 4.17 (m, 1H), 2.15-2.00 (m, 1H), 1.85-1.70 (m, 2H), 1.65-1.50 (m,
2H), 1.34 (d, J = 6 Hz, 1H), 1.03 (d, J = 5.8 Hz, 2H), 0.9-0.75 (m, 1H), 0.68 (m, 1H)
0.51 (dd, J = 8.9, 4.8 Hz, 1H, 0.30 (m, 1H); I3C NMR (75 MHz, CDCI3) 0 137.5, 122.8,
122.5, 108.5, 74.8, 74.6, 73.9, 28.3, 26.9, 26.1, 23.5, 23.4, 21.1, 21.0, 19.6, 19.2, 15.2,
14.5, 13.8, 13.6; HRMS-EI calcd for C13H2002, 208.1463; found, 208.1468.
OH
OH
(lS,2R)-3-Cyclopropyl-cyclohexa-3-ene-l,2-diol (457)
From (lR,2R)-3-Bromo-6-cyclopropyl-cyclohexa-3,5-diene-1 ,2-diol 433
Diol433 (100 mg, 0.43 mmol, 1 equiv) was dissolved in 4 mL MeOH and transferred to
a thick-walled hydrogenation flask. Distilled triethylamine (62 JlL, 0.43 mmol, 1 equiv)
was added followed by Pt02 (Adams' catalyst, 19 mg, 0.087 mmol, 20 mol %). The
flask was placed on a Parr hydrogenation apparatus, evacuated, and the headspace
replaced with hydrogen gas (3 atm). The flask was allowed to shake at rt for a period of
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1.5 hr. The reaction mixture was filtered through Celite and washed with several portions
of methanol, concentrated, and purified by flash column chromatography, (hexanes-ethyl
acetate, 3:2) and the solvent removed under reduced pressure to provide the title
compound as an oily solid, (27 mg, 41 %). Spectral data are consistent with that of the
same compound prepared by enzymatic oxidation from cyclopropyl benzene and
subsequent diimide reduction. Rf 0.27 (hexanes-ethyl acetate, 1:1); [a]D26 -33 (c 1.0,
MeOH), [a]D23 -126 (c 1.0, MeOH). 26% optical purity.
Meo'\(.-Sy I
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2-Iodo- 5-methoxythiophene (13).200
A flame-dried 100 mL round-bottomed flask was charged with 2-bromo-5-
methoxythiophene (0.5 g, 2.5 mmol, 1.0 equiv) dissolved in 32 mL anhydrous THF. The
flask was cooled to -60°C by submersion in a liquid nitrogen/acetone slurry. The
solution was then treated with nBuLi (1.75 mL of 1.6 M solution in hexanes, 2.8 mmol,
1.1 equiv), added over several minutes. The end of the addition was accompanied by a
color change from colorless to bright yellow. The solution was maintained at -60°C for
an additional half hour at which time a solution of iodine (710 mg, 2.8 mmol, 1.1 equiv)
in 3 mL THF at rt was added via cannula to the yellow solution of lithiated thiophene.
The reaction was allowed to warm to 0 °C over 2 h and quenched with a solution of 10%
aq Na2S203. The reaction mixture was diluted with 25 mL of diethyl ether and the
biphasic mixture transferred to a separatory funnel. The layers were separated and the
aqueous layer extracted with diethyl ether (2 x 10 mL). The combined organic extracts
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were washed with brine and dried over anhydrous MgS04. The crude product was
filtered through a short plug of silica, and the solvent removed under reduced pressure to
provide the title compound as a pale yellow oil, 277 mg, 76%.201
Rf 0.57 (5% ethyl acetate in hexanes); I H NMR (300 MHz, CDCI3) 0 6.80 (d, J =4.1 Hz,
IH), 5.85 (d, J = 4.0 Hz, IH), 3.77 (s, 3H), 13C NMR (75 MHz, CDCI3) 0 170.3, 140.3,
134.8, 106.1, 60.8.
2-Methoxy-5-ethynylthiophene (482).
2-Iodo-5-methoxythiophene 13 (3.0 g, 12.5 mmol, 1.0 equiv) was dissolved in 45 mL
freshly distilled triethylamine and cooled to 0° C. TMS-acetylene (1.38 mL, 13.75 mmol,
1.1 equiv) was added via syringe, followed by cuprous iodide (95 mg, 0.5 mmol, 0.04
equiv), and bis-(triphenylphosphino) palladium (II) dichloride (176 mg, 0.25 mmol, 0.02
equiv). The reaction was stirred 40 h at rt, during which time an orange precipitate
formed. The salts were removed by filtration on a Buchner funnel and the reaction
mixture diluted with 50 mL diethyl ether. The layers were separated and the organic
phase washed twice with 30 mL sat. solution of ammonium chloride. The aqueous layers
were combined and extracted twice with 15 mL diethyl ether. The ethereal extracts were
combined, washed with brine and dried over anhydrous MgS04. The drying agent was
removed by filtration and the solvent was removed under reduced pressure to provide an
orange oil (2.8 g) which was dissolved in 30 mL of THF and treated with tetrabutyl
ammonium fluoride (5.9 g, 18.7 mmol, 1.5 equiv). After 1 h, the reaction mixture was
treated with 20 mL sa. solution of ammonium chloride, 10 mL water, and 30 mL diethyl
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ether. The mixture was transferred to a separatory funnel and the aqueous layer separated
from the organic layer. The aqueous phase was extracted three times with 10 mL
portions of diethyl ether. The organic layers were combined, washed with brine, and
dried over MgS04• The solvent was removed in vacuo to provide a crude brown resin
which was distilled under vacuum (0.3 mm Hg/ 90°C), affording 1.lg of the alkyne
(65%) as a pale yellow oil which darkened when exposed to air: Rf 0.32 (5% ethyl
acetate in hexanes); IR (neat) v 3306, 2253, 1543, 1482, 908 em-I; IH NMR (300 MHz,
CDCI3) 0 6.74 (d, J = 4.1 Hz, 1H), 5.87 (d, J = 4.3 Hz, 1H), 3.72 (s, 3H), 2.95 (s, 1H);
I3C NMR (75 MHz, CDCI3) 0 167.4, 132.2, 108.5, 104.1, 79.4, 78.0, 60.6; HRMS-EI
Calcd for C7H60S 138.0139; Found 138.0135.
MeO~S~SyOMeu- u~ h
[his -(5-Methoxy)-2-thienyl]acetylene (12).
2-[(5-Methoxy)-thienyl]acetylene 482 (0.92 g, 6.66 mmol, 1.0 equiv) and 2-iodo-5-
methoxythiophene 13 (1.6 g, 6.66 mmol, 1.0 equiv) were dissolved in 90 mL anhydrous
THF. To this solution was added cuprous iodide (25 mg, 0.13 mmol, 0.02 equiv), bis-
(triphenylphosphino) palladium (II) dichloride (93 mg, 0.13 mmol, 0.02 equiv), and
diisopropylamine (1.4 mL, 10 mmol, 1.5 equiv). The suspension was stirred and
degassed using a stream of argon pressure for 15 minutes.. After removal of the argon
stream, the reaction mixture stirred for 14 h at rt at which time the reaction mixture was
treated with 5 mL saturated solution of ammonium chloride and diluted with 30 mL of
water and 100 mL of diethyl ether. The biphasic mixture was introduced into a
separatory funnel and the layers separated. The aqueous phase was extracted twice with
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ether and the ethereal extracts combined, washed with brine and dried over anhydrous
MgS04• Removal of the drying agent by filtration and evaporation of the solvent
provided a dark brown oil which was purified by flash column chromatography (5% ethyl
acetate in hexanes) affording the title compound as a yellow crystalline solid, 600 mg,
36% yield. Additionally, 2-iodo-5 methoxythiophene was recovered (800 mg).
Rf 0.2 (5% ethyl acetate in hexanes); Mp 80/82 °C; IR (film) v 2937, 1557, 1502, 1424
em-I; IH NMR (300 MHz, CDCI3) 0 6.92 (d, J =3.8 Hz, IH), 6.10 (d, J =4.1 Hz, IH),
3.92 (s, 3H); I3C NMR (75 MHz, CDCI3) 0 167.9, 131.2, 109.3, 104.4, 84.9, 60.5;
HRMS-EI Calcd for CI2HI002S2, 250.0122, Found, 250.0125; Anal. Calcd for
MeO~S~S~OMe
U·U
cis-his- 2-(2-Methoxy-5-thienyl)-ethylene (489).
Thiophene dimer 12 (60 mg, 0.24 mmol) and Lindlar catalyst (10 mg) were suspended in
2 mL methanol in a 10 mL thick-walled tube. The tube was placed in a Parr
hydrogenation/shaker apparatus, evacuated, and hydrogen gas introduced at 40 psi. The
reaction was allowed to proceed for 16 hours at which time the reaction mixture was
filtered through a short plug of Celite and rinsed with methanol. Removal of the solvent
under vacuum provided a brown residue which was purified by flash column
chromatography (5% ethyl acetate in hexanes) which gave the title compound as a yellow
crystalline solid, 65 mg, 80%. Rf 0.4 (25% ethyl acetate in hexanes); mp 105/108 °C; IR
(film) v 2933, 1553, 1499 em-I; IH NMR (300 MHz, CDCI3) 0: 6.5 (s, 2H), 5.95 (s, IH),
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3.8 (s, 3H); 13C NMR (75 MHz, CDCI3) 0: 165.2, 129.9, 124.0, 119.8, 104.3, 60.4;
HRMS-EI Calcd for C12H1202S2 (M+) 252.0279, Found: 252.0281.
(Methyl-2-thienyl)-vinylacetate (494).
To a 100mL round-bottomed flask under argon atmosphere was added freshly distilled
(100 °C /0.1 mm Hg) alcohol 492 (1.6 g, 12.5 mmol, 1 equiv), followed by DMAP (763
mg, 6.25 mmol, 0.50 equiv), and vinyl acetic acid (2.1 mL, 37.5 mmol, 3 equiv). The
flask was cooled to 0 °C before addition of DCC (5.4 g, 16.25 mmol, 1.3 equiv), which
initiated immediate precipitation of an off-white solid. The ice bath was removed after 1
h and the reaction mixture continued to stir for an additional 4 h. Filtration of the
precipitate through Celite and concentration of the resulting solution under vacuum
produced an orange residue, which was purified by flash column chromatography using
cyclohexane as eluent. Purification of the residue gave a 494 as a clear and colorless oil,
875 mg, 36%: Rf 0.39; (hexanes-ethyl acetate, 5:1); IR (neat) v 2983,2933, 1738, 1643
em-I; IH NMR (300 MHz, CDCI3) 0 7.27 (d, J = 5.0, 1H), 7.06 (d, J = 3.6 Hz, 1H), 7.00
(dd, J = 5.2, 1.5 Hz, 1H), 6.18 (q, J = 13.3,7.0 Hz, 1H); 5.92 (m, 1H), 5.19 (m, 1H), 5.17
(m, 1H), 3.11 (dd, 4.1, 1.7 Hz, 1H), 3.08 (dd, 4.1, 1.7 Hz, 1H), 1.64, (d, J = 5.0 Hz, 1H);
13 ~ .C NMR (75 MHz, CDCI3) u 170.7,144.4,130.0,126.5,125.3,125.2,118.6,67.8,39.2,
22.0; HRMS-EI Calcd for Cl0H1202S: 196.0558; Found 196.0562.
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3-Methyl-but-ene-oic acid-(I-thiophene-2-yl)-ethyl ester (497)
Alcohol 492 (641 mg, 5.0 mmol, 1 equiv) was dissolved in 40 mL anhydrous methylene
chloride and cooled to 0 °C. To this solution was added 3-methyl-but-3-en-oic acid 496
(651 mg, 6.5 mmol, 1.3 equiv), DMAP (184 mg, 1.5 mmol, 0.3 equiv), and DCC (1.24 g,
6.0 mmol, 1.2 equiv), and the mixture stirred overnight, slowly warming to rt. The white
precipitate was filtered and the filtrate concentrated under reduced pressure. The crude
oil was purified by flash column chromatography (5% ethyl acetate in hexanes) to
provide the ester as a clear and colorless oil, 350 mg, 33%. Rf : 0.38 (10% ethyl acetate in
hexanes); IR (film) v 2981, 2933, 1733 em-I; IH NMR (300 MHz, CDCI3) 0 7.18 (m,
1H), 6.98 (m, 1H), 6.88 (m, 1H), 6.11 (q, J = 13.2 Hz, 1 H), 4.82 (s, 1H), 4.76 (s, 1H),
2.91 (s, 2H), 1.71 (s, 3H), 1.58 (d, J =6.6 Hz, 3H); I3C NMR (75 MHz, CDCI3) 0:170.5,
144.3, 138.4, 126.5, 125.2, 125.2, 114.7, 67.7, 43.6, 34.9, 22.4, 21.9; Anal. Calcd for
CIIHI402S: C, 62.83; H, 6.71; Found: C, 62.91; H, 6.96.
Methyl-(I-thiophen-2-yl-ethylidene)-amine (500)202
A 150 mL thick-walled reaction tube equipped with magnetic stirring bar was charged
with 2-acetylthiophene 491 (lOg, 79.0 mmol, 1.0 equiv) in 35 mL toluene. The flask was
cooled externally to -40°C and gaseous methylamine was bubbled through the stirred
solution for a period of 15 min. Activated molecular sieves (5 g, 4A) were introduced
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followed by pTsOH (150 mg, 7.9 mmol, 1 equiv). The flask was capped and placed in an
oil bath heated externally to 60 °C.After 48 h, analysis of an NMR aliquot of the crude
reaction mixture indicated a full conversion to the imine. The crude reaction mixture was
filtered through a layer of Celite and the Celite washed with methylene chloride.
Evaporation of the solvent under reduced pressure provided the title compound as a
yellowish-orange oil which required no further purification (quantitative conversion). 1H
NMR (300 MHz, CDCI3) 0: 7.41-7.25 (m, 2H), 7.10-6.90 (m, IH), 3.28 (s, 3H), 2.24 (s,
3H); I3C NMR (75 MHz, CDCI3) 0: 161.8, 147.6, 128.4, 127.2, 126.4, 39.0, 15.0; IR
(neat) 1624 cm-I.
l-thienyl-l-methylaminoethane (501).
Imine 500 (6.5 g, 46.8 mmol, 1.0 equiv) was dissolved in 40 mL methanol and
transferred to a 100 mL round-bottomed flask under argon atmosphere. The flask was
cooled externally by means of an ice/water bath before addition of sodium borohydride
(3.45 g, 97.3 mmol, 2.0 equiv) in one portion. The reaction mixture was allowed to stir
for 12 h before being quenched by addition of 15 mL of a 15% aqueous solution of
sodium hydroxide. Methanol was removed under reduced pressure and the residue
extracted with chloroform (5 x 25 mL). The combined organic extracts were washed
with brine and dried over MgS04 and charcoal. Filtration and removal of the solvent
provided the title compound as a light yellow oil, which required no further purification,
(4.45 g, 68% yield); IR (neat) v 3305 (broad), 2972, 1475 cm-I; IH NMR (300 MHz,
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CDCI3) b: 7.22 (d, J = 4.8 Hz, 1H), 6.99-6.93 (m, 2H), 3.98 (q, J = 6.6 Hz, 1H), 2.40 (s,
3H), 1.41 (d, J = 8.7 Hz, 3H).
Furan-3-yl-acetic acid (1-thiophen-2-yl-)ethyl ester (499)
A 5 mL flame-dried flask under argon atmosphere was charged with (thienyl)-l-ethanol
492 (202 mg, 1.58 mmol, 1.0 equiv) dissolved in 1.5 mL anhydrous methylene chloride.
The flask was cooled externally to 0 °C by means of an ice/water bath. EDC (333 mg,
1.73 mmol, 1.1 equiv), carboxylic acid 498 (200 mg, 1.58 mmol, 1.0 equiv), and DMAP
(20 mg, 0.158 mmol, 0.1 equiv) were added sequentially. The reaction mixture was
allowed to slowly warm to rt over 2.5 h before being diluted with 10 mL methylene
chloride and quenched with 2 mL of 1 N solution of HCI. The aqueous portion was
extracted with methylene chloride, and the organic layers combined and washed with
brine. After drying over MgS04, the organic extracts were filtered through a short
column of silica gel to remove residual impurities. Evaporation of the solvent provided
499 as a clear and colorless oil which required no further purification, (187 mg, 62%).
Rf 0.4 (hexanes-ethyl acetate, 4:1); IR (film) v 2982, 2930, 1732 ern-I; IH NMR (300
MHz, CDCI3) b: 7.29 (d, J = 3 Hz, 2H), 7.15 (m, 1H), 6.98 (m, 1H), 6.89 (m, IH), 6.29
(8, 1H); 6.13 (dq, J =6.6, 1.2 Hz, 1H), 3.39 (s, 2H), 1.59 (d, J =7.2 Hz, 3H); I3C NMR
(75 MHz, CDCI3) b: 170.3,144.2,142.9,140.4,126.6,125.4,125.3, 117.1, 111.3,68.1,
31.1, 22.0; HRMS-EI calcd for CI2HI203S (M+), 236.1006; found, 236.0507.
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1-[2-Furanyl]-I'-aminomethyl-ethane (510)
Furan-2-methyl imine (1.0 g, 8.13 mmol, 1.0 equiv) was dissolved in 4 mL methanol and
transferred to a 10 mL flask equipped with reflux condenser. The flask was cooled
externally to 0 °C before addition of sodium borohydride (368 mg, 9.75 mmol, 1.2
equiv). The ice bath was removed and replaced with a warm water bath for 30 min.
After cooling to rt and stirring for 4 h, the reaction was quenched by addition of 3 mL of
15% aqueous solution of NaOH. The volume of the reaction was reduced to
approximately half under reduced pressure, and the remaining solution diluted with a
saturated sodium chloride solution and extracted with chloroform. The aqueous layer
was repeated extracted with chloroform and the combined extracts washed with brine and
dried over anhydrous MgS04. The drying agent was removed by filtration and the solvent
removed under reduced pressure to provide 833 mg of a yellowish oil. The oil was
purified by Kugelrohr distillation (200 °C / 80 mm Hg), affording the title compound as a
clear and colorless oil, 570 mg (56% yield). IR (neat) v 3290 (broad), 2978, 1649, 1374
em-I; IH NMR (300 MHz, CDCI3) 3: 7.37 (m, 1H), 6.34 (dd, J = 3.0, 1.8 Hz, 1H), 6.15
(d, J = 3.3 Hz, 1H), 3.78 (q, J = 6.9 Hz, 1H), 2.36 (s, 3H), 1.44 (bs, 1H), 1.42 (d, J = 6.9
Hz, 3H); I3C NMR (75 MHz, CDCI3) 3: 157.6, 141.3, 109.8, 105.3,52.8, 33.7, 19.8.
193
.~o
0\:d NHMe
If
(N-Methyl-N-[2-furanyl]-I-ethane)-3-furanyl-3-acetamide (511)
A 25 mL round-bottomed flask under argon atmosphere was charged with amine (500
mg, 4.0 mmol, 1.0 equiv) in 4 mL distilled methylene chloride. The flask was cooled to 0
°C before sequential addition of DMAP (46 mg, 0.4 mmol, 0.1 equiv), EDC (843 mg,
4.40 mmol, 1.1 equiv), and carboxylic acid 498 (572 mg, 4.0 mmol, 1.0 equiv). The
reaction mixture was slowly allowed to warm to rt over a 3.5 h period before being
diluted with 20 mL of methylene chloride. The organic solution was washed with 2 mL
of a IN solution of HCI, 15% NaOH, and brine, and dried over anhydrous MgS04. The
drying agent was removed by filtration and the solvent was removed in vacuo to provide
1.65 g of an orange oil. The oil was purified. by flash column chromatography (4:1
hexanes, ethyl acetate) to afford the amide as a light yellow oil and mixture of major and
minor rotamers, 810 mg (87%). Rf 0.56 (hexanes/ ethyl acetate, 1:1); IR (neat) 3117,
2981, 1651 em-I; IH NMR (300 MHz, CDCI3) b: 7.41 (m, IH), 7.38 (s, 2H), 6.41 (m,
IH), 6.33 (m, IH), 6.20 (m ,IH), 6.00-major rotamer (q, J = 9.3 Hz, IH), 5.14-minor
rotamer (q J =6.6 Hz, IH), 3.72- minor rotamer (q, J = 15.9 Hz, 2H), 3.55 (s, 2H),
2.71 (s, 3H), 1.47-minor rotamer (d, J = 8.1 Hz, 3H), 1.44-major rotamer (d, J =6.9
Hz, 3H); I3C NMR (150 MHz, CDCI3) b: 170.3, 170.2, 154.3, 153.4, 143.09, 143.00,
142.4, 142.2, 140.0, 118.6, 118.3, 111.3, 110.1, 110.0, 107.5, 107.3, 50.4, 45.0, 31.1,
30.8, 29.8, 27.4, 16.3, 15.1; HRMS-EI calcd for CI3HI5N03 (M+): 233.1051, found:
233.1057; Anal. calcd for CI3HI5N03 C, 66.94; H, 6.48; Found C, 66.68; H, 6.44.
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(N-Methyl-N-[2-furanyl]-I-ethane)-I-[3-furanyl]-2-ethylamine (512).
A 10-mL round-bottomed flask equipped with reflux condenser under argon atmosphere
was charged with furan derivative 511 (300 mg, 1.28 mmol, 1 equiv). The furan was
dissolved in a mixture of 3 mL ethyl ether and 5 mL THF and the flask cooled externally
by means of an ice bath. LAH (97 mg, 2.57 mmol, 2.0 mol equiv) was added in a single
portion to the solution of furan. The mixture was heated to refluxing temperature for a
period of 14 h. The flask was again cooled and the reaction quenched by careful addition
of 100 JlL distilled water, 200 JlL of 15% (aq) NaOH solution, and 300 JlL distilled water.
The so-formed aluminate salts were filtered and washed with warm ether. The filtrate
was diluted with 10 mL of fresh ether and 1 mL brine. The layers were separated and the
aqueous portion extracted with three portions of ether. The combined ethereal layers
were washed with brine and dried over anhydrous MgS04• The drying agent was
removed by filtration and the ether removed by evaporation to provide 261 mg of an oil
which required no further purification, 52%. Rf 0.35 (hexanes-ethyl acetate, 1:1); IR
(neat) v 2977, 2939, 2849, 1502 em-I; IH NMR (300 MHz, CDCI3) 0: 7.36 (d, J = 8.4 Hz,
2H), 7.27 (d, J =5.4 Hz, IH), 6.33 (m, IH), 6.28 (s, IH), 6.14 (m, IH), 3.94 (q, J =6.9
Hz, IH), 2.61 (m, 4H), 2.27 (s, 3H), 1.39 (d, J = 6.9 Hz, 3H); 13C NMR (150 MHz,
CDCI3) 0:156.1, 142.5, 141.4, 139.1, 123.1, 111.1, 109.6, 106.7, 56.1, 54.3, 37.7, 23.7,
14.8; HRMS-EI Calcd for C13H17N02 (M+): 219.1259, Found: 219.1262.
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2-Bromo-l-ethynyl-4-methoxy-3-(2-methyl-cyclohex-2-enyloxy)-benzene (523).
A solution of alcohol 522 (98 mg, 0.88 mmol, 1 equiv) in 15 mL distilled THF was
transferred to 50 mL round-bottomed flask under argon atmosphere, and the flask cooled
to an external temperature of -30°C. To this was added tri-n-butyl phosphine (438 JlL,
1.76 mmol, 2.0 equiv) was added by syringe in a single portion. DIAD (342 JlL, 1.76
mmol, 2.0 equiv) was added dropwise over 10 min to the solution. Simultaneously, a
solution of phenol 518 (200 mg, 0.88 mmol, 1.0 equiv) in 2 mL of distilled THF was
added by syringe over 10 min. The reaction mixture was allowed to slowly warm to rt
over a 24 h period. The crude reaction mixture was filtered through a short column of
silica and the filtrate concentrated under reduced pressure. The residue was
chromatographed on silica (9: 1 pentane, ethyl acetate) to furnish the aromatic ether 523
as clear oil which solidified on trituration with diethyl ether, (170 mg, 60% yield). Mp
88/91 °c (from MeOH); Rf 0.29 (hexanes-ethyl acetate, 9:1); IR (neat) v 3290, 2939,
2837, 2107, 1585, 1478 em-I; IH NMR (300 MHz, CDCI3) 0: 7.28 (d, J = 8.7 Hz, 1H),
6.82 (d, J =8.7 Hz, 1H), 5.74 (s, 1H), 4.74 (m, 1H), 3.87 (s, 3H), 3.29 (s, 1H), 2.10-2.00
(m, 3H), 1.90 (s, 3H), 1.58-1.48 (m, 3H); 13C NMR (600 MHz, CDCI3) 0: 154.4, 145.2,
133.1, 129.0, 127.7, 122.0, 117.4, 111.0, 82.3, 79.8, 78.6, 55.7, 28.3, 25.5, 21.2, 18.2;
HRMS-EI Calcd for C16H17Br02 (M+): 322.0392, Found: 322.0392; Anal. calcd for:
CI6HI7Br02: C, 59.83; H, 5.33; found: C, 59.99; H, 5.50.
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2-Bromo-4-methoxy-3-(2-methyl-cyclohex-2-enyloxy)-1-vinylbenzene (525)
A solution of DIAD (365 JlL, 1.86 mmol, 1.1 equiv) in 5 mL THF at 0 °c was treated
dropwise with tri-n-butylphosphine (0.46 mL, 1.86 mmol, 1.1 equiv). Disappearance of
the characteristic yellow color accompanied the addition of phosphine. After stirring 10
min, the solution of phosphine/DIAD was transferred by syringe over 5 min to a 100 mL
flask containing 2-bromo-6-methoxyl-3-vinyl phenol (371 mg, 1.62 mmol, 1.0 equiv)
and allylic alcohol 522 (176 mg, 1.45 mmol, 0.9 equiv) in 50 mL THF at 0 °C. A bright
yellow color appeared on addition of the phosphine/DIAD complex. The reaction
mixture was stirred at 0 °C for a period of 4 h and then concentrated under reduced
pressure to give a yellow residue. Purification of the oil by flash column chromatography
(9:1, hexanes, ethyl acetate) gave 399 mg (76%) of the aryl ether as a clear and colorless
oil. Rf 0.58 (Pentane/ Et20, 9:1); IR (film) 2938, 2837, 1623, 1586, 1464, 1484 em-I; IH
NMR (300 MHz, CDCI3) 0: 7.29 (m, 2H), 7.06 (dd, J = 17.1,6.3 Hz, IH), 6.87 (d, J = 8.4
Hz, IH), 5.72 (m, IH), 5.61 (dd, J = 17.4,0.9 Hz, IH), 5.25 (dd, J =10.8,0.9 Hz, IH),
4.75 (m, IH), 3.87 (s, 3H), 2.20-2.00 (m, 3H), 1.96 (s, 3H), 1.70-1.45 (m, 3H) ppm; I3C
NMR (75 MHz, CDCI3) 0: 153.1, 144.6, 136.0, 133.3, 131.5, 127.4, 121.1, 120.2, 114.6,
111.2, 78.4, 55.8, 28.3, 25.5, 21.2, 18.3 ; MS-EI: 244 (9.2), 230 (96.2), 228 (100),
215(15.9), 213 (15.1), 133 (16.8), 95 (72.1), 79 (42.3)
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6-Methoxy-9b-methyl-9-vinyl-3,4,4a,9b-tetrahydrodibenzofuran (526).
A 10-mL Teflon capped thick-walled sealed tube containing a magnetic stirring bar was
charged with aryl ether 525 (52 mg, 0.155 mmol, 1.0 equiv) dissolved in 7 mL distilled
and degassed benzene under a positive pressure of nitrogen. To the resulting solution
was added a catalytic amount (18 mg, 0.016 mmol, 0.1 equiv) of Pd(PPh3)4, triphenyl
phosphine (10 mg, 0.037 mmol, 0.23 equiv), and Proton Sponge™ (66 mg, 0.310 mmol,
2.0 equiv). The yellow solution was heated externally to an external temperature of 90°C
for a period of 15 h. Progress of the reaction was monitored by TLC and after 15 h an
additional 20 mg of catalyst was added and the reaction mixture heated for an additional
4 h period. The reaction mixture was cooled to rt and diluted with 50 mL of diethyl
ether. The ethereal solution was washed with a saturated solution of aq NH4CI (5 x 1
mL) and brine (2 x 1 mL). The organic phase was dried over anhydrous MgS04.
Filtration of the drying agent and evaporation of the solvent gave a crude brown oil,
which was purified by flash column chromatography to provide the title compound as a
slightly yellowish oil, (4 mg, 11 % yield) and returned 10 mg starting material (20%).
Rf 0.33 (pentane: ether, 9:1); IH NMR (300 MHz, CDCI3) 0: 6.99 (d, J = 8.4, IH), 7.00
(m, IH), 6.94 (d, J= 8.4, IH), 5.78 (s, 2H), 5.59 (dd, J= 17.4,1.2 Hz, IH), 5.27 (dd, J=
11.1, 1.2, IH), 4.59 (s, IH), 3.89 (s, 3H), 2.31-2.28 (m, 2H), 1.98-1.96 (m, 2H), 1.52 (s,
3H); 13C NMR (75 MHz, CDCI3) 0: 147.0, 144.4, 133.0, 130.4, 128.0, 126.3, 118.4,
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114.1, 111.2, 87.7, 77.2, 55.9, 45.8, 26.1, 22.9, 19.2; HRMS-EI calcd for CI6HIS02
(M+):242.1301, found: 242.1304.
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2-Bromo-3-[1(S),(6(S)-(tert-butyl-dimethyl-siloxy)-2-methyl-cyclohex-2-enyloxyl]-4-
methoxy-benzaldehyde (528).
Aryl bromide 302 (343 mg, 1.49 mmol, 1.0 equiv) and alcohol 527 (360 mg, 1.49 mmol,
1.0 equiv) were dissolved in 40 mL distilled THF and the solution cooled to an external
temperature of 0 ac. In a separate flask, nBu3P (406 ilL, 1.63 mmol, 1.1 equiv) was
added over one min to a solution of DIAD (331 mg, 1.63 mmol, 1.1 equiv) in 5 mL THF
under a argon atmosphere at 0 ac. Disappearance of the deep yellow color accompanied
the addition of the phosphine. After 10 min, the colorless solution of the
phosphine/DIAD complex was transferred over 5 min to the pre-cooled solution of the
alcohol and phenol and a deep yellow color change was observed. The reaction mixture
was slowly warmed to rt overnight. Evaporation of the solvent gave a brown oil, which
was purified by column chromatography to afford 170 mg of the pure aldehyde (25%) as
well as 130 mg of material of lower purity (19%). [a]20n: +92.6 (c 0.5, CHCI3); Rf 0.13
(hexanes: ethyl acetate, 95:5); IR (film) 2952, 2929, 1687, 1578, 1562, 1481 em-I; IH
NMR (300 MHz,CDCI3) B: 10.28 (s, 1H), 7.72 (d, J = 8.4 Hz, 1H), 6.96 (d, J = 8.7 Hz,
1H), 5.79 (s, 1H), 4.46 (s,lH), 4.02 (s, 1H), 3.95 (s, 3H), 2.12-2.17 (m, 2H), 2.03-2.02
(m, 1H), 1.88 (s, 3H), 1.70-1.68 (m,lH), 0.75 (s, 9 H), -0.12 (s, 3H), -0.17 (s, 3H) ppm;
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13C NMR (75 MHz, CDCI3) 0: 191.2, 158.1, 144.9, 129.5, 128.3, 127.5, 125.8, 123.3,
110.8, 81.6, 67.8, 55.9, 25.6, 25.3, 21.7, 20.7, 18.0, -4.9, -5.1; HRMS-EI (M+) Calcd:
454.1175; Found: 454.1181.
TBSO'"
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(58,68,9R)-6-(tert-Butyl-dimethyl-siloxy)-4-methoxy-9a-methyl-5a,6,7,9a-
tetrahydro-dibenzofuran-l-carboxaldehyde (529).
Aromatic ether 528 (262 mg, 0.57 mmol, 1 equiv) was dissolved in 8 mL of distilled and
degassed toluene and the solution transferred to a Teflon-sealed Schlenk flask containing
a magnetic stirring bar. Palladium acetate (19 mg, 0.086 mmol, 0.15 equiv), silver
carbonate (474 mg, 1.73 mmol, 3 equiv), and bis-diphenylphosphinoferrocene (48 mg,
0.086 .mmol, 0.15 equiv) were added sequentially. The flask was sealed and placed in a
80°C oil bath for a period of 14 h. The flask was then cooled to 11 and the black
suspension filtered through a short column of Celite. The black solution was
concentrated under reduced pressure and the residue purified by flash column
chromatography to provide the title compound as a white solid, 175 mg, 81 % yield. Mp
89-95 °C; [a]D20 +102.4, (c 0.8, CHCI3); Rf 0.33 (hexanes-ethyl acetate, 9: 1); IR (film) v
2929, 2855, 1693, 1610, 1571, 1435 em-I; IH NMR (300 MHz, CDCI3) 0: 9.98 (s, 1H),
7.40 (d, J =8.4 Hz, 1H), 6.88 Cd, J =8.4 Hz, 1H), 6.32 (d, J =9.9 Hz, 1H), 5.60 (m, 1H),
4.48 (d, J =6.3 Hz, 1H), 4.12 (m, 1H), 3.94 (s, 3H), 2.36-2.14 (m, 2H), 1.63 (s, 3H), 0.92
(s, 9H), 0.139 (s, 3H), 0.068 (s, 3H) ppm; 13C NMR (75 MHz, CDCI3) 0: 190.2, 149.9,
147.2, 130.4, 128.9, 126.4, 122.4, 110.3,92.4, 67.5, 55.9, 48.4, 29.7, 27.0, 25.8, 25.6,
18.1, -4.8, -5.1; HRMS-EI calcd for C17H2104Si (M+-57): 317.1209, found:317.1203;
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[3aR,7as]-4-(2-azidoethyl)-2,2-dimethyl-3a,6,7,7a-tetrahydro-benzo[1,3]dioxole
(539):
(IS,2R)-3-(2-azidoethyl)-cyclohex-3-ene-l,2-diol (10.0g, 54.6 mmol) was dissolved in
2,2-DMP (33 mL, 273 mmol, 273 mmol). A catalytic amount ofpTsOH was added, and
the reaction mixture stirred at rt for 18 h until complete conversion of starting material
was observed by TLC, at which time the reaction was quenched by addition of 10 mL of
a saturated solution of sodium carbonate, and excess 2,2-DMP was removed under
reduced pressure. The resulting residue was diluted with 10 mL of distilled water and 75
mL of ethyl acetate. The layers were transferred to a separatory funnel and the aqueous
layer drained. The aqueous layer was extracted with 3 portion of 50 mL ethyl acetate,
and the combined organic portions washed with brine and dried over MgS04• Removal
of the drying agent by filtration and evaporation of the solvent gave the title compound,
which required no further purification for the subsequent transformation, (12.5 g,
quantitative). An analytical sample of the azide was obtained by Kugelrohr distillation
(175 °CI 0.03 mm Hg), which provided a clear and colorless oil. Rf: 0.6 (hexanes, ethyl
acetate; 4:1); [a]D23 +44.3 (c 1.0, CHCI3); IR (neat) 2985, 2932, 2094, 1602 em-I; IH
NMR (300 MHz, CDCI3) 0 5.73 (m, IH), 4.38-4.32 (m, 2H), 3.44 (t, J = 7.2 Hz, 2H),
2.47-2.38 (m, 2H), 2.25-2.18 (m, IH), 1.91 (m,2H), 1.74 (m, IH), 1.39 (s, 6H) ppm; 13C
NMR (75 MHz, CDCI3) 0: 132.4, 127.8, 108.5, 73.6, 73.4, 49.6, 33.6, 27.9, 26.4, 25.3,
20.7 ppm; HRMS-FAB (NBA matrix) Calcd for CIIHlSN302 (M+ +1): 224.1399, Found
224.1333.
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[3aR,7as]-4-(2-aminoethyl)-2,2-dimethyl-3a,6,7,7a-tetrahydro-benzo[1,3]dioxole
(540).
Azide 539 (10.0 g, 44.8 mmol, 1.0 equiv) was dissolved in 600 mL THF
containing 2.4 mL distilled water and transferred to a 1-L round-bottomed flask equipped
with reflux condenser. Triphenylphosphine (21.5 g, 80.6 mmol, 1.8 equiv) was added
and the solution was heated to an external temperature of 55°C for a period of 24 h, at
which time the solution was cooled to rt and the solvent removed under reduced pressure.
The residue was dissolved in 100 mL of methylene chloride and acidified with 40 mL of
1 N (aq) HCI. The layers were separated and the aqueous portion basified with 10%
(w/v) NaOH until pH of approximately 10 was attained. Thebasified aqueous portion
was extracted with methylene chloride (4 x 50 mL) and the organic layer was dried over
Na2S04 and charcoal. The resulting suspension was filtered through basic alumina to
give the title compound as a slightly pinkish oil, (6.9 g, 78% yield).
[a]D23 +23.7 (c 0.75, CHCI3); IR (neat) 3362 (broad), 2983, 2927, 1576 em-I; 1 H NMR
(300 MHz, CDCI3) b: 5.68 (m, 1H), 4.37 (m, 1H), 4.31 (m, 1H), 2.92-2.78 (m, 2H), 2.2
(m, 1H), 2.17 (m, 2H), 1.97-1.86 (m, 2H), 1.73 (m, 1H), 1.41 (s, 3H), 1.40 (s, 3H), 1.26
(bs, 2H) ppm; 13C NMR (75 MHz, CDCI3) 133.7, 126.9, 108.2, 73.6, 73.5, 40.1, 38.5,
27.9, 26.4, 25.6, 20.8 ppm; HRMS-FAB (NBA matrix) Calcd for (M+ + 1) CI1H20N02:
198.1494, Found: 198.1472.
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[3aR,7as]-4-[N-methylcarbamoyI)ethyI]-2,2-dimethyI-3a,6,7,7a-tetrahydro-
benzo[I,3]dioxole (541).
Amine 540 (2.0 g, 10.1 mmol, 1.0 equiv) was dissolved in 45 mL distilled
methylene chloride and cooled to 0 °C before addition of distilled triethylamine (2.8 mL,
20.3, 2.0 equiv). After several minutes, methyl chloroformate was added in one portion.
Mter 19 h, the solvent was removed under reduced pressure, and the residue subjected to
purification by flash column chromatography (1:1 hexanes, ethyl acetate) to furnish 541
as a faint pink oil, (1.36 g, 52% yield). Rf 0.48 (hexanes-ethyl acetate, 2:1); [a]n23 +15.2
(c 0.9, CHCI3); !R(film) v 3342, 2984, 2932, 1703, 1534 em-I; IH NMR (300 MHz,
CDCI3) 0: 5.69 (m, 1H), 4.98 (bs, 1H), 4.34 (m, 2H), 3.67 (s, 3H), 3.35 (d, J = 6 Hz, 2H),
2.41 (m, 1H), 2.25-2.16 (m, 2H), 1.96-1.88 (m, 2H), 1.85-1.81 (m, 1H), 1.41 (s, 3H), 1.39
(s, 3H) ppm; I3C NMR (75 MHz, CDCI3) B: 157.0, 133.1, 128.0, 108.3, 73.6, 73.4, 51.9,
39.3, 34.8, 27.9, 26.3, 25.6, 20.8; HRMS-EI (M+-15) Calcd for CI2HISN04: 240.1235;
Found: 240.1240.
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[3aR,7as]-4-[2-(N-methylacetamido)ethyl]-2,2-dimethyl-3a,6,7,7a-tetrahydro-
benzo[I,3]dioxole (542):
To a suspension of LAH (357mg, 9.40 mmol, 2.0 mol equiv) in 30 mL THF at 0
°C was added a solution of methyl carbamate 541 in 10 mL ether over 10 min. Upon
complete addition of the substrate, the cooling bath was removed, a reflux condenser was
attached and the reaction mixture heated to reflux until complete consumption of the
starting material (approximately 4 h). The reaction mixture was cooled to 0 °C and
excess LAH was quenched by careful addition of 350 ilL distilled water, 700 ilL 15%
(w/v) aq NaOH solution, and 1 mL distilled water. The white solid was separated from
the organic solution by filtration, and the filtrate dried over anhydrous MgS04• Removal
of the drying agent and evaporation of the solvent provided the expected amine 545 in
quantitative yield. The material was used directly in the subsequent reaction.
The crude N-methyl derivative 545 (1.2 g, 5.67 mmol, 1.0 equiv) obtained from
the procedure described above was dissolved in freshly distilled pyridine (1 mL) and
methylene chloride (2 mL) and transferred to a 50 mL round-bottomed flask under argon
atmosphere. The solution was cooled to 0 °C and freshly distilled acetic anhydride (580
ilL, 6.26 mmol, 1.1 equiv) and DMAP (138 mg, 1.13 mmol, 0.2 equiv) were added to the
solution. After 18 h, the reaction mixture was diluted with 70 mL methylene chloride
and 10 mL of 1 N aq HCI. The layers were separated and the organic solution was
washed with 10% (w/v) aq CUS04 (3 x 10 mL). The organic solution was dried over
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MgS04. Filtration of the drying agent and removal of the solvent under reduced pressure
gave 1.32 g (92%) of the amide as a pale yellow oil. The material was of sufficient purity
to be used directly in the subsequent step. An analytical sample was obtained by
purification of the title compound by flash column chromatography, eluted with 10%
MeOH in EtOAc. Rf 0.19 (100% EtOAc); [a]D23 +5.83 (c 0.55, Et20); IR (film) v 2984,
2933, 1627, 1558 cm-I; IH NMR (300 MHz, CDCI3) 3: Pair of rotamers, A and B.
Rotamer A: 5.66 (m, IH), 4.45 (m, IH), 4.3 (m, IH), 3.74 (m, IH), 3.49-3.31 (m, IH),
2.99 (s, 3H), 2.30-2.14 (m, 3H), 2.11 (s, 3H), 1.80-1.73 (m, 3H), 1.40 (s, 6H); Rotamer B:
5.66 (m, IH), 4.32 (m, 2H), 3.49-3.31 (m, 2H), 2.94 (s, 3H), 2.30-2.14 (m, 3H), 2.06 (s,
3H), 1.80-1.73 (m, 3H), 1.40 (s, 6H); I3C NMR (75 MHz, CDCI3) 3: (mixture of
rotamers A and B) 170.5, 170.4, 133.4, 132.6, 127.9, 126.7, 108.5, 108.2,74.07,73.5,
73.4,50.1, 49.5, 45.9, 36.0, 33.3, 33.2, 31.6, 27.9, 27.9, 26.4, 26.4, 25.5, 25.4, 21.9, 21.2,
20.9,20.8 HRMS-EI Calcd for CI4H23N03 (M+): 253.1677, Found: 253.1684.
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[IS,2R]-3-[2-(N-methyl)acetamidoethyl]-cyclohexa-3-ene-l,2-diol (543).
The protected diol 542 was dissolved in 2 mL of methanol and 2 mL of a solution
of 3% conc HCI in MeOH was added. The mixture was stirred at rt for 48 h and then
heated to reflux for 3 additional h. The solvent was removed under reduced pressure, and
the residue purified by flash chromatography on silica gel (CHCI3: MeOH, 9:1) to afford
the diol as a clear and colorless oil, 140 mg (45%). RfO.25 (CHCI3:MeOH, 9:1); [a]D23 -
128 (c 0.5, CHCI3); IR (film) v 3388, 2933, 1620 cm-I; IH NMR (300 MHz, CDCI3) 0:
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5.42 (t, J =3.6 Hz, 1H), 4.30-4.21 (m, 1H), 4.01 (d, J =3.9 Hz, 1H), 3.67-3.60 (dt, J =
10.8,3.9 Hz, 1H), 3.03 (s, 3H), 2.93-2.89 (m, 1H), 2.37-2.28 (m, 2H), 2.06 (s, 3H), 1.73-
1.59 (m, 2H) ppm; 13C NMR (150 MHz, CHCI3) (mixture of rotational isomers) 5: 171.7,
170.5, 134.0, 128.4, 127.8,69.9,69.6,69.4,69.0,50.3,48.0,36.1,34.3, 33.4, 33.3, 25.5,
25.3, 24.4, 23.6, 21.7, 21.2 ; HRMS-EI Calcd for CIIH19N03 (M+): 213.1364, Found:
213. 1366.
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(lR,6S)-Phenyl-carbamicacid-2-[2-(N-methyl)-acetamidoethyl]-(6-tert-
butyldimethyl-silanoxy)-cyclohexa-2-enyl ester (544).
Alcohol 543 (100 mg, 0.30 mmol, 1.0 equiv) was dissolved in 2 mL of methylene
chloride and 0.20 mL pyridine. The solution was cooled to 0 °C and phenyl isocyanate
(132 JlL, 1.2 mmol, 4.0 equiv) was added. DMAP (15 mg, 0.12 mmol, 0.4 equiv) was
transferred to the reaction flask, and the resulting solution stirred for 48 h. After 18 h, the
reaction mixture was diluted with 30 mL methylene chloride, washed with 10% (w/v) aq
solution of CUS04 (2 mL x2), H20 (2 mL x 2), and brine. The organic solution was dried
over MgS04. Filtration of the drying agent and removal of the solvent gave a crude
yellow oil, which was purified by column chromatography (CHCI3/ MeOH, 97:3) to
provide the title compound a white foam, (64 mg, 47%). Rf 0.28 (hexanes/ethyl acetate,
1:1); [a]D24 -44.8 (c 3.1, CHCI3); IR (film) v 3255,3134,2928,2856,1724, 1632, 1603,
1546 em-I; IH NMR (300 MHz, CDCI3) mixture of rotational isomers A and B 5: Isomer
A: 7.48 (m, 2H), 7.32-7.26 (m, 2H), 7.08-7.03 (m, 1H), 5.73 (m, 1H), 5.32 (d, J =3 Hz,
1H); 4.06-4.02 (m, 1H), 3.92 (m, 1H), 3.39 (t, J = 7.8 Hz, 1H), 3.10 (m, 1H), 2.97 (s,
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3H), 2.31-2.24 (m, 2H), 2.13 (s, 3H), 2.13-2.04 (m, 2H), 1.78-1.70 (m, 2H), 0.86 (s, 9H),
0.095 (s, 6H); Isomer B: 7.48 (m, 2H), 7.32-7.26 (m, 2H), 7.08-7.03 (m, 1H), 5.65 (s,
1H), 5.27 (s, 1H), 4.06-4.02 (m, 1H), 3.92 (m, 1H), 3.39 (t, J =7.8 Hz, 1H), 3.10 (m,
1H), 2.90 (8, 3H), 2.31-2.24 (m, 2H), 2.13-2.04 (m, 2H), 2.09 (s, 3H), 1.70 (m, 2H), 0.86
(s, 9H), 0.077 (s, 6H) ppm; 13C NMR (75 MHz, CDCI3) mixture of indistinguishable
rotational isomers A and B 0:170.7, 170.3, 153.9, 153.7, 138.5, 138.0, 132.0,131.8,
130.8, 130.2, 128.9, 128.8, 128.2, 123.3, 122.9, 118.6, 77.2, 72.4, 71.2, 69.3, 68.7, 68.1,
60.3,50.4, 47.1, 50.4, 47.1, 36.1, 33.4, 33.0, 31.8, 26.8, 26.4, 25.7, 25.7, 24.2, 22.9, 21.9,
21.2, 18.1, -4.86, -4.99, -5.05.
NMeAe
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(IR,6S)-Aceticacid-6-acetoxyl-2-[2-acetyl-methyl-amino)-ethyl]-cyclohex-2-enyl
ester (14).
Protected diol 542 (1.22 g, 5.78 mmol, 1.0 equiv) was dissolved in 15 mL of methanol,
and 5 drops of 37% aq HCI was added. After 19 h, the solvent was removed under
reduced pressure, and the flask containing the resulting brown residue was then cooled to
o °C. Pyridine (5 mL), which had previously been pre-cooled to 0 °c, was added
followed by acetic anhydride (2.7 mL, 28.9 mmol, 5 equiv) in 2 mL methylene chloride.
Finally, DMAP (140 mg, 1.15 mmol, 0.2 equiv) was added. Mter 4 h, the reaction
mixture diluted with 50 mL chloroform, and the organic layer washed with 10% (w/v) aq
CUS04 (10 mL x 4) and 1 N HCI (10 mL). The organic portion was dried over anhydrous
MgS04. Removal of the solvent under reduced pressure gave a brown oil, which was
purified by passing through a column of silica gel and eluted with chloroform! methanol
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(95:5) to provide a clear and colorless oil, 755 mg (44% yield over two steps). Rf 0.26
(CHCI3, MeOH, 9:1); [a]n24 -102 (c 0.5, CHCI3); IR (film) v 3457, 2934, 1739, 1644, cm-
1; 1H NMR (300 MHz, CDCI3) 0: mixture of rotational isomers A and B: Isomer A: 5.76
(s, IH), 5.54 (s, IH), 5.01 (m, IH), 3.54 (m, IH), 3.34 (m, IH), 2.98 (s, 3H), 2.26~2.17
(m, 4H), 2.13-2.10 (m, 9H), 1.91 (m, IH), 1.61 (m, IH); Isomer B: 5.76 (s, IH), 5.54 (s,
IH), 5.01 (m, IH); 3.36-3.29 (m, 2H), 2.92 (s, 3H), 2.26-2.17 (m, 4H), 2.13-2.10 (m,
9H), 1.91 (m, IH), 1.61 (m, IH); 13C NMR (75 MHz, CDCI3) 0: (mixture of rotational
isomers) 170.7, 170.3, 170.2, 131.5, 130.6, 130.3, 129.0, 76.6, 73.4, 70.2, 69.8, 67.6,
67.6, 49.8, 46.6, 36.4, 33.2, 32.9, 31.5, 22.3, 22.2, 21.8, 21.1; HRMS-EI Calcd for
C1sH23NOs (M+): 297.1576, Found: 297.1583.
o
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(38,78)-4-(2-Acetoxy-ethyl)-2-hydroxy-2-phenyl-2,3,3a,6,7,7a-hexahydro-
benzofuran -3-carboxylic acid methyl ester (550a or 550b).
To a solution of triacetate 549 in 1 mL THF was added PPh3 (20 mg, 0.3 equiv, 0.075
mmol) and Pd(PPh3)4 (18 mg, 0.015 mmol, 0.06 equiv), and the resulting mixture stirred
at rt for 30 min. In a separate flask, ~-ketoester 533 (156 mg, 0.88 mmol, 3.5 equiv) was
added to a suspension of NaH (15 mg, 0.63 mmol, 2.5 equiv) in 2 mL of THF at rt. After
10 min, the resulting clear solution was transferred to the former mixture in a single
portion. The combined reaction mixture was heated to reflux for 20 h, after which time
the reaction mixture allowed to cool to rt, and the solvent was removed under reduced
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pressure. The residue was submitted to purification by column chromatography; elution
with gave the title compound as a clear oil, 29 mg (27%). Rf 0.38 (hexanes-ethyl
acetate, 9: 1); [a]D23 +161 (c 1.0, CHCI3); IR (film) v 3436 (broad), 3019, 1732, 1690,
1215 cm-I; IH NMR (300 MHz, CDCI3) 0: 7.75 (m, 2H), 7.41-7.34 (m, 3H), 5.95 (d, J =
5.4 Hz, IH), 4.80 (d, J= 8.4, IH), 4.36-4.28 (m, IH), 4.24-4.16 (m, IH), 3.67 (s, 3H),
3.22-3.14 (ddd, J = 13.3, 8.4, 4.5 Hz, IH), 2.59-2.52 (m, 2H), 2.14-2.09 (m, 2H), 2.09 (s,
3H), 1.98-1.89 (m, IH), 1.38-1.30 (m, IH); I3C NMR (75 MHz, CDCI3) 0: 171.0, 165.8,
165.4, 130.7, 130.3, 130.2, 129.3, 127.6, 107.9, 80.0, 62.8, 50.8, 42.2, 33.5, 25.1, 23.1,
20.9; HRMS-EI (M+) Calcd for CI2H220S: 342.1452; Found: 342.1469; Anal. calcd for
C12H220S: C, 70.16; H, 6.48; found: C, 69.70; H, 6.55.
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